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Introduction and Outline 
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Introduction and Outline 
Oral cancer is the sixth most common cancer in the world. It accounts for approximately 
4% of all cancers and 2% of all cancer deaths worldwide. Malignant tumors of the oral 
cavity account for approximately 30% of all head and neck cancers. With an incidence rate 
of invasive lip and oral cavity tumors in The Netherlands rising to 6.6%, oral cancer is a 
common malignancy that often requires resection of the tumor followed by reconstruction 
(1 ,2). 
In oral reconstruction, availability of mucosa is extremely restricted. Large intraoral 
defects are ideally reconstructed using like-with-like principles, with non-keratinizing, thin, 
pliable and well-vascularized tissue without significant wound contraction. Unfortunately 
mucosa is scarce and can only be reconstructed using skin using free or pedicled skin or 
musculocutaneous flaps from arm or leg. These techniques are well-established and 
successful. However, they have drawbacks such as donor site defects, bulkiness, sweating 
and hair bearing of the flaps (3-5). Therefore, a demand exists for further refinement using 
thin, non-keratinizing mucosa. 
In order to develop thin mucosal flaps, tissue engineering strategies were explored for 
expanding mucosa in vitro. Techniques are based on the Rheinwald and Green technique for 
culturing keratinocyte sheaths of keratinizing keratinocytes from skin on a feeder layer of 
lethally irradiated fibroblasts. This technique grows 1m2 of keratinocyte sheath from 1 cm2 
biopsied skin within 3 weeks (6) and is used to produce keratinizing skin substitutes for 
treatment of e.g. large burns. Similar to burns tissue is scarce in mucosal reconstruction. 
Using tissue engineering strategies, it proved possible to take a small biopsy of mucosa, 
isolate and culture keratinocytes and fibroblasts in vitro, seed them onto a dermal carrier 
and produce a Cultured Mucosal Substitute (CMS) to reconstruct the defect. The protocol 
takes approximately 4 weeks to produce a CMS from biopsy to a graft with a multi-layered, 
differentiated epidermis and has been tested clinically. 
The first clinical trials used collagen gels and membranes as dermal carriers and 
reported significant contraction of the CMS as a challenging problem (7-9). Other problems 
include infection, variable graft take (1 0) and high production costs. A number of problems 
can possibly be reduced by further in vitro and in vivo optimisation of protocols. 
In design and optimisation of protocols of CMS, a number of in vitro conditions have to 
be met for successful transplantation (table 1) . The choice of the dermal carrier is one of 
the key decisions to take in design of a CMS. Protocols should minimise culturing times using 
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optimised isolation protocols and culture media. Furthermore, culturing protocol must be 
robust with minimum variability in outcome and infection rates. After transplantation, goals 
are achievement of maximum take and survival. The constructs must be easy to handle and 
easy to suture in place by the surgeon. After grafting, hypoxia occurs as CMS is a-vascular. 
The first days after transplantation of a CMS cells are supported by plasmic imbibition and 
diffusion of nutrients and oxygen to the cells. During these first days after transplantation 
grafts are under hypoxic conditions until vasculature invaded the CMS from the wound 
bed by means of angiogenesis. The process of angiogenesis should be optimized. Finally, 
contraction of the CMS should be minimized and, as a vast majority of patients receive post-
operative radiotherapy, it should have reduced radiosensitivity. 
Table 1: Determinants of successful culturing and clinical application of CMS 
Factors for success 
In vitro Isolation protocol - Straight-forward surgical protocol 
- Communication between laboratory and surgeon 
- Planning of isolation before reconstructive procedure 
- Bacterial and fungal contamination rates 
- Fibroblast contamination 
- Cells/ cm2 biopsy 
- % stem cells/ cm2 biopsy 
Costs - Culture time 
- Isolation protocol 
- Technical difficulty protocol 
- % of successfully produced CMS 
- Infection rates 
In Vivo Surgery - Communication between laboratory and surgeon 
- Logistics, e.g. transportation to OR 
- Mechanical properties, handling of CMS for surgeon 
- Resistance of CMS to handling by the surgeon 
- Straight-forward surgical protocol 
-Straight-forward wound protocol for surgical and nursing staff 
Graft take - Angiogenesis 
- Resistance to hypoxia 
- Resistance to shearing forces 
- Susceptibility to Infection 
Long term - Wound contraction 
- Resistance to radiation 
- Impairment of intra-oral functions such as speech 
As mentioned, the choice of a dermal carrier is important for successful culturing and 
grafting. Dermal carriers reduce wound contraction and blistering compared to the use of 
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keratinocyte sheets alone. Various types of carriers are available and, such as collagen gels 
and acellularized, immunoligically inert, cadaver skin. To date, clinically used CMS were 
prepared using collagen gels. Clinical application of collagen gels, however is limited due to 
a number of problems. A collagen gel is mechanically weak; it cannot be sutured in place, 
in particular in the oral cavity where the tongue as well as the cheek is constantly moving. 
Secondly, a collagen gel contracts more than other dermal scaffolds, and is therefore less 
feasible for transplantation. On the other hand, cadaver skin that is acellularized and 
therefore immunologically inert, is commercially available as Alloderm® and clinically 
approved. Acellularisation is achieved by removal of the epidermis and subsequent radiation 
or soap treatment. Importantly, the basement membrane proteins remain present at the 
basal membrane site of the dermo-epidermal junction (DEJ), as well as in the remnants 
of the vascular basal membranes. This facilitates in vitro keratinocyte attachment and 
migration e.g. in wound margins (11, 12). Furthermore, the DEJ is responsible for resistance 
to shear forces that could separate the epidermis from the dermis, resulting in blister 
formation. Also, endothelial cells invade the dermis using basement membrane proteins at 
the remnants of capillaries as guides (13). 
Traditionally, acellularized cadaver skin is used for CMS in cultures without the 
supplementation of fibroblasts to the dermis. However, fibroblasts have various beneficial 
effects on the quality of CMS both in vitro as well as in vivo. Abdoel el Ghalbzouri, (LUMC 
Leiden, the Netherlands) developed a technique to centrifuge fibroblasts into a-cellular 
dermis (14). A clear improvement of epidermal morphology and a better formation of 
the DEJ as a result of the incorporation of fibroblasts in skin substitutes were seen using 
keratinizing skin keratinocytes. Moreover, fibroblasts made the addition of growth factors, 
such as Keratinocyte Growth Factor (KGF) and Epidermal Growth Factor (EGF) unnecessary 
(14, 15). In addition, in vivo studies have shown that fibroblasts enhance angiogenesis (16). 
Clinical reports in patients with extensive skin loss, such as in burns, report reduced wound 
contraction and enhanced wound healing upon the addition of fibroblasts to a dermal matrix 
(16-18). These results suggest that incorporation of fibroblasts in non-keratinizing mucosal 
substitutes might lead to important improvement of the quality and clinical performance of 
CMS. 
For clinical performance the behavior of CMS in hypoxia and its resistance to 
radiotherapy need to be studied. It has been demonstrated that epidermal hypoxia occurs 
frequently under physiological conditions (19). For example, wound margins become hypoxic 
immediately after wounding due to a reduced dermal blood supply by intravascular cloth 
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formation (20). Upon transplantation the a-vascular CMS becomes hypoxic as oxygen has 
to diffuse from woundbed to the cells. Semi- occlusive dressings render oxygen levels to 
a minimum in anticipation of angiogenesis to provide new vasculature with oxygen and 
nutrients. 
Hypoxia has a number of well-documented effects on cells and tissues. It enhances the 
secretion of survival enhancing factors such as Hypoxia Inducible Factor 1 (HIF-1 ), which 
in turn induces the secretion of angiogenic factors, such as VEGF i-NOS and PDGF-B(21) 
(22). Furthermore, hypoxia induces metabolic changes enhancing production of glycolytic 
enzymes favouring anaerobic glycolysis and cell survival (23,24). The effect of hypoxia in 
vitro on cell morphology, proliferation, survival and growth factor secretion is not known. 
Resistance or response of CMS to radiation therapy is another important clinically 
relevant issue as the vast majority of patients receive post-operative radiotherapy. In order 
to radiate this tissue, as a side effect, healthy mucosa is also irradiated. A major side effect 
of radiation therapy is oral mucositis. Clinical symptoms may vary from a mild erythema to 
severe, extremely painful ulcers in the mouth resulting in malnutrition and placement of a 
feeding tube (25). Incidences of 60% in patients receiving radiotherapy have been reported. 
For quite a few of these patients it requires breaks in therapy for periods up to several days 
or weeks and pain relief using morphine (26). This allows the defects to heal, while on the 
other hand oncological therapy is compromised and tumor cells can repopulate (27). Also, 
long term effects of radiation therapy, e.g. osteoradionecrosis, mucosal atrophy are related 
to the severity of the acute radiation response (28,29) 
The aim of this thesis was to develop, improve and test a Cultured Mucosal Substitute as a 
step towards clinical application, to take a step from lab bench towards bedside. 
Goals were to: 
Study the performance of current reconstructive techniques to identify possible issues 
that can be improved and challenges that the CMS will meet upon transplantation. 
Choose an optimal isolation protocol. 
Choose an optimal design of the CMS by choosing a dermal carrier and decide on the cell 
types included. 
Test our constructs behavior in vitro to clinically relevant environments and conditions 
such as hypoxia and gamma irradiation. 
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Various goals are discussed into detail in subsequent chapters of this thesis; Chapter 2 
reports functional and quality of life outcomes of the use of Free Radial Forearm Flaps, 
a commonly used flap in reconstruction of oral defects in the Erasmus Medical Centre 
in Rotterdam. The advantages and shortcomings of these reconstructions with skin flaps 
replacing mucosa are reported. 
An overview of techniques and Tissue Engineering strategies are discussed into further 
detail in chapter 3 of this thesis. 
Chapter 4 describes the comparison of two widely used techniques for keratinocyte 
isolation using histology and cell size analysis to minimize culture time of keratinocytes and 
our CMS. 
In chapter 5 the effect in vitro of adding fibroblast to the CMS is decribed in order 
to enhance morhphology and performance while once again reduce production times. Cell 
morphology, cell differentiation, proliferation and apoptosis were studied. 
Chapter 6 describes the effect of hypoxia on epidermal morphology, proliferation and 
apoptosis, as well as secretion of angiogenic growth factors in CMS. 
Chapter 7 describes the effect of radiation on CMS in vitro, and the development and 
validation of a quantitative model for damage to CMS in vitro. Gross morphology as well as 
various markers for DNA damage and DNA repair were used. 
Finally, in chapter 8, results are summarized and discussed with special focus on future 
directions of the (clinical) use of CMS in reconstructive procedures. 
Introduction and Outline 
References 
1. www.cbs.nl. 
2. www.baoms.org.uk. 
3. Badran, D., Soutar, D.S., Robertson, A.G., Reid, 0., Milne, E.W., McDonald, S.W., and Scothorne, R.J. 
Behavior of radial forearm skin flaps transplanted into the oral cavity. Clin A nat 11, 379, 1998. 
4. Beahm, E.K., Evans, G.R., and Colome-Grimmer, M.l. Histologic changes of intraoral free skin flaps. Am 
J Surg 174, 492, 1997. 
5. Rhemrev, R., Rakhorst, H.A., Zuidam, J.M., Mureau, M.A., Hovius, S.E., and Hofer, S.O. Long-term 
functional outcome and satisfaction after radial forearm free flap reconstructions of intraoral malignancy 
resections. J Plast Reconstr Aesthet Surg 60, 588, 2007. 
6. Rheinwald, J.G. Cell Growth and Division, a practical approach. Oxford: IRL Press, 1989. 
7. Lauer, G., Schimming, R., Gellrich, N.C., and Schmelzeisen, R. Prelaminating the fascial radial forearm 
flap by using tissue-engineered mucosa: improvement of donor and recipient sites. Plast Reconstr Surg 
108, 1564,2001. 
8. Lauer, G., and Schimming, R. Tissue-engineered mucosa graft for reconstruction of the intraoral lining 
after freeing of the tongue: a clinical and immunohistologic study. J Oral Maxillofac Surg 59, 169, 
2001. 
9. Lauer, G., and Schimming, R. [Clinical application of tissue-engineered autologous oral mucosa 
transplants]. Mund Kiefer Gesichtschir 6, 379, 2002. 
10. Sheridan, R.L., Morgan, J.R., Cusick, J.L., Petras, L.M., Lydon, M.M., and Tompkins, R.G. Initial 
experience with a composite autologous skin substitute. Burns 27, 421, 2001. 
11. Martin, P. Wound healing--aiming for perfect skin regeneration. Science 276, 75, 1997. 
12. Ralston, D.R., Layton, C., Dalley, A.J., Boyce, S.G., Freedlander, E., and Mac Neil, S. The requirement 
for basement membrane antigens in the production of human epidermal/ dermal composites in vitro. Br 
J Dermatol 140, 605, 1999. 
13. Demarchez, M., Hartmann, D.J., Regnier, M., and Asselineau, D. The role of fibroblasts in dermal 
vascularization and remodeling of reconstructed human skin after transplantation onto the nude mouse. 
Transplantation 54, 317, 1992. 
14. El Ghalbzouri, A., Lamme, E., and Ponec, M. Crucial role of fibroblasts in regulating epidermal 
morphogenesis. Cell Tissue Res 310, 189, 2002. 
15. el-Ghalbzouri, A., Gibbs, S., Lamme, E., Van Blitterswijk, C.A., and Ponec, M. Effect of fibroblasts on 
epidermal regeneration. Br J Dermatol 147, 230, 2002. 
16. Erdag, G., and Sheridan, R.L. Fibroblasts improve performance of cultured composite skin substitutes 
on athymic mice. Burns 30, 322, 2004. 
17. Lamme, E.N., Van Leeuwen, R.T., Brandsma, K., Van Marte, J., and Middelkoop, E. Higher numbers of 
autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar 
tissue formation. J Patho/190, 595, 2000. 
18. Wang, H.J., Pieper, J., Schotel, R., van Blitterswijk, C.A., and Lamme, E.N. Stimulation of skin repair is 
dependent on fibroblast source and presence of extracellular matrix. Tissue Eng 10, 1054, 2004. 
19. Evans, S.M., Schrlau, A. E., Chalian, A.A., Zhang, P., and Koch, C.J. Oxygen levels in normal and previously 
irradiated human skin as assessed by EFS binding. J Invest Dermatol 126, 2596, 2006. 
20. Chang, N., Goodson, W.H., 3rd, Gottrup, F., and Hunt, T.K. Direct measurement of wound and tissue 
oxygen tension in postoperative patients. Ann Surg 197, 470, 1983. 
21. Pugh, C.W., and Ratcliffe, P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 
9, 677, 2003. 
22. Szpaderska, A.M., Walsh, C.G., Steinberg, M.J., and DiPietro, L.A. Distinct patterns of angiogenesis in 
oral and skin wounds. J Dent Res 84, 309, 2005. 
Chapter1 ------------------------------------------------------------
23. Vaupel, P. The role of hypoxia-induced factors in tumor progression. Oncologist 9 Suppl5, 10, 2004. 
24. Vaupel, P., and Harrison, L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular 
response. Oncologist 9 Suppl 5, 4, 2004. 
25. Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., Komaroff, E., Nalysnyk, 
L., and Zilberberg, M.D. Mucositis incidence, severity and associated outcomes in patients with head 
and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. 
Radiother Oneal 66, 253, 2003. 
26. Van der Schueren, E., Van den Bogaert, W., Vanuytsel, L., and Van Limbergen, E. Radiotherapy by 
multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. lnt J 
Radiat Oneal Bioi Phys 19, 301, 1990. 
27. Barton, M.B., Keane, T.J., Gadalla, T., and Maki, E. The effect of treatment time and treatment 
interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oneal 23, 
137, 1992. 
28. Dorr, W., and Hendry, J.H. Consequential late effects in normal tissues. Radiother Oneal 61, 223, 
2001. 
29. Dorr, W. Modulation of repopulation processes in oral mucosa: experimental results. lnt J Radiat Biol79, 
531, 2003. 
Long-term Functional Outcome and 
Satisfaction after Radial Forearm Free Flap 
Reconstructions of Intraoral Malignancy 
Resections 
Rhose Rhemrev; Hinne A. Rakhorst; J. Michie! Zuidam; 
Steven E.R. Hovius; Stefan O.P. Hofer 
Department of Plastic and Reconstructive Surgery, Erasmus University Medical 
Center Rotterdam, Rotterdam, The Netherlands 
J Plast Reconstr Aesthet Surg(2007) 60(6) 588-92 
Chapter2------------------------------------------------------------
Abstract 
Purpose: Evaluation of objective and subjective functional follow-up results of intraoral 
radial forearm free flap reconstructions. 
Methods: A total of 149 patients had received radial forearm free flaps between January 
1996 and December 2005. Seventy-two patients completed an EORTC H&N35 questionnaire 
in the follow-up study. Patients were divided according to location of defect (anterior 
or posterior) or irradiation. Thirty-nine patients with anterior positioned flaps received 
standardized physical examinations. 
Results: Flap survival was 99.3%. Complications were divided in early (< 2 weeks; 23%) 
and late complications (20%). Most common complications were dehiscence or fistula, 
responding well to conservative treatment. Analysis of questionnaire subscales showed 
no statistically significant differences between anterior and posterior defects. Irradiation 
showed significant impairment for the ability to smell and taste. No important donor site 
impairment was found. 
Conclusion: The radial forearm free flap is an adequate method for reconstructions after 
resection of intraoral malignancies. Subjective functional outcome seemed to be defined 
by adjuvant radiotherapy, patient coping, and to a lesser extent flap bulk for anterior 
defects. 
Keywords: radial forearm free flap, head and neck cancer, quality of life, microsurgery 
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Introduction 
Radial forearm free flaps for intraoral reconstructions have been investigated extensively (1 )-
Versatility of the radial forearm free flap in combination with low flap loss and complication 
rates traditionally have been the most important factors for choosing this flap to restore 
inner lining if no bulk was needed(2). In contrast, others have emphasized the benefit of 
radial forearm free flap bulk, which is necessary for swallowing after partial glossectomy or 
soft palate reconstruction(3). 
Over the years, however, the classic radial forearm free flap for intraoral reconstruction 
has been under scrutiny due to newer flaps (4,5). Concerns with the radial forearm free 
flap consisted of excessive flap bulkiness due to replacement of very thin oral mucosa 
by skin and subcutaneous tissue, or insufficient bulk when reconstructing large defects of 
the area involved with deglutition. To overcome excessive bulkiness, efforts have been 
made to decrease flap thickness by applying oral mucosa to fascial forearm flaps without 
the skin component (6). To overcome insufficient bulk, alternate donor sites have been 
investigated (4,5). Donor site concerns consisted of the need to sacrifice the radial artery, 
decreased sensation in the course of the superficial radial nerve, decreased overall function 
of the hand and an unsightly donor site scar. A few studies have addressed these issues, 
generally showing acceptable cosmesis and normal function, especially after suprafascial 
radial forearm flap harvest (7,8). 
In literature, emphasis exists on technical refinements of reconstructive procedures to 
optimize functional results; however, little has been published on long-term subjective 
or objective functional outcome and associated quality of life with respect to individual 
reconstructive techniques (9, 10). 
The purpose of the current study was to evaluate perioperative flap complications, as well 
as oral functional outcomes and quality of life in patients who had radial forearm free flap 
reconstructions after resection of intraoral malignancies. In this fashion, the validity of its 
continuing use in head and neck reconstruction was evaluated. 
Patients and methods 
Patient and Tumor Characteristics 
A database search resulted in 149 patients who had received a radial forearm free flap for 
intraoral reconstruction after resection of an intraoral malignancy between January 1996 and 
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December 2005. Medical files were used to retrospectively retrieve patient characteristics, 
medical history, surgical data, and complications. Tumor characteristics are presented in 
table 1. The group consisted of 86 male and 63 female patients with an average age at 
time of operation of 58 ± 11 years (± SD; range 22 to 82 years). Risk factors in this group 
consisted mainly of smoking (59%), alcohol abuse (26%), cardiovascular impairment (28%), 
and pulmonary impairment (9%). In 52 patients (35%) more than one of these risk factors was 
present. The entire group of 149 patients was evaluated for perioperative complications. 
Follow-up Study Population Characteristics 
Since 64 of 149 patients had died, 85 patients were potentially available for inclusion 
in the follow-up study. Thirteen patients either declined to participate or were no longer 
traceable. The follow-up study group, therefore, consisted of 72 patients (44 male, 28 
female) with a mean age of 57± 11 years (± SD; range 33 to 79 yrs). Patients were divided 
into two groups according to the location of the defect. Group I with a tumor located at the 
floor of mouth and/or mobile tongue consisted of 39 patients (25 male and 14 female) with 
a mean age of 57± 12 years(± SD; range 33 to 78 yrs). Group II with a tumor location in the 
posterior oral cavity consisted of 33 patients (19 male and 14 female) with a mean age of 
58± 9 years(± SD; range 41 to 71 yrs). Risk factors in the follow-up study group consisted of 
smoking (I, 51%; II, 58%), alcohol abuse (I, 18%; II, 9%), cardiovascular impairment (I, 31%; 
II, 36%), and pulmonary impairment (I, 8%; II, 12%). In 33% of patients in each group more 
than one of these risk factors was present. Radiotherapy had been used as adjuvant therapy 
in 79% of patients included in the study (79% in group I and 79% in group II). 
To rule out a possible selection bias, several patient characteristics (age, sex, location 
of defect, flap size, radiotherapy, and postoperative complications) between 72 responders 
and 77 non-responders were compared. Chi-square and Fisher's exact tests, Mann-Whitney U 
tests and Student's t-tests did not reveal statistically significant differences (p-values > .05; 
data not shown) between-responders and non-responders, so we presume that participants 
are representative of the total group. 
Procedure 
All patients (n = 85) were invited by a letter explaining the study and asking them to 
participate after approval of the ethical committee of the local research institution. An 
EORTC HEtN35 questionnaire was sent, which they were requested to complete and return 
by means of a stamped envelope. The questionnaire was returned by 72 patients (85%). 
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All patients (n=39) in group I also visited the outpatient clinic. During this visit, a standardized 
physical examination of the oral cavity was performed. Patients with a radial forearm free 
flap reconstruction of the posterior part of the oral cavity (group II) were not invited to 
the outpatient clinic since it was felt that reliable inspection of these flaps would be too 
invasive and add no further information to that given in the questionnaire. 
Tablet: Tumour characteristics and staging in study group patients 
Tumour characteristics 
Tumour type 
Squamous cell carcinoma 
Adenoid cystic carcinoma 
Carcinoma in situ 
Muco-epidermoi"d carcinoma2 
Adenocarcinoma 
Undifferentiated carcinoma 
Osteosarcoma 
Tumour stage classification) 
0 
T na0 
N 64 
M 139 
•na, not applicable. 
4 
27 
0 
No. of Patients 
139 
2 
2 
2 
60 
46 
na 
2 
3 
57 
3 
na 
Follow-up Study of Functional Outcome and Satisfaction 
4 
20 
na 
na 
X 
8 
8 
10 
Differences in functional outcome and satisfaction were studied between group I and II, 
as well as between irradiated and non-irradiated patients. Subjective functional outcome 
and patient satisfaction after radial forearm free flap reconstruction in the oral cavity 
were studied by using the EORTC H&N 35 questionnaire. This questionnaire was specifically 
designed for patients with a malignancy of the head and neck region (11 ). It is a validated 
instrument for measuring functional outcome and satisfaction, which assesses symptoms 
directly related to site of reconstruction. It also comprises items concerning side effects of 
treatment, social function, body image, and sexuality. Results are given on a scale from 0 
(no limitations) to 100 (severe limitations). A change of 10 units on these response scales 
have been regarded as clinically important(11 ). Functional outcome and satisfaction were 
evaluated in general as well as in relationship to various risk factors. 
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Standardized physical examination of the oral cavity was performed by an independent 
investigator to prevent inter-observer bias. Flap appearance and consistency, and tongue 
mobility were assessed. Sensitivity was tested with static and moving two-point discrimination 
using a previously developed set of intraoral two-point discriminators (12). 
Statistical Analysis 
Chi-square tests, Fisher's exact tests, Mann-Whitney U tests, and Student's t-tests were 
used. Two-tailed p-values :.:;. .05 were accepted as statistically significant. 
Results 
Medical Data 
Patient characteristics 
Defects that were reconstructed with radial forearm free flaps were located in the anterior 
floor of the mouth and/or mobile tongue in 90 cases, and in the posterior part of the oral 
cavity in 52 cases. The remaining 7 defects were located on the inner cheek (Table 2). 
In 10 cases an osteocutaneous radial forearm free flap was used because of a segmental 
mandibular defect. The superior thyroid (54%) or facial (25%) arteries were mainly chosen 
as recipient vessels. Venous anastomoses were mainly made to the internal jugular (67%) 
or superior thyroid (12%) veins. Total operating theatre time for the combined ablative 
and reconstructive operation was on average 11.4 hours ± x (± SD; range 6 to 18 hours). 
Donor site closure was originally by split thickness skin graft exclusively, but changed to 
full thickness graft V-to-Y transposition (8) in most defects during the second half of the 
study period because of surgeon preference. Postoperative radiotherapy of 66 or 70 Gy was 
administered to 108 patients (72%) according to the protocol of the multidisciplinary head 
and neck team of our hospital. 
Post-operative complications 
Post-operative complications were divided into early (within two weeks) and late 
complications. Eighty-nine patients (60%) had an uneventful postoperative course. Critical 
review showed early complications in 34 patients (23%) and late complications in 30 patients 
(20%). One patient had insufficient perfusion of the hand requiring intraoperative placement 
of an interposition vein graft. Twelve patients (8%) required re-operation within 24 hours 
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because of compromised flap vascularization. In five patients venous thrombosis was found 
and in four patients both the artery and vein were occluded, which prompted microvascular 
revision resulting in one partial and one total flap necrosis. Persistent post-operative 
bleeding and/ or hematoma compromising flap vascularization required re-operation in 
the remaining three cases. Overall flap survival was 99.3%, with one total flap loss. Other 
early complications were partial wound dehiscence and/or fistula formation (n = 17) and 
hematoma (n = 3), which responded well to conservative treatment. Late complications 
consisted of mandibular osteoradionecrosis requiring further reconstructive surgery with 
fibula free flaps (n = 3) and one neck abscess which had to be drained. One patient required 
removal of infected internal fixation material. Late complications, responding well to 
conservative treatment, were dehiscence and/or fistula formation (n = 16). In one case a 
permanent tracheostomy was necessary. 
Table 2: Tumour location in study group patients 
Tumour Location 
Anterior 
Floor of mouth 
Mobile tongue 
Floor of mouth combined with tongue 
Posterior 
Tonsil 
Soft palate 
Retromolar trigonum 
Posterior alveolus 
Pharyngeal waLL• 
Base of tongue 
Other 
Inner cheek 
No. of Patients 
41 
38 
11 
21 
9 
8 
5 
6 
3 
7 
•combined with one or more of the above mentioned structures. 
Subjective Follow-up Results of Functional Outcome and Satisfaction 
The average follow-up was 43 ± 27 months (± SD; range 2 to 120 months). Analysis of the 
EORTC H&N35 questionnaires resulted in the following individual results of oral function. 
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Speech 
No difference in mean speech impairment between groups I (38 ± SD 26) and II (28 ± SD 
21) with different defect locations were seen (Mann-Whitney U test; p>0.05). Speech scale 
scores around 30 indicate moderate speech problems. 
Mastication and swallowing 
No statistically significant differences were found between the mean scores for 'swallowing' 
in groups I (30 ± SD 32) and II (28 ± SD 23) (Mann-Whitney U test; p>0.05). The scores of two 
other items of importance for mastication 'dry mouth' and 'sticky saliva' also showed no 
significant differences. 
Effect of postoperative radiotherapy 
Postoperative radiotherapy was administered to 57 of 72 patients (31 in group I, 26 in 
group II). In 15 patients no radiotherapy was necessary (8 in group I, 7 in group II). EORTC 
HEtN35 questionnaires showed a statistically significant difference for the subscale 'senses' 
(problems with smelling and tasting), which scored worse in the irradiated group (mean 31 
± SD 29) versus the non-irradiated group (mean 13 ± SD 22) (Mann-Whitney U test p<0,05). 
The subscale 'speech' scored worse in irradiated patients (mean 36 ± SD 24 versus mean 
12 ± SD 24), however, only a trend was seen since no statistical significance was reached 
(Mann-Whitney U test; p=0.07). 
EORTC HEtN35 questionnaires did not show significant correlations between dysfunction 
and follow-up time since their reconstruction. In addition, no significant relationships 
between known risk factors and functional outcome were found in the study group (data 
not shown). 
Objective Data 
Physical examination 
Intraoral inspection in 27 of 39 patients from the group with anterior defects showed the 
flap had blended into the surrounding mucosa. Ten of 39 patients had a bulky flap for that 
anterior location. These bulky flaps seemed to further decrease tongue mobility. Moving 
two-point discrimination reflected protective sensitivity in 24 patients, but was larger than 
12 mm in all patients. No reproducible data were obtainable in 8 patients. Three patients 
had hypersensitivity in their flaps causing a burning intraoral sensation. 
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Donor site outcome 
All donor sites have been extensively investigated previously. There was no decline in range 
of motion of wrist and fingers. Grip strengths were within normal range in accordance to 
age (8). 
Discussion 
The current study presents perioperative flap complications as well as objective and subjective 
oral functional outcomes in patients who had a radial forearm free flap reconstruction 
after resection of intraoral malignancies over a 1 0-year period. The radial forearm free flap 
was investigated to validate its continuing use in head and neck reconstruction. The radial 
forearm free flap has not been fully embraced by all reconstructive surgeons mainly due to 
the perceived donor site limitations, but also due to excessive or limited bulk for specific 
indications. Alternative flaps such as the lateral arm flap or the anterolateral thigh flap have 
been proposed as workhorse flaps (4,5). 
In this study almost two-thirds of the defects were located in the anterior part of the 
oral cavity (i.e. floor of the mouth, mobile tongue) and one third was used for posterior 
oral cavity reconstruction. Microsurgery related complications were very low with the need 
to reoperate due to arterial and/or venous thrombosis in 6% of cases leading to an overall 
flap survival rate of 99.3% (13, 14). This indicates that the radial forearm free flap is a 
reliable and safe flap to perform. Postoperative complications like dehiscences, fistulas, 
and hematomas were well within the range of previously reported data using different flaps 
for head and neck reconstruction (15, 16). Donor site complications had been thoroughly 
investigated in part of this group previously and shown no serious problems (8). 
The EORTC H8:N 35 questionnaire was used to evaluate subjective functional outcome 
and satisfaction of the study population, since reported validity and reliability are adequate 
and the various subscales are highly sensitive to difference within and between groups 
of patients (11 ). This is different from previous reports, which have mentioned objective 
functional outcome results in small groups for speech, deglutition, and swallowing as 
evaluated by videofluoroscopy (17). In our experience these objective results often do not 
match subjective satisfaction. We hypothesized that the group with anterior defects would 
have more speech problems and that the group with the posterior defects would have more 
swallowing problems. Both groups scored moderate impairment of speech and swallowing, 
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however, no significant differences were found. The lack of statistically significant differences 
most likely was caused by difference in individual coping of patients with their situation. 
This has been pointed out previously as well from patient data where defects and objective 
outcome data completely contradicted subjective outcome expectations (14). 
In addition, all patients who had been irradiated were compared to those who had not 
received radiotherapy. Irradiated patients showed a statistically significant deterioration 
in their ability to smell or taste as well as a strong trend for impaired speech. Here too 
individual coping of patients seemed to play an important role for outcome. In line with 
Smith et al. (9) the negative effects of irradiation on functional outcome and satisfaction, 
however, seemed clearly present. 
Non-invasive physical examination was performed in patients with anterior radial 
forearm free flap reconstructions only. Inspection revealed too bulky flaps, which additionally 
limited tongue mobility in 25.6%. Sensitivity testing proved difficult, as experienced 
previously (12). Protective sensitivity was not evident in every third patient, however, 
recurrent intraoral defects were not reported to be major a problem by patients. This 
unclear recovery of sensation indicates a potential benefit of using sensate flaps, which is 
not routinely performed at our institution. 
The major flaw in this study is the diversity of the defects and associated treatments. 
It is impossible to perform statistical analysis for all different subgroups since they would 
become too small. Also, the difference in coping of different patients with a similar 
situation makes that some patients will be satisfied with the exact same situation with 
which other patients will be very dissatisfied. Nevertheless, we believe that due to the 
rather high number of similar reconstructions some conclusions can be justified from the 
present findings. 
The radial forearm free flap is an easy and versatile flap with minimal donor site 
morbidity. It is still a valid method for reconstruction after resection of intraoral 
malignancies. Patient coping and postoperative irradiation influence functional outcome 
and patient satisfaction. Flap bulkiness plays a more limited role for anterior defects. 
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1. Introduction 
Substitution of lost tissue due to trauma, congenital defects, or resections is a challenge 
that plastic reconstructive surgeons are confronted with on a daily basis. Technical advances 
in the fields of microsurgery, allogeneic and autologous grafting has put the plastic surgeon 
at the forefront of medical science. 
A recent and rapidly growing set of tools for the reconstructive surgeon is being 
developed in a field known as tissue engineering. The goal of tissue engineering is to develop 
biological substitutes to restore, maintain or improve functionality of tissue (1 ). In other 
words; replacement of lost or damaged tissue by tissue grown in a laboratory. Engineered 
tissue can be manipulated and formed in a way that it meets the specific needs of a patient. 
Clinical use of for example cultured skin substitutes (2-4) in burn therapy and cartilage cells 
for repair of hyaline cartilage defects in the knee joint {5,6), illustrates the fact that tissue 
engineering is moving from lab bench to bed side. 
The basic technique of tissue engineering can be broken down into two ingredients; 
cells and scaffolds (figure 1 ). 
Transplantation into defect 
Figure 1: Basic principles of tissue engineering. Cells are isolated from a biopsy, cultured to 
expand cell numbers and combined with a three dimensional scaffold in vitro. Subsequently, this 
construct is transplanted to the patient. 
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Cells are typically isolated from a biopsy and are grown in vitro before use. Cell culturing 
times are related to dividing times of the cells and culture techniques, and will be discussed 
later in this chapter. For example, epidermal keratinocytes from a skin biopsy of an area of 
1 cm2 have a doubling time of approximately 24 hours and can be grown to a surface of about 
1m2 in approximately three weeks. 
Cultured cells are often combined with the second major component, a three-
dimensional matrix or scaffold. Scaffolds can be composed of a number of materials with 
distinctive characteristics that influence the behavior of the matrix (e.g. degradation times) 
and of the seeded cells (e.g. cell attachment), and will be discussed later in this chapter. 
After settling and attachment, the cells are guided by the scaffold to establish an organized 
three-dimensional tissue structure. 
The first part of this chapter will focus on the two basic components of tissue 
engineering, cells and scaffolds. The second part will discuss the current techniques used 
to grow and fabricate these two components into specific tissues of interest to the plastic 
reconstructive surgeon. 
2. Scaffolds 
Scaffolds in tissue engineering are either temporary or permanent three-dimensional 
frameworks used as a matrix for cells to attach and grow on. They are biocompatible and 
are usually comprised of materials that are natural or synthetic in origin. Some scaffolds 
are non degradable, such as Dacron or Teflon vascular constructs seeded with endothelial 
cells. However, most scaffolds used for implantation purposes, are composed of degradable 
materials. There are many scaffold materials used in tissue engineering, we will discuss some 
of the most popular biodegradable scaffolds, composed of natural or synthetic materials. 
A. Natural scaffolds 
1. Acellular tissue scaffolds 
Tissue, which has been treated to remove all cells in a process known as decellularization, is 
used as a scaffold to seed cells. Sources of the starting tissue can be allogeneic or xenogenic 
in origin. Procedures such as freeze-thaw cycles and washes with detergent are used to kill 
and remove all immunogenic living cells in the tissue. What remains is the immunologically 
inert extracellular matrix of the tissue. Most of the structural proteins (e.g. collagen, and 
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elastin) remain intact. This acellular material can subsequently be seeded with the cells of 
choice. For example, acellular dermis has been used as a skin replacement in treatment of 
burn wounds and reconstructive procedures (7,8). 
2. Type I collagen 
Collagen is the major component of the mammalian extracellular matrix. It provides tensile 
strength, and flexibility in tissues, such as skin, tendon and bone. Of the 14 types described, 
collagen type I makes up approximately 90% of all fibrous proteins, thereby being the most 
abundant type. Collagen has long been used in the medical setting in the form of sponges, 
fleece or fibers for haemostatic purposes. 
Collagen is often isolated from bovine skin, bovine tendons or rat-tail tendons by 
an acid extraction procedure. In vitro, after neutralizing the pH, the collagen can be re 
associated to form fibers or gels. Resorption of collagen polymers occurs by lysosomal 
enzymes, secreted by surrounding cells. 
To adjust the characteristics of collagen fibers to specific needs, the fibers can be 
cross-linked to various extends to provide additional strength. Besides adding strength, 
cross-linking increases the degradation time. Cross-linking reduces the rate of in growth of 
tissue into the collagen-based scaffolds and also reduces the ability of the polymer to absorb 
water (9). The collagen I polymers can be crosslinked with glycosaminoglycans. Addition of 
glycosaminoglycans provides a tool to optimize degradation times, pore sizes and elastic 
characteristics of the newly formed tissue after grafting (1 0-13). This technique is used in 
the case of the dermal substitute Integra® (Integra I LifeSciences corp.) (figure 2). 
Glycosaminoglycans are large, negatively charged molecules in the extracellular 
matrix. The GAG's provide compressive strength, shock absorption and turgor to the tissue 
by attracting water to the extracellular matrix. In the body, they are abundant in tissues 
such as cartilage and dermis. 
Examples of GAGs are hyaluronic acid, chondroitin sulphate, dermatan sulfate, 
keratan sulfate and chitin. GAGs are isolated from shark cartilage (chondroitin-
6-sulfate), rooster combs or are produced by a microbial fermentation process. 
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Figure 2: Highly porous sponge of bovine collagen type I and glycosaminoglycans (Picture courtesy 
of Integra UfeSciences Inc.) 
B. Synthetic scaffolds 
Certain synthetic polymers have been used to fabricate bioabsorbable sutures, pins, and 
fibers long before their use as a scaffold material in tissue engineering. They are usually 
fabricated from monomers that are of natural metabolites. Most commonly used are 
members of the a-hydroxy-acid family, such as glycolic acid (forming poly (a-glycolyc-acid) 
or PGA), lactic acid (forming poly (lactic acid) or PLA). For use in tissue engineering, the 
monomers can be polymerized into the form of fibers, fleeces, foams or gels. 
Copolymers of two or more monomers are often used. By varying the percentages of 
the components, characteristics of the resulting material can be changed. For instance, 
PGA is hydrophilic, and has a short degradation time. PLA however, has a longer degradation 
time and has a more hydrophobic character. PLA has better mechanical properties than PGA. 
When making a copolymer of the two molecules (forming the copolymer lactic-co-glycolic 
acid, or PLGA), these properties can be mixed, resulting in a polymer with the mechanical 
properties of PLA, and the hydrophilic and resorption properties of PGA. This product is on 
the market as Vicril© (Johnson & Johnson). 
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Once placed in the body, exposure to body fluids and cells leads to degradation of the 
polymers by hydrolization. The degradation products of the polymers are their monomers, 
lactic acid or glycolic acid, which are eventually converted into C02 and water by the 
Krebs cycle (14, 15). The acidic metabolites however, can cause lowering of the pH in the 
local environment of the scaffold, which can result in an inflammatory reaction in the 
surrounding tissue (16, 17). Furthermore, if the surrounding tissue is not capable of removing 
the byproducts due to insufficient vascularization, the accumulation of osmotically active 
degradation products can lead to hyperosmolarity of the tissue, leading to fluid accumulation 
and non-specific foreign body reactions. This problem is documented in the use of PLGA 
screws used in bone fixation. The degradation of the PLGA was associated with a non-
specific foreign body reaction in 7.9% of a population of 516 patients (18). 
C. Design of scaffolds 
For the design or choice of a scaffold, various aspects are taken into consideration (table 1 ). 
Optimization of these variables results in ideal cell seeding, cell attachment, cell growth, 
diffusion of nutrients, revascularization and degradation times of constructs. 
For example, an increase in the total number of pores and surface area of pores per 
volume provides a larger surface area for cells to attach (11 ). Coating scaffold materials 
with substances, such as collagen, fibrin, or other surface adhesion proteins further improves 
attachment of cells. Porous structures make it possible for cells to grow into multi layers, 
facilitates diffusion of nutrients and ingrowth of vasculature from the surrounding tissue. 
Pore sizes can be varied using salt-leaching techniques. In this process, scaffold material is 
mixed with water-soluble salt crystals that have a size similar to the desired pore size. After 
polymerization, the crystals remain in the matrix and can subsequently be washed out with 
water, leaving behind a porous structure. The resulting pores are relatively homogenous in 
size and distribution. Pore sizes and shapes can be changed by using different salts . 
Diffusion of nutrients is required for survival of cells in a scaffold. In vitro, nutrients 
from the culture medium feed the cells. Since tissue engineered constructs are typically 
avascular, during the first days after transplantation, the supply of nutrients for transplanted 
cells in vivo depends solely on diffusion from the wound bed. After grafting, formation of a 
new vascular network occurs by ingrowth of vasculature from surrounding tissue, providing 
a more solid nutrient supply to the cells. This limited distance of diffusion severely reduces 
the maximal size of the constructs. 
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Tablet: Some considerations in designing and choosing scaffold materials 
Biological properties 
Mechanical properties 
Chemical properties 
Manufacturing properties 
Biocompatibility 
Cell attachment 
Immunologic responses of host to scaffold materials 
Risk of disease transmission 
Sensitization host for scaffold material 
Possible bioactive properties (e.g. BMP inclusion into matrix) 
Stress-strain behaviour 
Pore size 
Surface area per volume 
Number of pores per volume 
Inter-pore connections 
Surface chemistry (e.g. coating with cell adhesion molecules) 
Degradation rate 
Byproducts of degeneration (e.g. Lactic acid in PLA degradation) 
Technical demands and costs of production 
Reproducibility of morphology and biological properties 
Possibilities for Large-scale production 
Costs of raw material 
Sterility 
Degradation rates vary from days to years depending on the size, structure and chemical 
components of the materials used (9). Half-lives of scaffolds can be adjusted to the time cells 
need to deposit sufficient autologous extracellular matrix material to support themselves 
in a three dimensional structure. Procedures, such as cross-linking and co-polymerization 
provide ways of manipulating this important characteristic of scaffolds. 
3. Cell isolation and culture 
The ability to culture and grow mammalian cells in a controlled and aseptic environment has 
made countless advances in research possible and has opened up the use of new, cell-based, 
therapies. In this part of the chapter, we describe how cells are obtained from various 
tissues sources, how cell cultures are initiated and kept in culture for extended periods of 
time and how complex liquid media that make cell culture possible are formulated. 
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A. Cell isolation 
For isolation of a specific cell type a small piece of normal tissue is obtained by biopsy, 
and minced up into small pieces. These pieces are subsequently treated with proteolytic 
enzymes, such as trypsin or collagenase, to digest proteins involved in cell-cell contacts and 
in the extracellular matrix. This process frees the cells from the surrounding extracellular 
matrix and generates a suspension of single cells. 
B. Cell culture 
Cell suspensions isolated from tissues are plated into a tissue culture dish, along with a rich 
liquid culture medium. Cells settle, attach and spread on the surface of the tissue culture 
dish. This is the first or primary cell culture. After an initial lag time of 1-2 weeks, the cells 
become adapted to the culture environment and begin to undergo cell division that can 
continue for many weeks depending on the cell type. 
As cell numbers increase, a state of confluence is reached, and the cells need to be 
plated onto new dishes. This process is known as serial passage or subculture. By using serial 
passage of cells, cell division can continue at a relatively constant rate for many weeks 
and give rise to many subcultures and a large number of cells. For example, normal diploid 
human dermal fibroblasts of the skin can be readily cultured in vitro. From only a 1cm2 
skin biopsy it's possible to establish a primary culture of a few thousand dermal fibroblasts. 
Under appropriate culture conditions, human fibroblasts can be serially passaged about 10 
times, which yields to a total of approximately 1016 cells. 
Cells in culture are able to perform a wide range of highly differentiated activities 
characteristic of their respective roles in vivo. For example, dermal fibroblasts secrete 
and assemble collagen fibers in culture. However, cell strains may differ in their inherent 
ability to perform these differentiated functions under certain in vitro conditions. For 
example, unlike the fibroblasts, chondrocytes lose these differentiated functions rapidly 
in a two dimensional culture. The cells lose their ability to produce collagen type II and 
start producing collagen type I, a process known as dedifferentiation, discussed later in the 
chapter. 
A wide variety of culture media and culture conditions have been developed over the 
years to facilitate the culture of specific cell types. In fact, each cell type has its preferred 
medium formulation and culture conditions, nevertheless, there are some fundamental 
common features. 
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Table2: Some components of a typical culture medium 
Basal medium components 
Sodium chloride 
Inorganic salts 
Sodium bicarbonate 
D-glucose 
Amino acids 
Vitamins 
Phenol red 
Serum 
Growth factors, hormones 
Antibiotics 
Function 
Osmotic pressure 
Provide electrolyte balance similar to blood 
Provides buffering capacity; with appropriate C02 level in the 
gas phase, maintains pH at 7.4 
Source of energy, carbon 
Source of nitrogen for protein synthesis 
Co-factors in various intracellular biochemical reactions 
Visual pH indicator 
Provides cell growth and attachment factors, hormones, 
carrier proteins 
Stimulate growth, function 
Prevent contamination by microorganisms 
The major components of a typical liquid medium to culture cells are summarized in Table 
2. Some aspects of the medium's composition (osmolarity, pH) are clearly meant to mimic 
blood and other physiological solutions. However, in many cases, the concentrations of 
nutrients and hormones/growth factors can be several folds higher than blood. Overall, 
culture media are typically very rich in nutrients in order to sustain growth and provide cells 
with an ideal culture environment. Through a process of trial and error, culture media have 
been optimized for the growth of different cell types. 
One of the main functions of medium is to provide sources of energy to the cell. The 
most important sources of energy in the medium are glucose, Pyruvate, and the amino acid 
glutamine. Glutamine, the essential amino acids in the medium and the other amino acids 
are also used for protein synthesis. Addition of non-essential amino acids is often desirable 
since intracellular synthesis of these amino acids can be a significant drain on the cell's 
energy pool. Complex medium preparations may also contain nucleosides, critic acid cycle 
intermediates, and lipids, which may be necessary when very low serum levels are used. 
One of the most common and important growth supplements is serum. Although serum 
is not a well-defined component and may exhibit batch-to-batch variation, it contains a 
wealth of factors that aid cell attachment and growth. In addition, the large load of carrier 
proteins provided by serum can help scavenge toxic impurities inadvertently supplied by 
the water, reagents, or cell culture apparatus. Serum is widely used and is generally added 
to the basal medium formulation in a proportion of 1 to 20% of the volume. The type of 
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serum most widely used is calf bovine serum, followed by fetal bovine serum that is used 
for more demanding cell lines. Human serum can be used for human cell lines, and can be 
autologous, to prevent transmission of disease. 
Cells in culture can be divided into two groups, anchorage dependent and anchorage 
independent cells. Anchorage dependent cells grow attached to a substrate. The nature and 
composition of this substrate is critical for cell function, these cells do not grow unless they 
are attached. Chondrocytes and some blood cells are able to grow without attachment. In 
these cases, the cells are referred to as anchorage independent. These cells grow embedded 
in a semi-solid agarose gel or as small spheroids or aggregates of cells in suspension in the 
liquid medium. For the majority of cells, attachment and spreading on a substrate are 
required for survival, growth and cell function. 
Knowledge of the two components has of tissue engineering has resulted in various 
products that are in clinical use or in development. We will describe some tissue-engineered 
products that are currently in use. 
4. Tissue engineered skin 
The standard for treating large skin defects is still closure with a full thickness or a split-
thickness autograft. Harvesting sites for autologous skin can be scarce, especially in the 
severely burned patient, and so, ways of growing and expanding cell numbers in vitro have 
been of interest. Research towards bioengineering skin substitutes has proceeded along two 
important lines; (1) the optimization of in vitro methods for the culture and proliferation of 
cells of the skin and (2) the development of biomaterials which mimic important properties 
of the skin. 
A. In vitro culture of epidermal keratinocytes 
Since new techniques of isolating and culturing keratinocytes were discovered, it has 
become a standard practice to grow keratinocytes in large numbers. Keratinocytes are 
readily available and expansion of an epidermal surface from a biopsy size of 1 cm2 to 1m2 
is realized in about 3 weeks. 
Keratinocytes are isolated from a full thickness biopsy of skin, approximately 1-2 cm2• 
After enzymatic digestion using Dispase®, the epidermis can be separated from the dermis 
as an epidermal sheet. The separated sheet is further digested with the enzyme trypsin. 
This typically results in a single cell suspension of keratinocytes. 
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Epidermal keratinocytes can be cultured in vitro using various methods (19,20). One method 
widely used for the clinic employs a feeder layer of murine fibroblasts (20) that have been 
lethally irradiated or treated with mitomycin C to prevent their proliferation. The feeder 
layer forms an optimal environment for the growth of keratinocytes by conditioning the 
medium through the secretion of growth factors and providing insoluble extracellular 
matrix proteins that are required for the clonal growth of keratinocyte colonies. Using this 
method, small colonies of 2-4 cells form within a few days after plating the keratinocytes. 
Doubling times for the keratinocytes are approximately 24 hours. As the cells proliferate, 
the colonies continue to expand until adjacent colonies merge and form a confluent sheet 
of keratinocytes. 
B. Skin substitutes 
There are three basic types of tissue engineered skin substitutes; the epidermal sheet, a 
dermal substitute, or a composite skin graft composed of a dermal substitution with a top 
layer of cultured keratinocytes. Substitutes for the epidermis and dermis are numerous 
(table 3). Some of the more popular ones will be described. 
Table3: Overview of commercially available skin substitutes 
Company 
Epidermal substitutes Genzyme Biosurgery, 
Cambridge, MA 
Dermal substitutes Integra LifeSciences, 
Plainsboro, NJ 
Product 
Epicel® 
Integra® 
Description 
Autologous cultured keratinocyte 
sheets. 
Composed of an upper epidermal 
silicone sheet and a collagen-GAG 
copolymer dermal substitute. 
LifeCell, Branchberg, NJ AlloDerm® Acellular allogeneic dermis. 
Advanced Tissue 
Sciences, LaJolla, CA 
Advanced Tissue 
Sciences, LaJolla, CA 
Composite substitutes Organogenesis Inc, 
Canton, MA 
Transcyte® Extracellular matrix proteins 
deposited by allogeneic human 
fibroblasts on a non-degradable 
matrix. Cells are killed prior to use. 
Top layer is a nonporous, silicone 
sheet. 
Dermagraft® Living, cultured allogeneic fibroblasts 
on a biodegradable matrix. 
Apligraf® Allogeneic cultured keratinocytes, 
seeded onto a dermal layer composed 
of allogeneic fibroblasts in a collagen 
gel. 
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1. Substitutes for epidermis 
Epidermal sheets are made of keratinocytes that have been cultured in vitro using the 
method described above. After growing the keratinocyte colonies to confluence, the final 
sheet of keratinocytes is a multi-cell layered sheet of epithelium approximately 2-8 cells 
thick. To detach this epithelium from the culture dish, the cultures are treated with Dispase®. 
This results in epithelial sheets of approximately 30cm2 in size and 2 to 8 cell layers thick. 
These grafts of autologous keratinocytes are attached to petrolatum gauze, and shipped 
to the hospital to be transplanted back to the patient. Genzyme Biosurgery (Cambridge, 
Massachusetts) provides Epicel®, a service that expands autologous keratinocytes into 
epidermal sheets with a surface area enough to cover the entire body in 16 days. The 
company reports that since 1988, over 600 patients have been treated using their epidermal 
sheets. 
Drawbacks of this technique are variable take, susceptibility of infection, fragility of 
the sheet during handling, and spontaneous blistering for periods up to a few months, due 
to the lack of a good dermal-epidermal junction. 
2. Substitutes for dermis 
There are several substitutes currently on the market. We will discuss two of the most 
important ones, lntegra®(lntegra LifeSciences, Plainsboro, NJ) and AlloDerm® (LifeCell, 
Branchburg, NJ). 
Integra® is a bilayer construct of a porous collagen-GAG polymer sponge as a substitute 
for the dermis, covered with a thin silicone membrane as a substitute for the epidermis 
(1 0,11) (figure 3 ). The dermal component is a suspension of extracellular matrix molecules: 
bovine collagen (isolated from bovine tendon), cross-linked with glycosaminoglycans from 
shark cartilage during the manufacturing process. Cross-linking optimizes pore structure 
and pore size of 70-200 microns and degradation times and furthermore increases elasticity 
of newly formed the skin after healing. The product is freeze-dried and stored in 70% 
isopropyl alcohol until usage. The collagen-GAG dermis is not immunogenic. However, 
after transplantation and subsequent invasion with autologous fibroblasts and endothelial 
cells, it induces a mild inflammatory reaction, which degrades the matrix in about 30 days. 
Autologous matrix deposited by the migrated fibroblasts, replaces the degraded material. 
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7 days after application 
14+ days after application 14+ days after application 
Figure 3: The two-step use of Integra® as a skin substitute. The substitute is placed on the 
wound (a), revascularization takes place (b) and after two weeks, the silicone layer can be 
replaced by a meshed split skin autograft (c,d) (Pictures courtesy of Integra LifeSciences Inc.) 
The epidermal component is composed.of a thin (0.009 inches) silicone layer. In addition to 
providing mechanical strength, this synthetic "epidermis" acts as a barrier to control loss of 
moisture and prevents bacterial contamination. 
A major advance in the care of serious burns has been the practice of early excision 
therapy. However, with extensive burns these excised areas require coverage and sufficient 
autograft may not be available. By providing a temporary substitute for skin, Integra® 
Artificial Skin aids the practice of early excision therapy. Integra® is particularly useful for 
children and elderly patients whose skin is thin and not easily harvested for repeat auto 
grafting. 
In a typical application, the burn wound is excised, covered with Integra® Artificial Skin, 
and over time the collagen-GAG dermal template promotes the formation of a vascularized 
neodermis. The silicone layer is peeled away (14-21 days after grafting) and the wound site 
is covered with an ultra thin (0.005 inches) epidermal autograft or a cultured epithelial 
sheet. 
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Another dermal substitute is AlloDerm®. This product is based on acellularized human cadaver 
skin. Since rejection of allogeneic skin grafts is based on immunological responses of the 
host immune system to the cellular components of skin, removal of the cellular components 
results in an immunologically inert structure, composed mainly of ECM molecules (21 ). 
Screened cadaver allografts obtained from tissue banks are first treated with a high 
salt solution and the epidermis is removed and discarded. The de-epidermalized dermis is 
further treated with a detergent containing a de-cellularizing solution, which also serves 
to inactivate potential contaminating viruses. The resulting acellular dermis is washed in 
a freezing medium and freeze-dried under controlled conditions to avoid disruption of the 
matrix proteins. This material still has its rete ridges and contains collagen and elastin. 
Very importantly, the epidermal side still contains many of the proteins of the basement 
membrane such as laminin, and collagen types IV & VII, which are important for the 
attachment and migration of epidermal keratinocytes (22). 
For usage, the acellular dermis can be meshed if necessary and is placed on a debrided 
wound bed, either in combination with an ultra thin meshed autograft or with a cultured 
epidermal layer (8). Two-step procedures are also used, where the epidermis is placed on 
the dermis only after initial revascularization of the dermis has taken place. 
3. Cultured composite skin grafts 
Composite skin grafts are composed of cultured keratinocytes and a dermal substrate (figure 
4). Typically, the surface of a dermal substrate is seeded with a single cell suspension of 
trypsinised keratinocytes in medium. This construct is submerged in medium for a few days. 
Keratinocytes attach to the dermis and grow into a confluent epidermal layer. As a next step, 
the dermis, with keratinocytes, is raised to the air liquid interface of the culture system. 
Exposure to air results in a stratified differentiated epidermis, complete with granular and 
cornified layers (23). 
After grafting, on a freshly debrided wound bed, fibro vascular structures invade the 
dermis. The keratinocytes secrete angiogenic factors (VEGF, FGF) and chemo attractant 
substances that support and accelerate this process (24,25). 
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Figure 4: Histology of normal human skin (a) compared to composite skin substitutes in the form 
of, Apligraf® (b), or a composite skin substitute of acellular dermis with cultured keratinocytes 
(c). (Pictures a and b, courtesy of Organogenesis Inc., picture c by courtesy of J.Cusick, 
Massachusetts General hospital! Shriners Burns Hospital Boston) 
Organogenesis, Inc. of Canton, MA, produces another type of composite skin graft. The 
product, Apligraf® (figure 4), has an epidermal layer of cultured allogeneic keratinocytes 
and a dermal analogue of cultured allogeneic fibroblasts in a collagen gel. When cultured 
fibroblasts are mixed with a solution of bovine collagen, they form a gel. The fibroblasts 
remain metabolically active and over time, begin to reorganize the bovine collagen as well 
as produce their own collagen and matrix proteins. The cells used for Apligraf® are isolated 
from neonatal foreskins. The surface of this dermal equivalent is seeded with cultured 
allogeneic keratinocytes that spread and proliferate to form a partially differentiated 
epidermal covering. This bilayered skin equivalent is raised to the air-liquid interface, 
resulting in the differentiation of the epidermis. 
According to the company, the cells obtained from one foreskin of approximately 1 cm2 
can be proliferated in vitro to manufacture approximately 1600 m2 of the Apligraf® product. 
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Unlike grafts of autologous cells, which require 2-3 weeks preparation time for each patient, 
grafts of allogeneic cultured cells can be made available for immediate use. However, due 
to the immunological mismatch, the engraftment of allogeneic cells is not permanent, but 
can provide temporary coverage, which promotes wound healing. 
Apligraf® is FDA approved for the treatment of venous and diabetic ulcers. Prospective 
randomized studies show thatApligraf® plus compression therapy improved complete wound 
closure compared to compression therapy alone in the case of venous ulcers. In treatment 
of diabetic foot ulcers, a significant increase in wound closure is observed when Apligraf® is 
used (26-28). 
C. Future perspectives 
Tissue engineered skin was one of the first tissues to enter clinical trials. Over two decades 
ago, the first coverage of large burn wounds with lab grown skin was reported (29). Since 
then, use of tissue-engineered skin has increased. However, there is still a long way to go, 
as illustrated by the current problems of variable take rates, long production times and high 
costs (30). 
Research continues in the field of bioengineered skin substitutes. Many labs, as well 
as physicians, are searching for the ideal combination of biomaterials and cultured cells 
that can provide reliable, definitive wound closure. Moreover, as the clinical success of the 
currently available skin substitutes increases, the issues of cosmetics of the healed skin, 
especially for the burned patient, will grow in importance. 
Efforts to reduce production times are found by use of allogeneic keratinocytes, 
or by mixing allogeneic cells with autologous cells in a so-called chimeric culture (31 ). 
Also, procedures where the collagen-GAG matrix has keratinocytes seeded in the pores of 
the matrix have been described (32,33). After grafting, the keratinocytes migrate up and 
repopulate the dermis, reducing production time and reducing cells necessary for providing 
a new epidermis. 
In the future, genitally modified skin substitutes may be useful for the local synthesis, 
secretion and delivery of wound healing growth factors or other therapeutic agents. 
Keratinocytes are relatively easy to genetically modify, and have been shown to produce 
high levels of various growth factors; human Growth Hormone (hGH) (34), Platelet Derived 
Growth Factor (PDGF) (35-37), Keratinocyte Growth Factor (KGF) (38), and Vascular 
Endothelial Derived Growth Factor (VEGF) (39), have been described. 
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5. Tissue engineering of bone 
Currently, bone replacement is usually accomplished by autologous or allogeneic bone 
grafting. Donor sites for autologous tissues are scarce and procedures, such as vascularized 
bone transplantation are technically challenging and time consuming. Complications of 
concern include unpredictable bone resorption, donor site morbidity, and infection (40). 
Tissue engineered bone constructs can provide an alternative source for bone. 
In the following part of this chapter we describe cell types used for bone healing 
purposes, followed by a description of currently used scaffold materials and developing 
materials. 
A. Cells producing bone 
Cells producing bone (e.g. osteoblasts) or cells that are capable of differentiating into bone 
producing cells (e.g. mesenchymal stem cells) are called osteogenic cells. Mesenchymal 
stem cells are multipotent and can differentiate into osteoblasts, chondrocytes and other 
cell types of connective tissues, such as fat or muscle cells (41-46 ). Differentiation of 
mesenchymal stem cells into bone phenotype is regulated by osteoinductive factors (e.g. 
fibroblast Growth Factor, bone morphogenetic proteins (BMP) (47·50). 
In bone, osteogenic cells are located in the bone marrow and periosteum. Osteogenic 
cells can be isolated by bone marrow aspiration, a relatively non-invasive, fast, simple, 
procedure with a high yield of osteogenic cells. The marrow can be used immediately or the 
mesenchymal stem cells (MSC) can be isolated and cultured in vitro (49,51 ,52). MSC can be 
cultured for 30 doublings, expanding cell numbers over one billion fold without losing their 
osteogenic potential (41 ). Alternative sources of osteogenic cells are periost and cancellous 
bone (53,54). 
Bone marrow has long been recognized for its osteogenic and osteoinductive 
properties. It is used in the clinic for treatment of non-healing bone fractures since the 
1980s (53). It can be injected into the surrounding bone as a cell suspension or combined 
with a carrier, such as demineralized bone. This prevents diffusion of the cell suspension, 
provides mass for correction of defects and in addition, the demineralized bone adds 
osteoconductive properties to the construct (54-57). Clinical reports describe similar 
mechanical and functional results using bone marrow in combination with demineralized 
bone compared with autologous grafting (56,58), however, more data are needed to confirm 
these observations. 
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B. Scaffold materials for bone substitutes 
Two widely used scaffolds for bone substitutes are allogeneic bone and demineralized bone 
matrix (DMB). The latter is obtained by a hydrochloric acid treatment of bone to extract the 
minerals. Both materials have clear osteoconductive characteristics, meaning the material 
guides bone healing by enhancing attachment, migration and distribution of cells responsible 
for the bone healing response. Furthermore, the allogeneic bone can be produced in various 
forms and shapes, such as blocks, chips and powders. It is porous, has many adhesion sites 
for osteogenic cells that invade the material from the surrounding host tissue. In addition, 
the matrix material contains osteoinductive factors, embedded in the extracellular matrix, 
such as Bone Morphogenetic Proteins (BMPs) (59,60). For survival of these osteoinductive 
factors processing techniques of the bone are important. This is illustrated by the fact that 
if donor bone is left at room temperature for more than 24 hours before harvesting, the 
biological activity is lost (61 ). 
Although allogeneic bone can be considered to be one of the optimal bone substitute 
by virtue of its mechanical and osteoconductive properties, drawbacks such as costs, 
variability of performance (e.g. resorption, incidence of stress fractures (62)), sensitization 
of recipients to graft specific histocompatibility antigens (63,64) and risk of transmission of 
disease, are significant. Therefore, alternative sources of bone replacement materials have 
been developed. 
Materials widely used are composed of ceramic materials, such as hydroxyapatite (calcium 
phosphate salt) and tricalcium phosphate (TCP). Hydroxyapatite can be derived from coral. 
Two kinds of coral are suitable for osteoconductive bone replacement materials. Both 
substitutes are highly porous, with a void volume up to 66%. One type has morphology 
similar to cancellous bone whereas the morphology of the second type is similar to cortical 
bone with parallel longitudinal pores and interconnecting pores (65,66). Native coral is 
composed of brittle calcium carbonate, but treatment by hydrothermal exchange at 900°C 
results in a very pure form of hydroxyapatite, with superior mechanical properties (65). 
Hydroxyapatite is a natural part of bone and after the hydrothermal reaction the product is 
protein free, making it an immunogenically inert material. 
Hydroxyapatite has a resorption rate of approximately 5 to 15% per year and therefore 
can be considered as a non-degradable material. It has shown its use in the clinic as an 
osteoconductive bone substitute (67-69) and is on the market as Pro Osteon® (Inter pore 
Cross, Irvine CA) (figure 5). Pro Osteon® is FDA approved for repair of metaphyseal defects, 
long bone cysts and tumor defects. Upon placement of this very porous substitute, it becomes 
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repopularized with fibrovascular cells, and osteogenic cells that deposit their matrix on the 
insoluble hydroxyapatite scaffold. 
a 
FigureS: A Higly porous coral based product (Pro osteon 200®) is shown in low magnification (a) 
and scanning electron microscope (b). It can be used to augment frontal cranium (c). After 11 
months, newly formed bone (gray) is deposited on the hydroxyapatite structure (white)(d). 
To shorten the long half-life of this material, the hydrothermal conversion can be partially 
completed, resulting in a concentric outer layer of slowly resorbed hydroxyapatite around an 
inner layer of more rapidly absorbing calcium carbonate. The outer layer of hydroxyapatite 
provides mechanical support and its slow resorption gives ingrowing cells time to attach and 
deposit extracellular matrix. After a few months, the outer layer becomes eroded, exposing 
the calcium carbonate that is resorbed at a faster rate. In a perfect setting, the newly 
formed bone will be matured enough to provide mechanical support before the outer layer 
is resorbed. Other ways of shortening resorption times include making co polymers with the 
more readily absorbable tricalcium phosphate. 
Another scaffold material used in bone substitutes is collagen type I. Collagen type I 
is the most abundant extracellular matrix protein in bone and has properties that facilitate 
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mineral deposition in the extracellular matrix. It has been mixed with hydroxyapatite, 
and is currently on the market (Collagraft® I Neu Coll inc., Palo Alto, CA). This product 
consists of bovine skin collagen type I mixed with hydroxyapatite. Prospective, randomized 
trials validated the use of this product in combination with autologous bone marrow cells. 
The trial showed no difference between use of autologous bone transfer and the use of 
hydroxyapatite in combination with autogenous marrow with respect to rates of union and 
prevalence of complications. Twelve of the 213 patients showed positive antibodies to bovine 
collagen. The authors conclude that use of hydroxyapatite in combination with marrow as 
an alternative to autogenous bone grafts for healing fractures in long bones is justified (70). 
According to the company, Collagraft® has been used successfully in the combination with 
autologous marrow as an osteoconductive, osteoinductive, and osteogenic cancellous bone 
replacement in more than 150,000 patients since 1994. 
C. Future perspectives. 
Research and development of new bone substitutes is focusing on several areas. One area 
focuses on increasing osteoinductive properties by incorporating osteoinductive growth 
factors, such as BMP into various scaffold materials (71-75). Another area of interest is the 
development of injectable ceramics and polymers that polymerize in situ. After mixing with 
a catalytic agent the polymerization process is started and the polymer is injected into the 
site of interest. A variable period of viscosity follows, when the material can be adjusted 
to fit the defect while the materials harden with minimal production of heat and without 
producing any harmful byproducts (76). Some of the newly developed polymers secrete C02 
during the process of in situ polymerization, resulting in a porous structure. In addition, the 
pressure generated by the C02 generates forces the scaffold to fit the defect seamlessly 
(77). 
Further areas of research include in the development of in vitro seeded natural and 
synthetic scaffolds (78-81 ). Bone constructs using cultured periosteal osteogenic cells 
seeded into a PLGA and PGA polymer scaffold have shown increase of bone formation in 
femoral shaft reconstructions (82) and in reconstruction of calvarial defects (83) in rats and 
rabbits. Cultured MSCs, in a coralline scaffold, have shown to increase bone regeneration in 
a femoral shaft defect in sheep (84). 
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6. Tissu~ engineering of cartilage 
Cartilage has many characteristics that make it suitable for tissue engineering purposes. 
Ease of isolation and the discovery of techniques for cell expansion in vitro have made 
it possible to obtain and grow cells for transplantation purposes. Lack of vascularization, 
low metabolic demands and possibilities to store for long periods of time make this tissue 
appropriate for usage in an engineered construct and for purposes of transplantation. There 
is a large demand for autologous cartilage due to its limited availability and marginal capacity 
to repair and regenerate in vivo. This has led to extensive research efforts into discovering 
ways of in vitro expansion and engineering of cartilage. Tissue engineered cartilage can be 
used in many ways in reconstructive plastic surgery. Treatment of nose septum defects or 
reconstructions of the external ear are only a few of the possible uses. 
A. Isolation and culture of chondrocytes 
There are three types of cartilage; elastic, hyaline and fibrocartilage. Elastic cartilage 
can be isolated from ears, nose septum and ribs. Fibrocartilage has more collagen I in its 
extracellular matrix, whereas the other two have more collagen type II in their extracellular 
matrix. The abundance of collagen type I makes fibrocartilage less water attracting, and 
gives it a more fibrous character than the other two. Formation of fibrocartilage is often 
observed as a healing response of hyaline cartilage after trauma. Hyaline cartilage is 
typically isolated from joints. Enzymatic digestion using Collagenase II and trypsin is used 
to remove the extracellular matrix and isolate the cells for subsequent culturing (88-91 ). 
Chondrocytes are slow growing cells; dividing only once or twice a week. In vitro, growth 
can be increased using growth factors, such as fibroblast growth factor (85,86). 
Cartilage mainly consists of extracellular matrix and water. This extracellular matrix is 
produced by chondrocytes and is composed of large polymers such as glycosaminoglycans, 
proteoglycans, and Collagen II and forms 95% of the tissue weight. As described earlier, these 
molecules are responsible for the turgor of cartilage by their ability to attract water. Cells 
in culture produce these molecules, such as collagen II and large aggregating proteoglycans. 
Production rate of these substances is used to monitor cell and tissue quality and can also 
be up regulated by certain growth factors, such as TGFB (85,87). 
An important process in chondrocyte culture is called dedifferentiation (88). 
Dedifferentiation is a morphological and functional change of the cells that occurs in 
monolayer cultures. Cells take on a fibroblast morphology and start to secrete collagen type 
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I instead of collagen type II, resulting in a more fibrous tissue than the normal cartilage 
(89). Dedifferentiation is a reversible process. Three-dimensional culture systems, such as 
cell suspensions, agarose gels (87,90,91), collagen gels (92) or collagen sponges (90,91), 
can prevent this process or even initiate differentiation of chondrocytes. The capacity of 
cartilage cells to redifferentiate however is limited. Due to the problem of dedifferentiation, 
cells can be passed only four to six times (86). 
A. Clinical applications and future perspectives 
There are three tissue engineering based strategies for repairing cartilage. One uses 
autologous cell expansion and subsequent transplantation back into the patient (Carticel®, 
Genzyme Biosurgery Inc /Cambridge, MA), the second uses scaffold materials that are 
placed in the defect in the cartilage. Healing of the cartilage occurs by migration of the 
surrounding tissue into the defect. The third approach uses a combination of scaffold and 
cells, combined in vitro and placed into the organism. Only the first strategy has reached 
the clinic. 
In 1994, the first clinical application of autologous, cultured chondrocytes for the repair 
of hyaline cartilage was described (6). Currently, Genzyme Biosurgery Inc (Cambridge, MA), 
provides Carticel® (figure 6), a service that cultures autologous chondrocytes commercially, 
using a similar approach. A healthy, autologous piece of cartilage is isolated from the 
patient by biopsy during an arthroscopic procedure. This piece of cartilage is shipped to 
the company where chondrocytes are isolated and cell numbers are expanded in vitro, 
approximately 10 fold. After cell expansion, chondrocytes are suspended in DMEM and 
shipped to the hospital, where the cells are placed back into the defect of the damaged 
joint. After accessing the knee by a small arthrotomy, the defect is debrided and covered by 
a periosteal flap sutured to the surrounding cartilage. This is done to seal off the defect and 
prevent spreading of the cells (6). Than, the cell suspension is injected under the periosteal 
flap. Genzyme Biosurgery reports that the Carticel® chondrocytes have been used to treat at 
least 3, 952 patients. Recently, promising long-term results of the use of autologous cultured 
chondrocytes in hyaline cartilage repair have been published (5, 93). Transplantation of 
autologous chondrocytes produces a durable and effective repair of full thickness cartilage 
lesions. New hyaline cartilage was observed by arthroscopic and histologic evaluation. 
However, comparison to other techniques requires prospective, randomized studies that 
are not yet available. 
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Figure 6: Carticel®, Chondrocytes are isolated from a biopsy, expanded in culture, placed back 
into the injured joint, covered by a flap of periost. (Picture courtesy of Genzyme Biosurgery) 
The other two mentioned techniques are still under investigation. The first places a scaffold 
in a defective area of cartilage (94). Chondrocytes from the wounds edge migrate into the 
scaffold where they deposit their extracellular matrix. Eventually the scaffold is degraded 
and new functional cartilage is formed. This approach is thought to be of use especially 
in the healing of hyaline cartilage defects. Another approach used synthetic (e.g. PLGA 
or PGA (94-98)) or natural (e.g. collagen gels and sponges (100, 105)) scaffolds materials, 
seeded with chondrocytes in vitro. The technique forms a tissue with similar mechanical, 
structural and histological properties as normal cartilage in vitro (1 00) as well as in vivo 
(1 01 ). Cartilage produced using PGA or PLGA polymers can be shaped into various forms, 
following the shape of the scaffold (97). An example of this is the fabrication of tissue-
engineered cartilage in the shape of an ear (1 02). Laboratory studies using these techniques 
are promising with respect to culturing techniques; construct designs and transplantability 
of the substitutes in animals. Potential use in a clinical setting is recognized, but more 
research is necessary to reach this goal. 
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7. Future perspectives of tissue engineering 
The basic principles of tissue engineering have been described in this chapter, as well as 
some tissue-engineered products that are currently available or will be in the near future. 
The potential of this emerging field is considerable, especially for the plastic reconstructive 
surgeon. However, there is still a long way to go until use of tissue-engineered constructs is 
accepted as a standard procedure. Improvements are needed in the fields of cell isolation, 
cell culture, scaffold design and transplantation of constructs before tissue engineering 
becomes widespread. 
In order to provide sufficient numbers of high quality cells for the formation of tissue 
engineered constructs, improvements in cell isolation and cell expansion in two dimension 
cultures, as well as in three-dimensional cultures are necessary. Stem cells are an exciting 
new area of research for tissue engineering. Development of isolation techniques for stem 
cells from various tissues, their high proliferative potentials and possibilities to differentiate 
into various cell types such as cartilage, bone, fat and muscle make them theoretically 
ideal candidates for use in tissue engineered constructs. Another exciting area of research 
for tissue engineering includes the genetical modification of cells. Genetic modification 
of cells can be used to improve the function and performance of many types of cells. The 
overproduction of growth factors for wound healing or factors that improve the function of 
cells and tissues are being tested. 
Research is also active in the development of new scaffold materials that are optimized 
with respect to cell adhesion. Polymers are produced that incorporate RGD (arg-gly-asp) 
adhesion sequences into their structures. These amino acid sequences are binding sites for 
a number of cell integrins involved in cell attachment. Incorporation of these sequences 
results in enhanced attachment of cells. The fabrication of injectable, in situ polymerizing 
polymers that can be used in a minimally invasive way, mixed with cells, and moldable 
before complete polymerization are also under development. 
In the area of transplantation, issues such as cell density, culture time, and scaffold variables 
are being optimized for each individual construct. In order to transplant larger constructs, 
or even tissue engineered organs, ways of inducing angiogenesis and innervation are areas 
of active investigation. 
Of the tissues discussed, skin is the only clinically approved tissue that is commercially 
produced in a three dimensional construct. In order to increase the number of commercially 
available tissue engineered cell seeded scaffold products, production costs will need to be 
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reduced, production times need to be shortened and new ways for large scale production 
need to be developed. Future products need to be practical, easy to handle and competitive 
if not superior in performance to the current modalities of treatment. If the field of tissue 
engineering meets these challenges it may reach its full potential. 
Websites for Tissue Engineering 
Tissue Engineering and Regerative Medicine network: 
www. termis.org 
wikipedia http: I I en. wikipedia.orglwikiiTissue_engineering 
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Abstract 
Introduction: New reconstructive techniques for reconstructing large defects of the floor of 
the mouth include the use of cultured mucosal substitutes. The purpose of this study was to 
compare dispase and thermolysin for keratinocyte isolation. 
Materials and methods: Keratinocyte yield per surface area of rabbit buccal mucosa was 
assessed by histology, cytokeratin 13 staining, seeding efficiency analysis and cell diameter 
quantification. Surface areas of cultured mucosa were calculated. 
Results: Histology showed that treatment by thermolysin resulted in incomplete separation 
of epidermis from dermis. Also, the absolute number of keratinocytes per cm2 isolated 
mucosa, cell yield, cell size and seeding efficiencies was higher in the dispase group. A 3.45 
fold larger graft could be reconstituted using dispase. 
Conclusion: The use of dispase to isolate cells from buccal mucosa is favourable to 
thermolysin. 
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Introduction 
In vitro culture of oral keratinocytes is used to study various processes, such as carcinogenesis 
(1), or effects of e.g. tobacco (2). Moreover, this technique has been used for clinical 
purposes, to culture keratinocyte onto a dermal carrier in repair of intra oral defects 
resulting from oncological resections (3). Oral cancer is the sixth most common cancer 
in the world. It accounts for approximately 4% of all cancers and 2% of all cancer deaths 
worldwide (4).Malignant tumors of the oral cavity account for approximately 30% of all 
head and neck cancers. With an incidence rate of invasive lip and oral cavity tumors in 
The Netherlands rising to 6.6%, oral cancer is a common malignancy that often requires 
resection of the tumor followed by reconstruction (5). 
Reconstruction is typically performed using free skin flaps such as the radial forearm flap 
(6 ). Drawbacks to the use of skin flaps include donor site defects, bulkiness and hairbearing 
of flaps (7). Alternative reconstructive approaches using cultured mucosa as a substitute are 
being developed (3). These involve the culture of keratinocytes and subsequent combination 
of these cells with a biomaterial that serves as a dermal carrier. The most important factor 
delaying clinical implementation is the culturing time necessary to expand cells to cover 
the average defect size of approximately 30-45 em (8,3) Culture time, therefore, needs to 
be minimized. An important factor determining culture time is the number and the quality 
of cells harvested from the biopsy. 
The predominant cell type of the epidermis is the keratinocyte. The keratinocytes 
located in the basal layer, are the cells with the highest proliferative capacities in vitro 
and are therefore the cells that need to be isolated to establish successful primary 
cultures (9, 10). Basal keratinocytes have a number of characteristics that can be used for 
identification. They are small and have capacities to form colonies if cultured in vitro. 
Suprabasal keratinocytes, on the other hand, are larger, express cytokeratin 13 and are less 
efficient in forming colonies (11-13). 
Widely used cell isolation techniques include explantation and enzymatic dissociation. 
Enzymatic protocols often involve a two-step procedure, using either dispase or thermolysin 
(14-18) to separate the epidermis from the dermis. Keratinocytes are typically cultured on 
a feeder layer of lethally irradiated fibroblasts (19). Advantages of the use of an enzymatic 
protocol include reduced fibroblast contamination; higher cell yields and reduced risk of 
bacterial contamination. Although various cell isolation procedures have been reported 
in the literature for skin keratinocytes, there are no reports on direct comparison of 
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cell qualities between dispase or thermolysin isolation for oral mucosal keratinocytes. 
Therefore, the goal of this study was to compare two enzymatic protocols for quality of 
mucosal keratinocyte retrieval. By histology, measuring cell size, colony forming efficiencies 
and expression of keratins in basal keratinocytes with high proliferative capacities were 
identified. Furthermore, the presence of fibroblast contamination was evaluated. 
Materials and methods 
Upon approval of the local animal ethics committee, keratinocytes were isolated from 
biopsies of buccal mucosa from four rabbits. The samples were treated using either 
thermolysin or dispase to separate epidermis from dermis. Cell characteristics, such as cell 
yield, size and CK13 expression were analyzed using one rabbit. As mucosal substitutes are 
typically fabricated using cells at passage one to two, the cell populations were analyzed 
again at the first passage. 
Keratinocyte isolation and cell culture 
Buccal mucosa was harvested from the cheek of four New-Zealand white rabbits. The 
mucosa was incubated in antibiotic cocktail for 1 hour (Penicillin/Streptomycin (100 U/ml I 
100 j.Jg/ml), Gentamycin (50 j.Jg/ml), Amphotericin B (2.5 j.Jg/ml), all Invitrogen, Breda, The 
Netherlands). Subsequently, six 6mm punch biopsies (0,28 cm2) were cut from the samples. 
Half of the biopsies were transferred to dispase (2.5 mg/ml, (Invitrogen)) in Dulbeco's Modified 
Eagle Medium (DMEM (Invitrogen)) the other half in thermolysin 500ug/ml (Invitrogen) in 
DMEM, at 4°C overnight. Enzyme concentrations and diluents were chosen according to the 
manufacturers instructions. The next day, biopsies in enzyme solutions were put in 37°C for 
20 minutes prior to separation of the epidermal sheath from the dermis. Subsequently, the 
epidermal sheaths were put in Trypsin-EDTA, 0.25% (Sigma, Zwijndrecht, The Netherlands) 
at 37°C for 15 minutes to obtain a single cell suspension. From two rabbits, two samples 
were used for histological evaluation. Three million cells of each of the three biopsies used 
for cell analysis were divided into three T-25 culture flasks (25 cm2) with a feeder layer 
of lethally irradiated 3T3 fibroblasts (a kind gift from dr. von den Hoff, Department of 
Orthodontics and Oral Biology, University Medical Centre, Nijmegen, The Netherlands) in 
seeding medium, according to the Howard & Green protocol (19,20). Keratinocyte seeding 
medium was composed of a 3:1 mixture of DMEM and Ham's F12 (Invitrogen), supplemented 
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with 10% FBS; adenine, 1.8x1 o-4M (Sigma); cholera toxin, 10-10 M (VWR international, 
Amsterdam, The Netherlands); hydrocortisone, 0.4 tJg/ml (VWR); insulin, 5tJg/ml (Eli Lily, 
Houten, the Netherlands); triiodo-L-thronine, 2x1 o-9 M (Sigma) and penicillin-streptomycin, 
1001U/ml-100tJg/ml (Invitrogen). 24 Hours after seeding, mouse epidermal growth factor 
(EGF, Sigma) was added to a concentration of 100ng/ml. This keratinocyte culture medium 
(KCM) was changed every other day. 
Subconfluent keratinocyte cultures were subcultured by first removing the fibroblast 
feeder layer with 5mM EDT A and treating the keratinocytes with trypsin-EDTA. 3T3 Fibroblasts 
were routinely passaged in DMEM (high glucose) supplemented with 10% FBS and penicillin-
streptomycin (1001U/ml-100tJg/ml) and incubated at 37°C with 10% C02• 
Colony forming efficiency was investigated by seeding 1000 isolated cells from each of 
the three biopsies of one animal in triplicate onto 6 well dishes with a feeder layer in KCM. 
Fibroblast contamination was studied by seeding 1000 isolated cells isolated cells from each 
of the three biopsies in triplicate on a 6 well dish in DMEM with 10% FBS. After 21 days, 
6 well dishes were rinsed using PBS and stained using eosin for 1 minute and subsequent 
rinsing using tap water. The number of round, single colonies was counted. 
Cell count and cell size analysis 
Viable cell numbers were counted after the addition of trypan blue using a haemocytometer. 
Cell suspensions of one representative rabbit studied into further detail by reconstituting 
cells to 1 million cells per millilitre. Cell size analysis was performed using a CASY® cell 
counter (Scharfe systems, Reutlingen, Germany). Triplicates of 75tJl cell suspension (75.000 
cells) per biopsy were analyzed. Cell sizes were normalized to facilitate comparison. 
Histology 
Samples of biopsied mucosa, as well as remnants of dermis and the epidermal sheath after 
enzyme treatment were used for histology. Haematoxylin and Eosin staining was performed. 
For immunohistochemical staining for differentiated keratinocytes, Cytokeratin 13 (CK13) 
was used. The CK13 protocol was as follows. Paraffin sections were deparafinnized and 
cooked in citric acid buffer (2.15g citric acid monohydrate in 750ml of water). Endogenous 
peroxidases were blocked using citric acid phosphate buffer with 30% Hz02 (Fluka, 
Zwijndrecht, The Netherlands). After a blocking step using 10% normal rabbit serum (NRS, 
Sanquin blood bank, Rotterdam, The Netherlands) and 10% normal goat serum (NGS, 
Sanquin blood bank) diluted in first step buffer (1 0% NRS (Sanquin blood bank) in PBS, the 
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primary antibody was added, mouse anti human CK13 monoclonallgG2a (Euro Diagnostica, 
Arnhem, The Netherlands). The next day, samples were washed using washing buffer (0.1% 
tween in PBS) and incubated with the secondary antibody, biotin labelled goat anti mouse 
immunoglobulins (Dako, Glostrup, Denmark) in secondary buffer (2% NGS, 2% NRS and 5% 
Bovine Serum Albumin in PBS). Following a washing step, streptavidin-HRP complex (Dako) 
was added in secondary buffer followed by another washing step. Next, the substrate (241.ll 
of 30% Hz02 in PBS in 1.2ml 5% DAB (Sigma)) was added and the reaction was stopped using 
tap water. Counterstaining was performed using haematoxylin. Samples were mounted 
using Vectamount (Dako). Statistical analysis For comparison of the cell yield of the two 
protocols, we used a non-parametric Mann-Whitney test. Significance was reached with 
P-values <0.05. 
Results 
Dispase isolates more cells per biopsy than thermolysin 
In two out of 10 biopsies treated with thermolysin the digestion was incomplete. The 
epidermis did not separate from the dermis, which is why these were excluded from 
analyses. 
Cell counts were performed on in totalS 6mm punch biopsy specimens after thermolysin 
and 10 biopsies after dispase treatment (figure 1 ). Dispase isolation resulted in cell yields 
of 12.07 (±2.5 (SD)) million/cm2 whereas thermolysin isolation resulted in an average of 
3.70 (±1.9 (SD)) million/cm2, a 3.26 fold decrease (p = 0.02,). Colony forming efficiencies, 
expressed as % of keratinocytes seeded onto a feeder layer forming a colony were 0.38% 
(± 0.13 (SEM)) for dispase and 0.31% (± 0.10 (SEM)) for thermolysin. This difference was not 
significant. No fibroblast colonies were found in both isolation protocols. 
After seeding 1 million cells per biopsy and culturing these to passage 1, cells were 
counted per flask at 80% confluency. The dispase treated group had significantly more cells 
per flask (average 8.3 million cells) than the thermolysin treated group figure 1 C (6.3 million 
P = 0.04). Average culture time to the first passage was 8.6 and 9.3 days for the dispase 
and thermolysin treated mucosa respectively and did not reach a statistically significant 
difference (Figure 1 D). 
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Figure 1: Dispase isolates more cells per biopsy than thermolysin. 1A; The number of isolated 
cells per surface area using the dispase protocol (black, n = 8, the two biopsies where separation 
was Impossible were excluded) or the thermolysin protocol (grey, n = 10). 1 B; Colony forming 
efficiencies per protocol, expressed in %of 1000 seeded keratinocytes forming colonies (n = 9). 
1 C: Cell yield per T25 culture dish at passage 1 (n = 3). 1 D: Days between seeding 1 million cells 
and first passage per isolation protocol (n = 3). * P < 0.05 
Thermolysin results in incomplete separation of epidermis and dermis As shown on H8:E 
staining of pieces of dermis treated with dispase or thermolysin, the epidermis was separated 
from the dermis. Dissociation using thermolysin however, resulted in the epidermis partly 
remaining attached to the dermis (figure 2 A-D), in particular basal cells in the papillae of 
the dermis. Also, it was noted that all epidermises of the dispase treated biopsies were 
easily separated from the dermis. This is in contrast to the thermolysin treated biopsies, 
where 2 out of 10 of the epidermises did not separate at all. Moreover, the epidermises 
separated by thermolysin were macroscopically thin (data not shown). 
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Cytokeratin 13 (CK13) is expressed in suprabasal, differentiated keratinocytes of mucosa. 
These keratinocytes have less proliferative potential than the CK13 negative cells at the 
basal layer of the epidermis. For analysis of the keratinocytes remaining attached to 
the dermis after thermolysin treatment, biopsies were stained for CK13 expression. The 
remaining cells at the dermis proved to be CK13 negative, suggesting them to be basal cells 
with a high proliferative potential (figure 2). 
Figure 2: Thermolysin results in incomplete separation of epidermis and dermis. 2A: 
Haematoxyllin and Eosin staining (H&:E) of dermis after dispase treatment, all but a few cells 
are removed upon separation of the epidermal sheath. The Line of separation is the derma-
epidermal junction. 2B: H&:E of dermis after thermolysin treatment. Large quantities of basal 
cells remain attached in the papillae of the dermis. The Line of separation seems to be the 
suprabasal Layer of the epidermis. Immunohistochemical staining for differentiation marker 
CK13 shows basal, CK13 negative, cells remaining attached to the dermis of the thermolysin 
treated dermis (2D), whereas the dispase treated dermis (2C) shows hardly any attached CK13 
negative keratinocytes. (magnification 200x) 
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Figure 3: Cell Sizes. 3A: CASYanalysis was performed to measure cell diameters of dispase treated 
biopsies (dark grey) or thermolysin treated biopsies (light grey) at isolation . 3B: Cell diameter 
distributions for both enzymatic protocols were compared at passage1. Similar distributions 
were observed in both protocols. Figure 3C and D show a cell diameter increase upon upon in 
vitro propagation of keratinocytes isolated by dispase or thermolysin treatment respectively. 
Bars represent the SEM of triplicate measures of three biopsies, a total of 9 measurements per 
protocol. Measurements were expressed as percentages to assess relative size distributions. 
Dispase results in an increased number of small keratinocytes per cm2 Basal keratinocytes 
with high proliferative potentials are small. Typically their diameters are less than 14 IJm. 
In figure 3, cell sizes of the cell population less than 151Jm are plotted as percentages at 
isolation and first passage of the cells. As illustrated in figure 3A size distributions at isolation 
are similar between the dispase protocol and the thermolysin protocol. The absolute amount 
of small keratinocytes per surface area of biopsy therefore is 3.26 fold higher. 
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Upon isolation, cells are cultured and start to differentiate and cell size should increase. 
This was confirmed by our data (figures 3C and D). However, similar cell size distributions 
between the two isolation groups were observed at passage 1 (figure 3B), indicating no 
influence of isolation protocol on cell size differentiation during culture. 
Discussion 
In establishing primary cultures from epidermis a number of problems can be encountered. 
Fibroblast overgrowth occurs as a result of fibroblasts isolated as passenger cells. Other 
problems include bacterial contamination as sterilizing the contaminated oral cavity 
prior to the biopsy is technically challenging. Several approaches in tackling these issues 
have been developed. The use of specific media formulations (21 ), as well as the use of a 
radiated fibroblast feeder layers have been developed to discourage fibroblast growth and 
selectively stimulate the keratinocytes to proliferate (19). Also, the use of proteases that 
cleave the epidermis from the dermis at the derma-epidermal junction were introduced 
(17). After cleaving the epidermis from the dermis, the epidermis is trypsinized separately. 
This approach results in a decrease in fibroblast contamination, and is less laborious than 
previous enzymatic protocols where biopsies are minced rigorously and processed in trypsin 
in spinning flasks for long times. Moreover, it is the experience of our laboratory that 
bacterial contamination is reduced, as clumps of cells and matrix are removed prior to 
culture facilitating the antibiotics to penetrate the tissues. 
In order to choose an optimal protocol to isolate mucosal keratinocytes for expansion in 
vitro, thermolysin and dispase were tested. These enzymes have been well characterized for 
their use in isolation from keratinizing skin and are routinely used by many well-established 
laboratories (17). Unlike the use for keratinocyte isolation from keratinizing epidermises, a 
comparative study using the two most popular enzymes for non-keratinizing epidermises has 
not been found. 
In the present study, both enzymes proved to be convenient and suitable for cell 
isolation shortly after harvesting of biopsies, ensuring optimal viability of the cells. 
Keratinocytes were successfully cultured using either of the two enzymes. Additionally, no 
fibroblast contamination was observed in any of the protocols. 
The results of this study show a clear advantage of the use of dispase. First of all, cell 
yields per surface area of biopsy were 3.26 times higher in the dispase treated groups. This 
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was shown by cell counts and confirmed by histology. Moreover, the decrease in cell yield 
per surface area of biopsy seemed to be caused by a supra-basal separation level of the 
epidermis and dermis. Analysis of expression levels of differentiation marker CK13 (11) in 
the keratinocytes remaining attached to the dermis upon thermolysin treatment proved the 
remaining keratinocytes to be basal cells with high proliferative capacities. Also, the enzyme 
proved to be unpredictable in its effectiveness as only part of the epidermises separated 
following overnight incubation. Other reports on the use of thermolysin in keratinizing skin 
report separation at the dermo-epidermal junction. Supra-basal split of the epidermis using 
thermolysin in keratinizing skin has been reported previously (14). No histological analysis 
has been reported on the use of thermolysin for non-keratinizing mucosa. 
The data indicating no relative difference in proliferative capacities were confirmed 
by the data obtained by measuring the colony forming efficiencies and cell size analysis. 
The colony forming efficiency test showed a non-significant increase in number of colonies 
using the dispase protocol. Percentages correspond to previous reports using cultured 
keratinocytes isolated from skin biopsies (15, 16). 
Cell size has been a long used method to identify basal keratinocytes. Small cells with 
diameters between 9 and 141Jm have high nucleus/cytoplasm ratios and are considered 
keratinocyte stem cells with high proliferative potentials. Although DNA content as well as 
nuclear size remain constant, a differentiation dependent increase in cell diameter concurs 
with appearance of differentiation specific proteins such as involucrin and differentiation-
specific keratins, as well as the disappearance of basal cell markers such as B1 intergrins 
(12,13). In the present study, an increase in size was seen as a result of culturing the 
cells as cells differentiate, corresponding to earlier reports on cell diameter changes of 
keratinocytes in culture (22,23). Our data show similar cell size distributions between both 
tested protocols suggesting that no differences occur upon culture in vitro. 
In conclusion, we measured the differences between two enzymatic protocols in isolation 
of mucosal keratinocytes. Although relative differences between cell populations were 
minimal, the 3.26 fold difference in cell yields per surface area and the significant increase 
in surface area of cultured keratinocytes justify the use of dispase over thermolysin. 
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Abstract 
Reconstruction of large mucosal defects of the floor of the mouth is typically performed 
with keratinizing skin. Drawbacks include donor site defects and hair bearing of the 
flaps. Cultured mucosal substitutes (CMS) have been developed for clinical use to replace 
keratininzing skin. A-cellular dermis is often used as a dermal carrier for autologous cells, as 
it reduces wound contraction and is easier to handle by the surgeon than e.g. collagen gels. 
A major problem of CMS using a-cellular dermis is variation in epidermal quality. 
To improve the quality of the CMS, human fibroblasts were incorporated into the a-cellular 
dermis and seeded with human keratinocytes. To study the role of the fibroblasts on epidermal 
morphology and basement mebrane formation, CMS were stained for differentiation 
markers 131 integrin, cytokeratin 10 and involucrin after one and two weeks in culture. 
Basement membrane formation was analysed by laminin 5 and collagen IV and VII staining, 
proliferation by Ki-67 staining. 
Epidermis of fibroblast-containing CMS matured faster into a well-organized epithelium. 
A 52.7% increase in basal cells, a 53.5% increase in mitosis index and a 78% increase in 
keratinocyte cell-layers was observed. 
Addition of fibroblasts reduced culturing time, enhanced proliferation, maturation and 
quality of the epidermis. 
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Introduction 
Oral cancer is the sixth most common cancer in the world. It accounts for approximately 
4% of all cancers and 2% of all cancer deaths worldwide. Malignant tumors of the oral 
cavity account for approximately 30% of all head and neck cancers. With an incidence rate 
of invasive lip and oral cavity tumors in The Netherlands rising to 6.6%, oral cancer is a 
common malignancy that often requires resection of the tumor followed by reconstruction 
(1 ,2). 
Reconstruction of large defects of mucosa in the mouth is typically performed using 
free or pedicled skin flaps. Drawbacks to the use of skin flaps include donor site defects, 
bulkiness, sweating and hair bearing of the flaps (3,4). The feasibility of culturing oral 
mucosa in vitro for use in reconstructive surgery has been described. The first successful 
clinical trials, using collagen gels and membranes, report significant contraction of the 
cultured mucosal substitutes (CMS) as a challenging problem (5-7). 
Dermal carriers reportedly reduce contraction compared to the use of keratinocyte 
sheets alone. Moreover, clinical reports on the use of cultured skin substitutes in patients 
with extensive skin loss, such as in burns, report reduced wound contraction and enhanced 
wound healing upon the addition of fibroblasts to a dermal matrix (8-10). Furthermore, 
the addition of fibroblast to the dermal carrier seems to enhance quality of the cultured 
epidermis and determines the phenotype of keratinocytes (11, 12). In addition, in vivo 
studies have shown that fibroblasts enhance angiogenesis (8). 
In case of cultured mucosal substitutes, the effect of fibroblasts on reconstituted 
epidermis has been illustrated using collagen gels. Clinical application of collagen gels, 
however is limited due to a number of problems. A collagen gel is mechanically weak; it 
cannot be sutured in place, in particular in the oral cavity where the tongue as well as the 
cheeks are constantly moving. Secondly, a collagen gel contracts more than other dermal 
scaffolds, such as a-cellular cadaver skin, and is therefore less feasible for transplantation. 
On the other hand, a-cellular cadaver skin is commercially available as Alloderm® and is 
clinically approved. Basement membrane proteins remain present at the basal membrane 
site of the dermo-epidermal junction (DEJ), as well as in the remnants of the vascular basal 
membranes. This facilitates in vitro keratinocyte attachment (13), as well as migration of 
endothelial cells invading the dermis upon transplantation (14). The DEJ is responsible for 
resistance to shear forces that could separate the epidermis from the dermis, such as in 
the case of a blister. Furthermore, DEJ proteins facilitate migration of keratinocytes e.g. 
in wound margins (15). Recently, one of the authors developed a technique to centrifuge 
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fibroblasts into a-cellular dermis(16). A clear improvement of epidermal morphology and a 
better formation of the DEJ as a result of the incorporation of fibroblasts in skin substitutes 
were seen using keratinizing skin keratinocytes. Moreover, fibroblasts obsoleted the addition 
of growth factors, such as KGF and EGF (16, 17). These results suggest that incorporation of 
fibroblasts in non-keratinizing mucosal substitutes, might lead to important improvement of 
the quality of the cultured mucosa. 
To date, no reports on the specific effects of bioactivation of a-cellular dermis using 
viable autologous fibroblasts on the epidermis was found in the literature. Therefore, the 
aim of this study was to evaluate whether incorporation of fibroblasts affects mucosal 
epidermal morphogenesis. This was done by evaluating the expression of several keratin, 
integrin and proliferation markers and the expression of basement membrane proteins. 
Materials and methods 
Culture of human keratinocytes 
Upon approval of the local medical ethics committee, healthy human buccal mucosa was 
harvested. The mucosa was incubated in an antibiotic cocktail for 1 hour (Penicillin/ 
Streptomycin (100 U/ML/100 !Jglml), Gentamycin (50 !Jg/ml), Amphotericin B (2.5 !Jg/ml), 
all Invitrogen, Breda, The Netherlands). The biopsy was transferred to dispase (2.5 mg/ 
ml, (Invitrogen)) in Dulbeco's Modified Eagle Medium (DMEM (Invitrogen)), at 4°C overnight. 
Next day, the biopsy in dispase was put in 37° for 20 minutes prior to gentle separation 
of the epidermal sheet from the dermis. The dermis was used to isolate fibroblasts as 
described below. Subsequently, the epidermal sheet was put in Trypsin-EDTA, 0.25% (Sigma, 
Zwijndrecht, The Netherlands) at 37°C for 15 minutes. After neutralisation of the trypsin 
by DMEM with 10% Fetal Bovine Serum (FBS) (Sigma) a single cell suspension was obtained 
by gentle pipetting. Cells were seeded in a T75 culture flask onto a feeder layer of lethally 
irradiated 3T3 fibroblasts (a kind gift from dr. von den Hoff, Department of Orthodontics and 
Oral Biology, St. Radboud University Medical Centre, Nijmegen, The Netherlands) in seeding 
medium, according to the Rheinwald &Green protocol (18-20). Keratinocyte seeding culture 
medium was composed of a 3:1 mixture of DMEM, high glucose and Ham's F12 medium 
(Invitrogen), supplemented with 10% FBS; adenine, 1.8x1Q-4M (Sigma); cholera toxin, 10·10 
M (VWR international, Amsterdam, The Netherlands); hydrocortisone, 0.4 !Jg/ml (VWR); 
insulin, 5 !Jg/ml (Eli Lily, Houten, the Netherlands); triiodo-L-thronine, 2x1 o-9 M (Sigma) 
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and penicillin-streptomycin, 1 OOIU/ml-1 001-Jg/ml (Invitrogen). 24 Hours after seeding, 
proliferation medium was added to the cells. Proliferation medium is composed of seeding 
medium supplemented with 10 ng/ml mouse epidermal growth factor (EGF, Sigma). The 
medium was changed every 2 days. 
Isolation and culture of human fibroblasts 
Upon separation of the epidermis from the dermis, the dermis was washed once more in 
PBS, minced and put into DMEM with 1.5 mg/ml collagenase I and 2.5 mg/ml dispase at 
3T C for 90 minutes. Subsequently, the enzyme solutions were filtered using a 100 IJm cell 
strainer prior to centrifugation at 1200 RPM (200 G) for 5 minutes. Next, cells were seeded 
onto culture dishes in 10% FBS in DMEM and cultured at 37°C, 10% C02. Fibroblasts at passage 
three to five were used for seeding into a-cellular dermis. 
Preparation of a-cellular dermis 
Human cadaver skin (CMV, HIV and HBV negative), cryopreserved in 10% glycerol, was 
obtained from the European Skin Bank, Beverwijk, The Netherlands. The epidermis was 
pealed off the dermis after overnight incubation in 1 Ox PBS with antibiotic cocktail and 
ethylene-diamine-tetra-acetic-acid (EDTA). The remaining dermis was acellularized using 
irradiation of the skin by 35Gy using gamma irradiation. Next, the dermis was maintained in 
antibiotic cocktail at 4°C for an additional week prior to centrifugal seeding of fibroblasts. 
Centrifugal seeding of fibroblasts 
To incorporate mucosal fibroblasts into the acellular dermis, a centrifugal seeding technique 
for fibroblasts was used, as described elsewhere (16, 17). In short, 1.3 cm2 pieces of dermis 
were placed with their basal membrane side down onto 35ml of DMEM I 1% agarose gel 
in a 50 ml Falcon tube (BD biosciences, Alphen aan den Rijn, The Netherlands) at room 
temperature. Next, 1 ml of fibroblast suspension containing 800.000 cells was added. Grafts 
were centrifuged at 200g for 60 minutes before keratinocytes were seeded onto the papillary 
side of the dermis. In order to estimate the number of cells incorporated into the dermis, 
cells in the supernatant were counted. 
Culturing mucosal substitutes 
After centrifugal seeding of fibroblasts, pieces of a-cellular dermis were placed with the 
papillary side up into 6 well dishes. A stainless steel seeding ring with a 1 em diameter 
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was placed on the dermis and subsequently filled with keratinocyte suspension containing 
250.000 third passage keratinocytes in seeding medium (composed of DMEM/F12 (3:1), 
FBS 1%, cholera toxin 10·10M, hydrocortisone 200 ng/ml, insulin 51Jg/ml, ascorbic acid 50 
J..lg/ml (Sigma) and penicillin-streptomycin 1001U/ml-100 J..lg/ml, as described elsewhere 
(21 ,22)). Grafts were produced in duplicate for two separate experiments. The next day, 
culture medium was changed to priming medium, which was the same as seeding medium 
but supplemented with bovine serum albumin (BSA) 24 1-1M (Sigma), fatty acid cocktail 
(oleic acid 251JM. linoleic acid 15 IJM, arachidonic acid 7 1-1M, palmitic acid 25 1-1M) (Sigma), 
L-carnitine 10 1-1M (Sigma l) and L-serine 1 mM (Sigma). Grafts were maintained in this 
medium submerged for an additional 2 days. The next day, grafts were placed on a stainless 
steel mesh in a 6 well dish and were raised to the air-liquid interface for 7 or 14 days 
to generate an epidermis. The air-liquid interface medium was composed of serum-free 
priming medium supplemented with 1 ng/ml EGF (Sigma). The medium was changed every 
2 days. 
Morphology and Immunohistochemistry 
Duplicate grafts per group of two separate experiments were harvested and cut in half. 
Subsequently, one half was snap frozen and one half embedded in paraffin. Paraffin sections (6 
J..lm) were deparafinized, rehydrated and prepared for morphological or immunohistochemical 
analysis of K10, K13, B1 chain, involucrin and vimentin. Immunohistochemical analysis of 
K16, K17, K10, a6 chain, B4 chain, laminin 5, and collagen type IV and VII was performed 
using 5 1-1m frozen section, which after sectioning at -20°(, were air-dried overnight, fixed 
in acetone for 10 minutes. The primary antibodies used in the present study are listed in 
table 1. 
In brief, the following procedure was used for the paraffin sections: for the 51- integrin 
antigen retrieval was done by cooking in citric acid buffer (2.15g citric acid monohydrate 
in 750ml of water) for 15 minutes in a microwave. After a cooling down for a period of 60 
minutes in the citric acid buffer, sections were washed in PBS. For the vimentin and K1 0 
protocols, a protease digestion step was introduced by exposing the samples to 0.5mg/ml 
trypsin in PBS for 10 seconds before neutralizing using 1% FCS in PBS for 5 seconds. After 
washing, endogenous peroxidases were blocked for 15 minutes using citric acid phosphate 
buffer with 30% H20 2 (Fluka, Zwijndrecht, The Netherlands. Thereafter, another washing 
step using PBS, aspecific binding was blocked using blocking buffer, composed of 10% normal 
rabbit serum (Sanquin blood bank, Rotterdam, The Netherlands) and 10% normal goat serum 
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(Sanquin blood bank) diluted in first step buffer (1 0% normal human serum (Sanquin blood 
bank) in PBS, for 30 minutes at room temperature. 
Table 1: Primary antibodies used for immunohistochemical staining of tissue section 
Sections Antibody designation Source* 
Paraffin embedded B1 chain(CD29) 
CK13 
Lab Vision, Duiven, The Netherlands 
Euro Diagnostica, Arnhem, The Netherlands 
Euro Diagnostica 
Frozen 
CK10 
lnvolucrin 
Vimentin 
Ki-67 
K16 (LL0025) 
K17 (CK-E3) 
K10 (DE-K10) 
B6 chain (JEB5) 
Lab Vision 
Euro Diagnostica 
DAKO, Heverlee, Belgium 
Dr. I.M. Leigh, London, England 
Sigma, Saint Louis, Missouri 
ICN Biochemicals Inc, Ohioa 
Dr. A. Sonnenberg, Amsterdam, The Netherlands 
B4 chain(3E1) Biomol, Hamburg, Germany 
Laminin 5 (P3E4) Chemicon, Temecula, CA 
Collagen type IV (PHM12) Chemicon 
Collagen typeVII (LH7.2) Dr. I.M. Leigh 
•Antibodies not purchased from indicated sources were personal gifts from the investigator named. 
All primary antibodies are listed in table 1. All primary antibodies were monoclonals. Mouse-
anti-human-CD29-IgG1 (1 :200 dilution, Lab Vision, Duiven, The Netherlands) for B1-integrin, 
CK13 (1 :25 mouse anti human CK13 monoclonal lgG2a (Euro Diagnostica, Arnhem, The 
Netherlands), CK1 0 (Mouse- anti-human-keratin 10 lgG1 (1 :50, Euro Diagnostica), involucrin 
(1 ;1600, mouse-anti-human-involucrin lgG1 , Lab Vision) vimentin (1 :100, mouse-anti-human-
vimentin lgG1, Euro Diagnostica) and Kl-67 (1 :200, mouse-anti-human-Ki-67 lgG1, Heverlee, 
Belgium) were added in first step buffer and incubated at 4°C overnight. As controls, isotype 
controls were added as a primary antibody, as well as no primary antibody. 
The next day, samples were washed using washing buffer (0.1% tween in PBS) and 
incubated with the secondary antibody, biotin labelled goat anti mouse immunoglobulins 
(Dako) in secondary buffer (2% normal goat serum, 2% rabbit serum and 5% Bovine Serum 
Albumin in PBS) for 30 minutes at room temperature. Biotin labelled goat anti-mouse lg-G 
was used for B1-integrin staining under the same conditions. Following a washing step using 
washing buffer, streptavidin-HRP complex (Dako) was added 1:300 in secondary buffer for 
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30 minutes at room temperature followed by a washing step with washing buffer. In the case 
of vimentin, streptavidin-ABC-HRP (Dako) was used under the same conditions. Next, the 
substrate (24).Jl of 30% H20 2 in PBS was added to 1.2ml 5% DAB (Sigma)) was added to the 
samples for 5 minutes before stopping the reaction using tap water. Next, counterstaining 
was performed using haematoxylin for 10 seconds. The samples were mounted using 
Vectamount (Dako) after drying. 
Cell counting and statistical analysis 
For analysis of cell layers and number of basal cells, 6 fields of view per graft were counted 
using a 100x magnification. Duplicate grafts of two separate experiments were quantified. 
For statistical analysis a non-parametric Mann-Whitney test was used. 
Results 
Fibroblasts remain present in the dermis upon centrifugation 
Success of the seeding protocol was confirmed by vimentin staining to identify the fibroblasts 
in the dermis. Fibroblasts were homogeneously incorporated in the seeded dermises (Figure1 
A, B). High power magnification of the incorporated fibroblasts in the dermis show vialble 
cells with normal nuclear morphology and nucleus/cytoplasma ratios (figure 1C). Control 
samples without fibroblasts showed no dermal vimentin staining. Quantification of the 
number of fibroblasts in supernatant of centrifuged cell suspensions showed 220.000 cells 
remained in the dermis per cm2 graft. 
Fibroblasts Enhance Epidermal Morphology 
Fibroblasts were centrifuged into the reticular side of acellular dermis to study the effect 
of fibroblast on epidermal quality. This was followed by seeding of keratinocytes onto de 
papillary side of the dermis and rising of mucosal constructs to the air-liquid interface. 
Histological analysis of 7 days samples revealed a clear epidermis of differentiated 
keratinocytes with basal, spinal and granular layers. 
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Figure 1: Fibroblasts remain present in the dermis upon centrifugation. Vimentin staining shows 
fibroblast incorporation in to the a cellular dermisat at dayl and day 14 of culture at the air-
liquid interface (magnification A and 8, 40x). Color images available online at www.liebertpub. 
com/ten. 
Histogenesis of mucosal constructs in the presence of fibroblasts at the 7th and 14th day at 
air-liquid interface (figure 2 a and b) showed a much more developed epidermis than samples 
without fibroblasts. Quantification of the number of basal cells per surface area showed an 
increase in grafts with fibroblasts incorporated of 52.7% at the 7th day (P = 0.03) and 41.1% 
at the 14th day (P = 0.02). In addition, the number of cell layers increased 78.2% (P = 0.03) 
and 49.0% (P = 0.02) respectively (figure 3a and b) as a result of fibroblast incorporation. 
Furthermore, it was noted that the number of basal cells had significantly decreased after 
14 days in the grafts without fibroblasts (P = 0.02). Fibroblast addition resulted in a stable 
number of basal cells per surface area. A significant decrease in cell layers of keratinocytes 
was observed (P = 0.02) in the constructs without fibroblast. Fibroblast incorporation, on 
the other hand, resulted in a significant increase in cell layers over time (P = 0.05). 
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NoMbrobbsts. With fibroblasts 
Figure 2: Histology of cultured mucosal substitutes at 14 day sculturing at the air-liquid 
interface. The left column indicates grafts without fibroblasts, and the right column has 
fibroblasts incorporated into the dermis. (A, B) Hematoxylin and eosin staining showing a better· 
organized epidermis upon fibroblast incorporation. (C,D) and (E,F) Cytokeratin 10 and involucrin 
staining for differentiated keratinocytes showing fibroblast incorporation delays keratinocyte 
differentiation. (G,H) and (l,J) f31 integrin and its a6 subunit staining confirming delayed 
keratinocyte differentiation in the fibroblast-incorporated group of dermises (magnification 
A-J, 200x).Color images available online at www.liebertpub.com/ten. 
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Fibroblasts Delay Differentiation 
The role that fibroblasts play in epidermal regulation of differentiation was investigated by 
examining expression of proteins related to keratinocyte differentiation. K10 and involucrin 
expression (figure 2 c-f) in mucosal constructs containing fibroblasts showed suprabasal 
expression in all samples, as can be observed in natural mucosal tissues. In contrast, 
fibroblast free cultures showed expression of K1 0 in the basal cells as well as in suprabasal 
keratinocytes. 
Expression of integrin subunits flp a6 and 54 was evaluated as well (figure 2 g-j). A 
clear increase in number of positive cells per cm2 of graft and expression levels of these 
cells at the basal layer was observed in the CMS with fibroblasts. In addition, expression of 
the integrin at suprabasal levels of the epidermis was observed in the fibroblast containing 
CMS. 
Fibroblasts Enhance Proliferation in the Epidermis 
Ki-67, a marker expressed in proliferating cells, was used to quantify the number of 
proliferating basal cells (figure 4). The mitosis index (MI), expressed as % of basal cells 
positive for Ki-67 was calculated. This showed that fibroblast incorporation leads to an 
increase in Ml of 52.8% at day 7 and 53.5% at day 14. These differences were statistically 
significant with P values of 0.03 and 0.02 respectively. Other indicators of hyper proliferation 
include suprabasal cells expression of Ki-67 as well as 51 integrin or its subunits. This was 
only observed in grafts with fibroblasts. 
Concurring with these data are the levels of expression of hyperproliferation-associated 
marker K17 (figure 5 f·h). At day 7, K17 is expressed less in grafts without fibroblasts than in 
the grafts with fibroblasts. At day 14, K17 expression was noted in both groups, although a 
decreased expression of K17 at the basal segment of the epidermis in fibroblast containing 
CMS was observed compared to its day ?·time point. 
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Figre 3: Quantification of the number of basal cells pe rhigh-power field (A) and the number 
of epidermal cell layers (B). At all time points, the incorporation of fibroblasts into the dermis 
resulted in an increase in basal cells, as well as an increase in cell layers. Data represent mean 
±standard error of the mean. Six fields of view were counted in duplicate grafts per time point 
of 2 separate experiments. 
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100~-------------------------, 
E IIIII Without Fibroblasts 
With Fibroblasts 
Day 7 Day 14 
Figure 4: Ki-67 staining at day 7 (A, B) and day 14 (C,D) shows that the incorporation of fibroblasts 
(rightcolumn) results in enhanced proliferation in the basal cells. Furthermore, suprabasal 
proliferation was observed in the fibroblast group. Quantification of the prolife rating basal 
cells (E) using high-power magnification showed an increase of up to 30% as a result of fibroblas 
tincorporation. Data represent mean standard error of the mean. Six fields of view we recounted 
in duplicate grafts per time point of 2separate experiments (magnification A-D, 200x). Color 
images available online at www.liebertpub.com/ten. 
Fibroblasts Enhance Basement Membrane Protein Deposition 
Several proteins were evaluated to study whether fibroblasts played a role in basement 
membrane development. Staining for basal membrane components, such as collagen type 
IV and laminin-5 showed that the incorporation of fibroblasts did not affect expression of 
these basement membrane markers. Collagen type VII at day 7 however (figure 5 a-d), was 
expressed only in fibroblast containing CMS. In 7 days old fibroblast-free constructs collagen 
type VII is not expressed. At day 14 this difference was less pronounced. The expression 
of all analysed BM proteins was confined to the DEJ. In addition, presence of laminin-5 
was noted in the remnants of vasculature basement membrane proteins in the a-cellular 
dermis. 
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No Fibroblasts With Fibroblasts 
A B 
G H 
Day14 
Figure 5: Staining for basal membrane componen tcollagen VII and cytokeratin 17. Cultured 
mucosal substitutes without fibroblasts are indicated in the left column, and grafts with fibroblast 
are shown in the right column. Collagen VII staining showed that, at day 7, the air-liquid interface 
(A, B) and, at day 14 (C,D), the incorporation of fibroblasts results in enhanced deposition of this 
protein at the basal membrane. Hyperproliferation- associated marke rcytokeratin 17 (E-H) was 
enhanced as well as are sultof incorporation of fibroblasts. At day 14, however, the fibroblast 
group showed less expression in the basal cells (magnification A-J, 200x). Color images available 
on line at www.liebertpub.com/ten. 
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Discussion 
The objective in mucosal engineering is to have a well-differentiated epidermis, which is 
firmly attached to the dermal carrier at the basement membrane. Furthermore, certain 
in vivo characteristics play key roles in successful transplantation. Contraction should be 
minimal and angiogenesis maximal for optimal vascularisation ensuring the delivery of 
nutrients, cells and antibiotics to the grafted tissue. For successful clinical application the 
graft should be easily handled and sutured in place by the surgeon. Finally, culture time 
should be minimized. 
Problems of blistering, fragility and wound contraction in early ventures for clinical 
use of cultured epidermal substitutes without dermal carriers showed the necessity 
of a dermal component for clinical use (23). The use of collagen gels as dermal carriers 
encountered problems in handling and wound contraction. Of the various clinically approved 
dermal analogues, an a-cellular dermis ensures minimum wound contraction and optimal 
mechanical properties. Furthermore, the vasculature can invade into the dermis from the 
wound bed using the basement membrane proteins present in the remaining proteins of 
basal membranes of the donor vasculature (12, 14,24,25). A problem encountered in our 
laboratory in producing CMS using a-cellularized cadaver skin, however, is varying quality of 
the newly formed epidermis. 
Studies using collagen gels showed the beneficial effects of addition of fibroblasts 
on epidermal quality of a construct (12, 17). Incorporation of fibroblasts into an a-cellular 
dermis, however, has proved to be technically challenging and its effects have not been 
described for mucosal substitutes. From our study, a number of observations illustrate the 
extent to which fibroblast determine the quality of the epidermis. 
In this study it became clear that fibroblasts incorporated into an a-cellular dermis improves 
epidermal morphogenesis. A better-organized epidermis at day 7 and day 14 in the fibroblast 
supplemented grafts, as well as a higher number of cell layers and better cell alignment at 
the basal layer illustrated this. Another indication of improved epidermal development by 
the addition of fibroblast was the increase in cell layers and stable number of basal cells 
over time. 
Evaluation of integrin subunits 81, a6 and 84 revealed suprabasal integrin expression 
while in the fibroblast free matrices expression was confined to the basal layer. Also Ki-67 
staining for proliferative cells showed suprabasal proliferation in the CMS with fibroblasts 
incorporated. In addition, it showed a significant increase in Ml of the basal keratinocytes. 
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Finally, hyperproliferation associated marker K17 was expressed, irrespective of the 
absence or presence of fibroblasts. These results indicated a hyperproliferative state of the 
epidermis. This finding indicates that the grafts are in an activated state. Hyperproliferation 
of the epidermis is commonly seen as the first phase in wound healing and is considered 
beneficial to the process (15,26,27). Moreover, decreased proliferation in the epidermis, 
one of the effects of ageing, is correlated to impaired wound healing (28,29). 
The observed activated state of the epidermis might be caused by paracrine factors 
secreted by the fibroblasts. A number of studies described the paracrine pathway by changing 
the phenotype of epidermis by heterotypical recombination experiments. Examples include 
studies performed by Okazaki et al. (11 ,30), where nail matrix fibroblasts were combined 
with skin keratinocytes. The keratinocytes started to express nail specific keratins. Also, 
they have shown the expression of mucosa specific keratins when mucosal fibroblasts were 
combined with skin keratinocytes and vice versa (30,31). An important paracrine growth 
factor that is known to affect the epidermis is Keratinocyte Growth Factor (KGF). KGF is 
a member of the FGF family and is also known as FGF-7. It is produced by fibroblasts, not 
by keratinocytes and it affects keratinocytes through the receptor that is expressed on 
keratinocytes. It is cytoprotective and known to be a mitogen and motogen (21 ,32,33). 
Another growth factor that might be responsible for the activated epidermis is EGF 
(Epidermal Growth Factor). This growth factor has been supplemented to the culture media 
and documented earlier as an epidermal activator (34,35). Interestingly, the epidermis 
formed in fibroblast-seeded matrices resembled the epidermis that can be seen in cultured 
skin substitutes, which are stimulated using EGF or KGF (20,21 ,33). One more explanation 
might be the high amount of fibroblasts incorporated into the matrices. El Ghalbzouri et al. 
(16) has shown in skin substitutes that a specific number of fibroblasts incorporated per 1 
ml collagen results in epidermal normalization (absence of K6, K16 and K17). For mucosal 
substitutes the optimal fibroblast concentration should be established as well. As for the 
preparation of C. M.S., hyperproliferation is probably advantageous to the fabrication 
process, as it reduces culture time. Expression of hyperproliferative markers is expected to 
normalize upon transplantation (24). 
Fibroblasts promoted early maturation of the derma-epidermal junction (DEJ). The 
DEJ plays an important role in prevention of separation of the epidermis from the dermis. In 
disorders such as inherited Junctional Epidermolysis Bullosa, the deposition and attachment 
of keratinocytes to basal membrane proteins, such as laminin 5 is disturbed (36). Here the 
D.E.J. is incomplete, resulting in blisters. Additionally, basement membrane components 
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play a role in re-epitheliasation. Proteins, such as laminin 5 and collagen VII, a component of 
the anchoring fibrils, are deposited by fibroblasts and keratinoctytes (37,38). Furthermore, 
laminin 5 plays an important role in the restoration of the basement membrane, as it 
stimulates keratinocyte migration and proliferation (39,40). In our in vitro study a more 
rapid maturation of the DEJ was observed as a result of fibroblasts being present in the 
dermis. This concurs with data from other authors. El Ghalbzouri showed this effect for 
keratinizing skin by culturing grafts in fibroblast-conditioned medium (37,38). This suggests 
that this phenomenon is of a paracrine origin. The observation has clinical implications as a 
more mature DEJ might result in a firmer anchoring of the epidermis to the dermis, resulting 
in reduced problems of blistering or loss of the epidermis upon transplantation into the 
mechanically challenging oral environment. 
Another positive in vivo effect can be expected from seeding dermal carriers with 
dermis-derived fibroblasts in vitro, as it provides a carrier for the proper type of fibroblast 
to the wound upon transplantation. In the case of a construct without fibroblasts, fibroblasts 
migrate into the dermis from the wound bed. The wound bed derived fibroblasts often 
originate from fat or scar tissue, which contains a large number of myofibroblasts. Others 
have shown, that addition of fat derived fibroblast or myofibroblasts to a dermis leads to 
enhanced dermal contraction by a-smooth-musle actin expressing myofibroblasts (8-10). 
Therefore, the addition of dermal fibroblasts to our CMS prior to transplantation could 
result in reduced scar contraction and better wound healing (12). In addition, Erdag et al 
have shown that the addition of fibroblasts to the constructs enhances angiogenesis and 
improves graft survival. 
Conclusion 
From these observations presented in this study we conclude that the addition of fibroblasts 
to an acellular dermal carrier resulted in a clear improvement of epidermal morphology. 
Addition of fibroblast resulted in an increase of basal cells per surface area and early 
ripening of the DEJ, facilitating early transplantation. The in vitro data predict a possible 
improvement of in vivo behavior of these grafts. From our data it can be concluded that 
development of epidermis and basal membrane takes significantly less time, which is an 
important step forward towards clinical implementation of these techniques (41 ). his 
might have consequences for the culture time prior to transplantation. Further studies 
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will be performed looking at the optimal time for transplantation for the construct with 
fibroblasts. 
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Abstract 
Cultured mucosal substitutes (CMS) have been developed for clinical use. Upon transplantation 
of CMS, a period of hypoxia occurs as vasculature invades the a-vascular dermis. This makes 
the CMS fragile and susceptible to e.g. infection. 
In this report, the effect of hypoxia on epidermal morphology, proliferation and differentiation 
was studied using reconstructed mucosal substitutes as a three-dimensional model. Hypoxia 
was shown using a pimonidazole staining after 24 up to 72 hours in hypoxic culture using 
1.5% oxygen. CMS were stained for the differentiation marker cytokeratin 10 (K1 0) and the 
integrin subunit P.l1• Epidermal proliferation was examined by a Ki-67 staining. Finally, the 
secretion of VEGF was examined by ELISA 
The results show that hypoxia disturbed epidermal architecture and decreased B1 integrin 
expression in basal keratinocytes, while the differentiation program (K10 expression) was 
altered as well. In addition, mitotic indices decreased after hypoxic treatment. Finally, a 
transient upregulation of VEGF secretion was observed the first 48 hours. 
In conclusion hypoxia delays differentiation, reduces proliferation, and decreases metabolic 
activitity. 
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Introduction 
Oral cancer is the sixth most common cancer in the world. It accounts for approximately 
4% of all cancers and 2% of all cancer deaths worldwide. Malignant tumors of the oral 
cavity account for approximately 30% of all head and neck cancers. With incidence rates of 
invasive lip and oral cavity tumors in the Netherlands rising to 6.6%, oral cancer is a common 
malignancy that often requires resection of the tumor followed by reconstruction (1 ,2). 
Reconstruction of large intraoral mucosal defects is typically performed using free or 
pedicled skin or muscle flaps. Drawbacks to the use of skin flaps include donor site defects, 
bulkiness, sweating and hair bearing (3,4). The feasibility of culturing oral mucosa in vitro 
for use in reconstructive surgery has been described. Clinically used Cultured Mucosal 
Substitutes (CMS) typically are composed of cultured mucosal keratinocytes seeded onto an 
a-vascular dermal carrier such as a-cellularized cadaver skin. 
Clinical use of CMS using non-keratinizing keratinocytes have been troubled by problems 
such as infection and partial graft take. Upon transplantation, a phase of plasmatic inbibition 
occurs prior to vasculature invading the a-vascular dermis. Cells are depending on diffusion 
to provide oxygen and nutrients. During this period grafts are hypoxic and vulnerable to 
infection. 
Hypoxia has a number of well-documented effects on cells and tissues. It enhances 
the secretion of survival enhancing factors such as Hypoxia Inducible Factor 1 (HIF-1 ), 
which in turn induces the secretion of angiogenic factors, such as VEGF i-NOS and PDGF-B 
(5,6). Furthermore, hypoxia induces metabolic changes enhancing production of glycolytic 
enzymes favouring anaerobic glycolysis and cell survival (7,8). On the other hand, hypoxia 
induces cell cycle arrest (9) and finally apoptosis through e.g. P53 pathways (1 0,11 ). 
In contrast to hypoxia, hyperbaric oxygen therapy seems to be beneficial to survival of 
skin grafts by increasing oxygen tension in the grafts and reducing bacterial contamination 
(14-17). Also, overexpression of VEGF by genetic modification of cultured skin grafts has 
been shown to result in enhanced survival of grafts and angiogenesis (18, 19). 
To date, published reports discussed changes in two-dimensional systems. No data 
have been published on the effect of hypoxia on three-dimensional CMS. Therefore the 
aim of this study was to characterize the CMS in hypoxic conditions in vitro as a model for 
the early period post transplantation. More specifically, the effect of hypoxia on epidermal 
morphology, differentiation and proliferation, as well as secretion of angiogenic growth 
factors in CMS has been evaluated. 
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Materials and methods 
Culture of human keratinocytes 
Upon approval of the local medical ethics committee, human buccal mucosa was harvested 
from patients during scheduled ablative intra oral procedures. The mucosa was incubated in 
an antibiotic cocktail for 1 hour (Penicillin/Streptomycin (1 00 U/ ML/1 00 tJg/ml), Gentamycin 
(50 tJg/ ml), Amphotericin B (2. 5 tJg/ ml), all Invitrogen, Breda, The Netherlands). Biopsies were 
transferred to dispase (2.5 mg/ ml, (Invitrogen)) in antibiotic cocktail, at 4°C overnight. After 
which they were put at 37° for 10 minutes prior to gentle separation of the epidermal sheets 
from dermis. The dermis was used to isolate fibroblasts as described below. Subsequently, 
epidermal sheets were put in Trypsin-EDTA, 0.25% (Sigma, Zwijndrecht, The Netherlands) at 
37°C for 20 minutes. After neutralisation of trypsin by DMEM with 10% Fetal Bovine Serum 
(FBS) (Sigma) a single cell suspension was obtained by gentle pipetting. Keratinocytes were 
seeded into a T75 culture flask onto a feeder layer of lethally irradiated 3T3 fibroblasts (a 
kind gift from dr. von den Hoff, Department of Orthodontics and Oral Biology, University 
Medical Centre, Nijmegen, The Netherlands) in seeding medium, according to the Howard 
&. Green protocol (20-22). Keratinocyte seeding culture medium was composed of a 3:1 
mixture of DMEM, high glucose and Ham's F12 medium (Invitrogen), supplemented with 10% 
FBS; adenine, 1.8x10-4M (Sigma); cholera toxin, 1 o-10 M (VWR international, Amsterdam, 
The Netherlands); hydrocortisone, 0.4 tJg/ml (VWR); insulin, 5tJg/ml (Eli Lily, Houten, the 
Netherlands); triiodo-L-thronine, 2x10·9 M (Sigma) and penicillin-streptomycin, 100 IU/ml-
100tJg/ml (Invitrogen). 24 Hours after seeding, proliferation medium was added to the cells. 
Proliferation medium was composed of seeding medium supplemented with 10ng/ml mouse 
epidermal growth factor (EGF, Sigma). The medium was changed every 2 days. 
Isolation and culture of human fibroblasts 
Upon separation of epidermis from dermis, the dermis was minced and put into DMEM 
with 1.5 mg/ml collagenase I and 2.5 mg/ml dispase at 3JOC for 90 minutes. Subsequently, 
enzyme solutions were filtered using a 1 OOtJm cell strainer prior to centrifugation at 1000 
RPM (200 g) for 5 minutes. Next, cells were seeded onto culture dishes in 10% FBS, penicillin-
streptomycin 1001U/ml-100tJg/ml and gentamycin (50 tJg/ml) in DMEM and cultured at 37°C, 
10% C02• Fibroblasts at passage three to five were used for experiments. 
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Preparation of a-cellular dermis 
Human cadaver skin, cryopreserved in 80% glycerol, and CMV, HIV, HBV negative, was 
obtained from the European Skin Bank, Beverwijk, the Netherlands. The epidermis was 
pealed off the dermis after overnight incubation in 1 Ox PBS with antibiotic cocktail and 
ethylene-diamine-tetra-acetic-acid (EDTA). Remaining dermis was acellularized by gamma 
irradiation (35Gy) and cut into pieces of 1.5 cm2 and stored in DMEM supplemented with 
penicillin-streptomycin and gentamicin. 
Centrifugal seeding of fibroblasts 
To seed mucosal fibroblasts into the acellular dermis, a protocol was optimized using a 
centrifugal seeding technique and a-cellular dermis, as described elsewhere (23,24). 1.5 cm2 
pieces of dermis were placed with their basal membrane side down onto 40 ml of DMEM I 1% 
agarose gel in a 50 ml Falcon tube (BD biosciences, Alphen aan den Rijn, The Netherlands) at 
room temperature. Next, 1 ml of fibroblast suspension containing 800,000 cells was added. 
Grafts were centrifuged at 200 g for 90 minutes. 
Culturing mucosal substitutes 
Upon centrifuging fibroblasts into dermis, pieces were placed with basal membrane side up 
onto 6 well dishes. Grafts were produced in duplicate. A stainless steel seeding ring with a 1 
em diameter was placed on the dermis and subsequently filled with keratinocyte suspension 
containing 250,000 third passage keratinocytes in seeding medium, composed of DMEM/F12 
(3:1), FBS 1%, cholera toxin 10·10 M, hydrocortisone 200 ng/ml, insulin 5 1-Jg/ml, ascorbic 
acid 50 1-Jg/ml (Sigma) and penicillin-streptomycin 100 IU/ml-1001-Jg/ml, as described 
elsewhere (25,26). Next day, priming medium, which is seeding medium supplemented with 
bovine serum albumin (BSA) 241-JM (Sigma), was added, fatty acid cocktail (oleic acid 25 1-JM, 
linoleic acid 15 1-JM, arachidonic acid 7 1-JM, palmitic acid 251JM) (Sigma), L -carnitine 10 11M 
(Sigma) and L-serine 1 mM (Sigma). Grafts were maintained in this medium submerged for 
an additional 2 days. Next, grafts were placed on a stainless steel mesh in a 6 well dish and 
were raised to the air-liquid interface for 7 or 14 days. Air-liquid interface medium was 
composed of serum-free priming medium supplemented with 1 ng/ml epidermal growth 
factor (EGF)(Sigma). Medium was changed every 2 days. 
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Hypoxia protocol 
After 14 days at air-liquid interface, medium was changed and 5ml of medium was added 
to CMS on grids in 6 well plates remaining at the air-liquid interface. Next, six grafts were 
placed in 1.5% oxygen, 5% C02, and six grafts were placed in a regular stove using 20% 
oxygen, 5% C02• At time points 24, 36, 48, 60 and 72 hours media samples (1.5ml) were 
harvested from all CMS cultures and 1.5ml of fresh media was added. Harvested media 
samples were centrifuged and stored in -20°C until analysis using ELISA was performed. At 
time points 0, 24, 48, and 72 hours, duplicate grafts were harvested and cut in two parts for 
paraffin embedding and cryosectioning. 
Morphology and Immunohistochemistry 
Protocols for morphology and immunohistochemistry were performed according to protocols 
as published earlier (27,28). In short, harvested mucosa cultures were snapfrozen or washed 
in PBS, fixed in 4% paraformaldehyde, dehydrated and embedded in paraffin. Sections (6 
11m) were cut, deparaffinized in ethanol and rehydrated in preparation for morphological 
or immunohistochemical analysis of keratin 10, 16, integrin subunit B1 and Ki67. 
Immunohistochemical analysis of K16 and K1 0 was performed using 5 11m frozen sections, 
which after sectioning at -20°(, were air-dried overnight, fixed in acetone for 10 minutes. 
The primary antibodies used in the present study are listed in Table 1. 
Table 1: Primary antibodies used for immunohistochemical staining of tissue sections 
Antibody designation 
Paraffin-embedded 
Frozen 
Keratin 10 (CK-10) 
B1 chain (CD29) 
Hypoxiprobe-1 
Ki67 (Mb67) 
Keratin 1 6 (LL0025) 
Sourcea 
Euro Diagnostica, Arnhem, The Netherlands 
Lab Vision, Duiven, The Netherlands 
Chemicon International, Huizen, The Netherlands 
DAKO, Heverlee, Belgium 
Dr.I.M.Leigh, London, England 
•Antibodies not purchased from indicated sources were personal gifts from the investigator named. 
After incubation with primary antibodies, sections were stained with avidin-biotin-peroxidase 
complex system (streptABcomplex/HRP, DAKO), as described by the suppliers with the 
following minor modifications: phosphate-buffered saline was used instead of Tris-buffered 
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saline and for Ki67 staining antigen retrieval was performed by immersing slides in 0.1 M 
citrate buffer (pH 6.0) for 30 min at 100°( followed by slow cooling to room temperature 
for at least 3 hours prior to staining of the sections. All sections were counterstained with 
hematoxylin. 
Visualization of Hypoxic Cells 
For visualization of hypoxic cells, a Hypoxiprobe-1 kit was used (Chemicon international, 
Huizen, The Netherlands). This kit contains Pimonidazole and stains hypoxic cells using 
immunohistochemistry. Parafinized slides were used according to company's instructions. 
ELISA for FGF and VEGF 
Culture media were assayed for basic Fibroblast growth factor (bFGF) and vascular endothelial 
growth factor (VEGF) using duo sandwich ELISA kits (R&D systems, Abbingdon, UK). Samples 
of each 12 hours were assayed in triplicate, according to the company's instructions. 
Mitosis Index 
For analysis of proliferation, Ki-67 positive cells in the basal layer of 6 fields of view per 
graft were counted using a 1 OOOx magnification. Duplicate grafts per group were quantified. 
The resulting data were expressed as the mean ±SD. 
Statistical analysis 
For statistical analysis a non-parametric Mann-Whitney test was used for both Ki-67 and 
ELISA data. 
Results 
Mucosal grafts are hypoxic in 1.5% oxygen 
Grafts were cultured at air liquid interface for 14 days. After 14 days one half of the grafts 
were cultured under hypoxic conditions in 1.5% oxygen up to 72 hours. To test whether this 
treatment resulted in hypoxia a pimonidazole staining was used. Normoxic cultures (figure 
1A) showed no hypoxic cells. After 24 hours hypoxic cultures show an intense staining in 
epidermis as well as in dermal fibroblasts that were centrifuged into the dermis, indicating 
intracellular hypoxia in 1.5% oxygen (figure 1 B), 
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Figure 1: A-B:Hypoxic cultures show intense staining, even after 24 hours, pimonidazole, 
indicating hypoxia (figure 18). Normoxic cultures showed no hypoxic cells (figure 1A). C-D: 
Hematoxyllin and Eosin stainging showed a disturbed architecture of basal cell/ayers in hypoxic 
grafts, Normoxic grafts (left column) displayed 1-2 well aligned rows of basal cells with round-
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shaped nuclei. Hypoxic grafts (right column) seemed to have only 1 row of basal cells after 
24 hours. This row was not well-organized and showed reduced numbers of cells per layer of 
keratinocytes. Moreover, after 72 hours in hypoxic culture the number of cell layers in hypoxic 
grafts proved to be more than in the epidermises of normoxic grafts. E-F: lntegrin [31 was 
expressed at the suprabasal cell layers of normoxic CMS. Hypoxic conditions on the other hand 
induce differentiation after 48 hours 81 expression was reduced to the basal layer. Figure 1G-H: 
K10 expression in mucosal constructs showed suprabasal expression in all normoxic mucosal 
tissues. Hypoxic cultures showed increased differentiation of the epidermis as jugged by the 
expression of K10 in the basal cells as well as in suprabasal keratinocytes. Magnification 200x 
Hypoxia reduces number of viable cell layers 
After confirming hypoxia, morphologic analyses were performed. H&E staining showed a 
disturbed architecture of basal cell layers in hypoxic grafts. While normoxic grafts (figure 
1 C) displayed 1-2 well-aligned rows of basal cells with round-shaped nuclei; hypoxic grafts 
seemed to have only 1 row of basal cells (figure 1 D). This row was not well-organized and 
showed reduced numbers of cells per layer of keratinocytes. Moreover, after 72 hours in 
hypoxic culture the total number of cell layers in epidermises of hypoxic grafts proved to be 
less than those of normoxic grafts. 
Hypoxia enhances K10 expression and reduces B1 integrin expression 
After showing altered morphology, epidermal differentiation patterns were studied. lntegrin 
subunit B1 was used as a marker for basal cells while K10 was used to show differentiation. 
The integrin B1 was expressed at basal and suprabasal cell layers of normoxic CMS as 
was described previously (27). However, after 48 hours hypoxia, B1 levels were reduced, 
indicating differentiation (figure 1 E,F). 
K1 0 expression (figure 1 G ,H) in mucosal constructs showed suprabasal expression in all 
norm oxic mucosal tissues. Concurring with our B1 data, K1 0 staining showed hypoxia induced 
differentiation of keratinocytes as K1 0 was expressed in basal as well as in suprabasal 
keratinocytes. Both K1 0 and B1 are correlated to proliferative qualities of keratinocytes, 
hence results indicated a decrease in keratinocyte proliferation. 
Hypoxia results in a decrease in proliferation 
To evaluate whether hypoxia affects the epidermal proliferation process, we examined 
the expression of Ki-67 and K16 (hyper-proliferation associated keratin) in hypoxic and 
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normotoxic cultures (figure 2 A and B). Kertinocyte proliferation was only observed in the 
basal cell layers under both conditions. Mitosis index (MI) was calculated and showed a 
significant decrease in percentage of proliferating basal keratinocytes per surface area after 
24 hours of hypoxia from 88.8% (±1.19) in normoxia to 55.1% (± 0.57) in hypoxia (P<0.05). 
This difference increased up to a 51.6% reduction, from 84% (± 5. 79) in normoxia to 40.7% 
(± 1.35) after 72 hours (P < 0.05, figure 3c). No differences were observed in the expression 
of the hyperproliferation associated protein K16 in hypoxic and norm oxic cultures (data not 
shown). 
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Figure2: Proliferation marker Ki-67 showed proliferation confined to the basal cell/ayers (Figure 
2A). From gross morphology at 100x magnification after 72hrs in hypoxic culture (figure 28), 
a obvious decrease in proliferation can be observed. Mitosis indices (MI) were calculated and 
confirmed a significant decrease after 24 hours of hypoxia up to a 51% reduction after 72 hours 
(figure 2c, magnification 200x, *= P < 0. 05). 
Hypoxia transiently upregulates VEGF expression 
The effect of hypoxia on secretion of angiogenic growth factors that play a role in 
vascularisation was studied, since hypoxia is thought to stimulate angiogenesis partly by 
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up-regulation of VEGF, We analyzed the presence of VEGF and FGF in the medium of the 
cultures using ELISA (figure 4). Results showed an immediate difference in VEGF secretion 
by hypoxia. This difference was significant up to 48 hours (P < 0.05). Differences were up to 
1. 72 fold after 24 hours in hypoxic culture conditions. Concentrations of VEGF in the media 
of hypoxic cultures rises rapidly in the first 24 hours after which concentrations remain 
stable. The VEGF concentrations in normoxic culture media on the other hand rises until 72 
hours, resulting in a reduction of the difference between normoxic and hypoxic conditions 
to 2%. Concentrations of FGF did not differ between normoxic and hypoxic conditions (data 
not shown). 
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Figure 3: Culture medium was analyzed for VEGF concentration. The results show an immediate 
and significant increase in VEGF secretion in hypoxia within the first 48hrs of up to 1.72 fold. 
VEGF Concentrations in normoxic culture media rise over time, resulting in reduction of these 
differences to 2% at 72 hours(, *= P < 0.05). 
Discussion 
The aim of this study was to characterize responses of three-dimensional cultured mucosal 
substitutes to hypoxic conditions. This is the first report on the clinically highly relevant 
behavior of CMS under hypoxic conditions. Others have reported on the effect of hypoxia 
using two dimensional cell culture. In contrast to a two-dimensional system, a three-
dimensional construct, has a natural multi-layered structure, where cells interact with 
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eacht other as well as with the extracellular matrix. Also exposure of individual cells to 
their environment is different, depending on cell position in the epidermis. 
It has been demonstrated that epidermal hypoxia occurs frequently under physiological 
conditions (29). For example, wound margins become hypoxic immediately after wounding 
due to a reduced dermal blood supply by intravascular cloth formation (30). Also, in bone 
marrow, progenitor cells are physiologically subjected to hypoxic conditions (31 ). In vitro, 
keratinocytes in the CMS survive on diffusion of oxygen from the air and culture media. 
Upon transplantation oxygen levels will decrease while the (semi) occlusive dressings render 
oxygen levels to a minimum. 
Pimonidazole staining showed epidermises to be hypoxic in the 1.5% oxygen culture 
conditions. Pimonidazole is a marker for hypoxia, forming protein adjuncts in hypoxic cells. 
It has been well-established to study hypoxia wound healing (32) tumors (33) and tissue 
engineered constructs (34). 
Hypoxia altered epidermal morphology. Architecture of the epidermis was disturbed 
and thickness of the epidermis was reduced as less cell layers were formed. This may be a 
result of reduced proliferation, a hypothesis that was confirmed by our immunohistological 
data. Expression of the integrin subunit B1 was reduced while differentiation marker 
K1 0 was enhanced. B1 expression is typically considered to be confined to proliferative, 
basal cells in the epidermis while K10 expression concurs with differentiation and loss of 
proliferative capacities (35), On top of this our Ki-67 data showed a decrease in mitosis 
indices by hypoxia. K16, a marker for hyper proliferation, was equally expressed by the 
keratinocytes, indication that this process is not altered by hypoxia. An explanation for this 
observation might be the presence of EGF in the medium. EGF is considered to activate 
the epidermal proliferation program (24). Our data on proliferation concur with others who 
have shown in two-dimensional cell culture that hypoxia in vitro leads to growth arrest of 
cultured keratinocytes. Moreover, some groups have shown this arrest to be temporary and 
reversible upon re-oxygenation (9). 
In our three-dimensional model, FGF was not enhanced by hypoxic conditions, which 
concurs with recent data on mesenchymal stem cells in hypoxic culture (37). No reports 
on skin or CMS have been published on this subject. VEGF secretion on the other hand was 
increased in hypoxic cultures and reached its maximum after 36 hours in culture. At later 
time points, VEGF levels remained constant while secretion in normoxic grafts seems to 
increase. This observation is in line with data obtained by others on cultured keratinocytes 
(6,38,39). 
------------- Effect of Hypoxia in Vitro on Cultured Mucosal Substitutes 
The current study validated the use of CMS under hypoxic conditions as a model for the early 
period post transplantation. From our data it was seen that hypoxia results in decreased 
metabolism as well as differentiation. Also, VEGF was rapidly but transiently up regulated. 
Whether these two effects enhance survival by decreasing demand for nutrients and oxygen 
while angiogenesis is enhanced in the wound bed is one hypothesis that warrants further 
research. 
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Abstract 
Oral mucositis is a major side effect of radiation therapy. Development of strategies 
for reduction of this problem calls for quantitative models. The goal of the present 
study was to test the feasibility of detecting double·strandbreaks (DSBs) and DSB repair 
proteins upon radiation of mucosa in a 3-dimensional culture system using morphology and 
immunohistochemistry. 
Human oral keratinocytes and fibroblasts were seeded onto and into anacellular dermal 
carrier to produce a cultured mucosal substitute (CMS). CMSs were gamma-irradiated with 
0,2, and 12Gy. One group received 4 Gythrough 2 Gyfractions with a 24-h interval. 
Radiation-induced damage was quantified using hematoxylinandeosin (H&.E). DSBs and DSB 
repair proteins were visualized and quantified using antibodies against P53 binding protein 
1 (53BP1 }, MRE11, and RAD51. As in cell culture, CMSs showed intranuclear loci of damage 
and repair, mostly in the proliferative basal cell layers. Maximum percentages of damaged 
basal layer keratinocytes were 54.8% using H&.E (12Gy) up to 78.9% (12Gy )for 53BP1. 
This study shows the feasibility of DNA repair markers to quantify radiation damage. This 
is an important step forward in the study of mucositis and the development of treatment 
and prevention strategies, proving once more the power and clinica limportance of tissue 
engineering. 
DNA Damage and Repair in Vitro Cultured Mucosal Substitutes 
Introduction 
Oral mucositis is considered a major side effect and complication in patients receiving 
chemotherapy, bone marrow transplantation, and radiotherapy for head and neck tumors. 
Clinical symptoms may vary from mild erythema to severe, painful ulcers in the mouth, 
resulting in malnutrition and placement of a feeding tube (1 ). Incidences of 60% in patients 
receiving radiotherapy have been reported. For many of these patients, it necessitates 
breaks in therapy for periods up to several days or weeks and pain relief using morphine 
(2). This allows the defects to heal, although at the same time, oncological therapy is 
compromised because of repopulation by tumor cells (3). Also, long-term effects of radiation 
therapy (e. g., osteoradionecrosis, mucosal atrophy) are related to the severity of the acute 
radiation response (4,5). 
Mucositis is a clinical diagnosis of multifactorial origin (4-6). Damage to the epidermis 
is a result of direct DNA damage from radiation or indirect DNA damage from re-active 
oxygen species released upon radiation. Other causes of indirect damage include the 
release of cytokines and matrix metalloproteinases by epidermal and dermal cells, such 
as endothelial cells and fibroblasts, inducing an inflammatory response and edema. This 
reduces tissue vascularization and oxygenation. The final result is ulceration of the mucosa 
and colonization of the ulcer by the commensal bacteria that are present in large quantities 
in the oral cavity. No in vitro model is available to study radiation-induced damage to 
mucosa. Such a model potentially holds a large number of advantages over in vivo models. 
Tissue engineering might be useful in the development of an in vitro model. 
Radiation primarily affects proliferating cells, causing highly proliferative tumor cells 
to be more radiosensitive than non-dividing cells in healthy tissues. Mucosa, however, is 
a tissue with a physiologically high cell turnover rate, mak-ing the cells susceptible to 
radiation damage. Damage can be observed especially in the basal layer of the epidermis, 
where proliferation of the epidermis occurs. Radiation re-sults in a number of different 
DNA lesions, the DNA double-strand break (DSB) being a particularly genotoxic one. A DSB 
induces cell-cycle arrest, giving time for the cell to recruit repair proteins. Alternatively, 
the cell goes into apoptosis and dies. 
Cells have a number of guarding mechanisms that locate damage and initiate a suitable 
repair mechanism (7). One of the proteins involved in the detection of DSB is P53 binding 
protein 1 (53BP1), a protein that rapidly locates at the site of a DSB, as early as 5 min after 
irradiation. Generally, 12 to 14 h after irradiation, protein localization returns to normal 
(8). 
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DSBs are repaired using processes of the error-prone non-homologous end joining (NHEJ) or 
the error-free homo-logous recombination (HR) (9). The choice of mechanism depends in 
part on the phase of the cell cycle or, more spe-cifically, the number of chromatid copies 
(1 0). In G1 and early S phase, a single copy is present, and the cell uses NHEJ as a repair 
mechanism of choice. During S and G2 phase, how-ever, chromosomes are duplicated such 
that they consist of 2 identical sister chromatids. HR repairs a DSB on 1 sister chromatid, 
using the other intact chromatid as a template. In the processes of NHEJ and HR, a vast 
array of proteins are involved (7, 9,11 ). A number of these proteins locate at the site of the 
DSB and can be used to observe sites of gamma irradiation-induced DSB repair. 
MRE11 is part of a protein complex with the RAD50 and NBS1 proteins. Mutations in 
genes encoding for these pro-teins cause an ataxia-telangiectasia-like disorder or Nijme-
gen breakage syndrome (12). Patients with this disorder or syndrome are radiosensitive and 
cancer prone. A biologi-cally relevant activity of the MRE11 complex is bridging of broken 
DNA ends early in DSB repair (13-16). This activity can be important in the NHEJ and HR 
pathways of DSB repair, even though they are mechanistically distinct. 
The RAD51 protein is another protein playing a key role in DSB repair, specifically in 
the HR pathway. RAD51 mediates DSB repair by promoting pairing of the intact identical 
se-quence on the sister chromatid (17-19). Mutations in HR's in-teracting partner, the 
product of the breast cancer-associated 2 gene (BRCA2}, reveal the clinical importance 
of HR medi-ated by RAD51. Cells with mutated BRCA2 are unable to activate the RAD51 
protein properly, and patients have a life-time risk of approximately 80% of developing 
breast cancer, demanding prophylactic mastectomy (20). 
Upon gamma irradiation of cells, 53BP1, RAD51, and MRE11 localize in sub-nuclear 
structures. They accumulate in large quantities at the site of a DSB, forming ionizing 
radiation-induced foci (IRIF) in the cell nucleus. These DSB-marking foci can be visualized 
using immunofluorescence. In vitro studies have shown the number of cell nuclei with IRIF 
to be dependent on radiation dose using 2-dimensional cultures on plastic (8,21 ,22). 
The goal of the present study was to test the feasibility of detecting DSBs and DSB 
repair proteins upon radiation of mucosa in a 3-dimensional (3D) culture system using mor-
phology and immunohistochemistry. Antibodies that detect 53BP1, MRE11 and RAD51 were 
tested. 
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Materials and methods 
Culture of human keratinocytes 
Upon approval of the local medical ethics committee, human buccal mucosa was harvested. 
The mucosa was incubated in an antibiotic cocktail for 1 h (penicillin/strep-tomycin (100 
IU/ml/100 IJg/mL), gentamycin (50 IJg/mL), amphotericin B (2.5 IJg/mL), all Invitrogen, 
Breda, the Netherlands). The biopsy was transferred to dispase (2.5 IJg/mL, Invitrogen) in 
antibiotic cocktail at 48°C overnight. The next day, the biopsies in the enzyme solutions were 
held at 37°C for 10 min before gentle separation of the epidermal sheets from the dermis. 
The dermis was used to isolate fibroblasts as described elsewhere below. Subsequently, the 
epidermal sheets were put in trypsin-ethylenediaminetetraacetic acid EDTA, 0.25% (Sigma, 
Zwijndrecht, The Netherlands) at 378C for 20 min. After neutralization of the trypsin using 
Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum (FBS) (Sigma) a 
single-cell suspension was obtained by gentle pipetting. Keratinocytes were seeded into 
a T75 culture flask onto a feeder layer of lethally irra-diated 3T3 fibroblasts (a kind gift 
from Dr. von den Hoff, Department of Orthodontics and Oral Biology, University Medical 
Centre, Nijmegen, the Netherlands) in seeding medium, according to the Howard and Green 
protocol (23-25). 
Keratinocyte seeding culture medium was composed of a 3:1 mixture of high-
glucose DMEM and Ham's F12 medium (Invitrogen) supplemented with 10% FBS, adenine 
1.8x1 o·4M (Sigma), cholera toxin 10·10 M (VWR inter-national, Amsterdam, the Netherlands), 
hydrocortisone 0.4 IJg/mL (VWR), insulin 5 g/ml (Eli Lily, Houten, the Netherlands), 
triiodo-L-thronine 2x10·9M (Sigma), and penicillin/streptomycin 100 IU/ml/100 11g/ml 
(Invitrogen). Twenty-four h after seeding, proliferation medium com-posed of seeding 
medium supplemented with 10 ng/ml mouse epidermal growth factor (Sigma) was added to 
the cells. The medium was changed every 2 days. 
Isolation and culture of human fibroblasts 
Upon separation of the epidermis from the dermis, the dermis was washed once more in 
PBS, minced, and put into DMEM with 1.5 mg/ml collagenase I and 2.5 mg/ml dispase 
at 37°C for 90 min. Subsequently, the enzyme solutions were filtered using a 100-11m cell 
strainer before centrifugation at 1000 RPM (200 g) for 5 min. Next, cells were seeded onto 
culture dishes in 10% FBS, penicillin/strepto-mycin 100 IU/ml-100 11g/ml and gentamycin 
50 j.Jg/ml in DMEM and cultured at 37°C, 10% carbon dioxide (C02). Fibroblasts at passages 
3 to 5 were used for experiments. 
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Preparation of a cellular dermis 
Human cadaver skin, cryopreserved in 85% glycerol and cytomegalovirus, human 
immunodeficiency virus, and hepatitis B negative, was obtained from the European 
Skin Bank (Beverwijk, the Netherlands). The epidermis was peeled off the dermis after 
overnight incubation in 1 OxPBS with antibiotic cocktail and EDTA. The remaining dermis was 
acellularized using gamma irradiation (35Gy). The dermis was cut into pieces of 1.5 cm2 and 
stored in DMEM supplemented with penicillin /streptomycin and gentamicin. 
Centrifugal seeding of fibroblasts 
To seed mucosal fibroblasts into the acellular dermis, a protocol was optimized using a 
centrifugal seeding techni-que and acellular dermis, as described elsewhere (26,27) Pieces 
of 1. 5-cm2 dermis were placed with their basal membrane side down onto 40 mL of DMEM/ 1% 
agarose gel in a 50 mL Falcon tube (BD Biosciences, Alphen aan den Rijn, the Netherlands) at 
room temperature. Next, 1 mL of fibroblast suspension containing 800,000 cells was added. 
Grafts were centrifuged at 200 g for 90 min. 
Culturing mucosal substitutes 
After the fibroblasts were centrifuged into the dermis, pieces were placed with the basal 
membrane side up in 6-well dishes. Grafts were produced in duplicate for 3 separate 
experiments. A stainless steel seeding ring with a 1-cm diameter was placed on the dermis 
and filled with keratinocyte suspension containing 250,000 third-passage keratinocytes in 
seeding medium composed of DMEM/ Ham's F12 (3:1), FBS 1%, cholera toxin 10-10M, hydro-
cortisone 200 ng/mL, insulin 5 IJg/mL, ascorbic acid 50 IJg/mL (Sigma), and penicillin/ 
streptomycin 100 IU/mL/1001Jg/ mL, as described elsewhere (28,29). The next day, 
culture medium was changed to priming medium, which is the same as seeding medium 
but supplemented with bovine serum albumin (BSA) 24 !JM (Sigma), fatty acid cocktail 
(oleic acid 25 !JM, linoleic acid 15 !JM, arachidonic acid 71JM, palmitic acid 25 !JM) (Sigma), 
L-carnitine 10 !JM (Sigma), and L-serine 1 mM (Sigma). Grafts were maintained in this medium 
submerged for an additional 2 days. Next, the grafts were placed on a stainless steel mesh 
in a 6 well dish and were raised to the air-liquid interface for 7 or 14 days. The air-liquid 
interface medium was composed of serum-free priming medium supplemented with 1 ng/ 
mL epidermal growth factor (Sigma). The medium was changed every 2 days. 
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Radiation protocol 
After 13 days at the air-liquid interface, 3 CMSs per group were gamma-irradiated at dosages 
of 0, 2 and 12 Gy. One group received a fractionated dose of 4 Gy by 2 doses of 2 Gy with 
an interval of 24 h. Subsequently, grafts were incubated for 6 hat 37°C, 10% C02• Next, the 
CMSs were harvested and cut in 2 parts for paraffin embedding and cryo-sectioning. 
Morphology and immunohistochemistry 
Harvested CMSs were snap frozen or embedded in paraffin. Paraffin sections (5 ~m) were 
deparaffinized, re-hydrated, and prepared for morphological or immunohistochemical 
analysis. Cryo-sections (6 ~m) were fixed with 2% para-formaldehyde. Next, samples were 
processed for immunohistochemical detection of radiation damage and repair, apoptosis, 
and proliferation. 
Histology 
Hematoxylin and eosin (H&E) staining was performed on the paraffinized sections. 
Visualization of DNA breaks and repair proteins 
DSBs were detected using 53BP1, and repair proteins were detected using antibodies against 
MRE11 and RAD51. After sectioning, cryo-sections were fixed with 2% para-formaldehyde. 
Mesenchymal stem cells were permeabilized with 0.1% Triton X-100 in PBS and washed 
with PBSp(O. 5% BSA and 0.15% glycine) to prevent aspecific binding of the antibodies. The 
following antibodies were used: rabbit anti-human 53BP1 (rabbit polyclonal antibody, Novus 
Bio-logicals, Littleton, CO), rabbit anti-human RAD51 (nr. 2307, rabbit polyclonal antibody) 
(30), rabbit anti-human MRE11 (nr. 2244, rabbit polyclonal antibody) (31 ). Samples were 
incubated for 90 min at 3JOC in a humidified chamber and washed with 0.1% Triton X-100 in 
PBS followed by a quick washing step with PBS. Subsequently, the secondary antibody (Alexa 
Fluor 594, goat a-rabbit immunoglobulin G; Molecular Probes, Inc., Leiden, the Netherlands) 
was applied for 60 min at 37°C in a humidified chamber and washed with 0.1% Triton X-1 00 in 
PBS and PBS. The sections were cover-slipped with 40'6-diamidino-2-phenylindole /DAPCOA/ 
Vectashield and sealed. 
Quantification of radiation damage 
Radiation damage was quantified using morphology and immunohistochemical staining. 
In H&E samples, the percentage of atypical, pyknotic nuclei was quantified in the basal, 
proliferative layer. A nucleus was considered pyknotic when it showed cytoplasmic shrinkage 
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as well as nuclear condensation or fragmentation (figure 1). As for DNA damage and repair 
proteins, the percentage of nuclei with one or more IRIF was calculated in the basal layer. 
The percentage was also determined in the suprabasallayers, where no clear dose response 
was observed (data not shown). Six fields of view were counted per graft at high-power 
magnification (1000x). Triplicate grafts per time point were counted. 
Apoptosis assay 
For detection of apoptotic cells in the CMSs at various radiation doses, a TUNEL assay 
(DeadEnd Colorimetric TUNEL System; Promega, Leiden, the Netherlands) was used as 
described by the manufacturer. After incubation with the DAB substrate, the sections were 
counterstained using hematoxylin. 
Cellproliferation 
For detection of cells in G1, S, G2, or M phase of the cell cycle, Ki-67was used (Dako, Heverlee, 
Belgium). The secondary antibody, biotin-labelled goat anti-mouse immunoglobulins (Dako) 
in secondary buffer (2% normal goat serum (Sanquin Blood bank, Rotterdam, the Netherlands) 
2% human plasma (Sanquin), and 5% BSA (Sigma) in PBS) for 30 min at room temperature. 
Streptavidin-ABC-HRP (Dako) in PBS was used under the same conditions. Next, the substrate 
(1.2 ml 5% DAB (Sigma) with 241-JL of 30% hydrogen peroxide in PBS) was added to the samples 
for 5 min before stopping the reaction using tap water. Counterstaining was performed using 
hematoxylin for 10 s. After drying, the sections were coverslipped using Vectamount (Dako) 
and sealed with nail polish. Mitotic indices were expressed as a percentage of positive basal 
cells per high-magnification field of view. 
Cell counting and statistical analysis 
For analysis of the percentage of basal cells with IRIF, one author counted cells in the basal 
layer of 6 fields of view per graft using 1000x magnification. Cells were considered positive 
when more than 2 IRIF were present. Triplicate grafts per group were quantified. Statistical 
analysis was performed using the Mann-Whitney test. Statistical significance was reached 
if p < 0.05. 
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Figure 1: (A-D) High magnification of hematoxylin and eosin-stained basal epidermal Layers 
revealed the appearance of py-knotic nuclei from the dose of 2 Gy (original magnification 1000x). 
(E) Quantification of the number of pyknotic nuclei per surface area at various radiation doses 
was performed. A dose response was observed. Error bars represent standard errors of the mean 
of 3 grafts per group; approximately 120 cells per graft were counted (* p < 0.05). Color images 
available online at www.Liebert pub.comlten. 
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Results 
Effect and quantification of radiation on epidermal morphology 
Radiation damage in the epidermis was studied invitro using 3D cultures of human oral 
mucosal keratinocytes. To determine the effect of radiation on quality of the epidermis in a 
CMS, H&E staining was performed (figure 2 A-D). The unirradiated samples showed a well-
differentiated, multi-layered epidermis after 14 days of culturing the CMS at the air-liquid 
interface. The epidermis of the CMS resembled the natural mucosal epidermis (32) and 
was well organized into a basal layer and a spinous layer. Upon irradiation, a number of 
changes were observed. Gross morphology did not change significantly at doses of 2 Gy or 
at a fractionated dose of 4Gy administered by 2 times 2 Gy with a 24-h interval (2 + 2 Gy). 
At 12 Gy, however, the epidermis appeared to be severely damaged, resulting in drastic 
changes in morphology. 
H&E 
Figure 2: Hematoxylin and eosin stain of cultured mucosal sub-stitutes at various radiation 
doses. (A) Unirradiated epidermises show differentiated keratinocytes with basal, spinal, and 
granular layers, as can be seen in natural mucosal tissue. (B-D) From an irradiation dose of 2 
Gy, pyknotic nuclei, composed of severely condensed material, appear in the keratinocytes of 
the proliferative basal layer (black arrows). Original magnification 200x, bars re-present 50 um. 
Color images available online at www.liebertpub .com/ten. 
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Next, we examined the effect of radiation on the mor-phology of the CMS in more detail. 
Upon radiation, cells with highly condensed, pyknotic nuclei started to appear in the basal 
and spinous layers of the epidermis (figure 1 A-D). To quantify the effect of radiation in 
CMS, the number of pyknotic cells in the proliferative, basal compartment of the epidermis 
were determined (Figure 1 E) relative to the total cell number per high-power field of view. 
Percentages were dose dependent, rising from 4.4% (±1.1) in the unirradiated group to 
53.5% (±16.5) in the 12 Gy irradiated group. In samples that received 2 + 2 Gy, the number 
of pyknotic cells was 54.8% (±9.1 ). 
TUNEL 
Figure 3: TUNEL stain (right column) TUNEL staining showed that positive cells were most 
prevalent in the basal cells of the epidermis, most conspicuously in the 2 + 2 Gy groups. The 
nuclei staining positive for the apoptosis marker TUNEL were pyknotic (grey arrows). Bars 
represent 50 um. Color images available on-line at www.liebertpub.com/ten. 
To extend observations from morphological changes in-dicative of apoptosis, biochemical 
analysis was performed using TUNEL as a marker (Figure 3 A-D) to visualize whether 
radiation induced apoptosis. TUNEL-positive, apoptotic cells were observed in the basal 
layers, most prominent in the pyknotic nuclei. As was observed in morphology, there was a 
dose-dependent increase in TUNEL-positive cells as radiation doses increased. 
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Figure 4: (A) Radiation damage was detected using an antibody for P53 binding protein 1 (53BP1 ), 
a protein involved in the detection of double-strand breaks (DSBs). Intranuclear radiation induced 
foci (/RtF) for 53BP1 were observed. (B) Quantification of the percentage of cells with IRIF in the 
basal layer showed a response to increasing radiation doses. (C) Radiation damage repair was 
detected in the keratinocytes by staining for MR£11. IRIF for MR£11 were observed most clearly 
in the basal cells. (D) Quantification of number of MR£11-positive nuclei at the basal layer of 
the epidermis shows a response of expression to radiation doses. The number of nuclei with /RtF, 
however, seems to reach a maximum after 2 Gy, as the response flattens out. (E) DSB repair 
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was shown using the RAD51 antibody for homologous recombination. (F) Quantification of the 
percentage of cells showing IRIF for RAD51 showed a maximum in deoxy-ribonucleic acid repair 
in the group receiving 2 doses of 2 Gy. (G) Because homologous recombination only occurs in the 
Late S phase, mitosis indices were measured using Ki-67 staining. (H) Quantification showed an 
up-regulation of mitosis index at a dose of 2 Gy. Overall, however, cell proliferation decreased 
as radiation doses increased. Error bars represent standard errors of the mean of 3 grafts per 
group; approximately 120 cells per graft were counted (*p < 0.05). Color images available online 
at www.Liebertpub.com/ten. 
Quantification of doserelated radiation damage using 53BP1 IRIF 
To develop a model for the quantification of radiation damage, 53BP1 was used as a marker 
for DSBs. 53BP1 is one of the first proteins that can be observed at the site of damage in 
the cascade of DSB repair. Therefore, we used 53BP1 to quantify radiation damage in the 
epidermis. Upon irradiation, 53BP1 was observed as IRIF in the proliferative basal layer 
(Figure 4A) and, less evidently, in the suprabasal cells. Quantification of the percentage of 
basal cells with IRIF showed a response to increasing doses of radiation (Figure 4B). Starting 
at 9.9% (±8.7) in the unirradiated group and increasing to 46.1% (±13.5) in the 2 Gy group 
and 78.9% (±3.5) in the 12 Gy group; 2 + 2 Gy resulted in 38.3% (±7.7), similar to a single 2 Gy 
dose. Quantification of the number of IRIF per nucleus showed a response as well, starting 
from 4. 9% (±3.3) in the control group, 9. 9% (±3.4) in the group receiving 2 Gy, and 11.9% 
(±0.6) in the group receiving 12 Gy. The fractionated-dose group showed an average of 5.7% 
(±2.5) IRIF per positive nucleus, again comparable with that of the group receiving a single 
dose of 2 Gy. Similar responses were observed for the suprabasal layers. These responses 
were less marked than in the pro-liferative basal layer (data not shown). 
Quantification of doserelated radiation damage using MRE11 IRIF 
Next, MRE11 was used to reveal DSB repair in the cell nucleus, and cells with IRIF were 
quantified. In all samples, IRIF were observed in the basal layer (Figure 4C). IRIF were also 
present in the suprabasal layer. The number of IRIF-positive nuclei in the suprabasal layer, 
however, did not change as radiation doses increased (data not shown). Quantification of 
the percentage of cells with IRIF in the basal layer showed a rapid response to increase in 
radiation dose (Figure 4D) between 0 and 2 Gy, starting at 25.7% (±1. 9) in the unirradiated 
group and rising to 63.4 (±1 0.1) and 63.3 (±3.1) for the groups that received 2 Gy and 12 
Gy, respectively. For the group that received 2 + 2 Gy, a percen-tage of 68.6% (±7.5) was 
measured. The response seemed to level off at a dose of 2 Gy. 
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Quantification of dose-related radiation damage using RAD51 IRIF 
RAD51 was used to study IRIF in S and G2 phase when HR is performed. Upon irradiation, 
RAD51 IRIF were observed. No IRIF were formed in the unirradiated samples. 
The IRIF were only present in the proliferative, basal cell layers of the epidermis 
(Figure 4E), with none in the suprabasal levels of the epidermis. Quantification of the 
percentages of cells with IRIF showed a response to increasing doses of radiation (Figure 
4F). In the irradiated groups, the percentage of IRIF nuclei was 14.7% (±1.9) for the group 
that received 2 Gy, rising to 24.1% (±2.0) for the group receiving 12 Gy. The groups receiving 
a fractionated dose of 2 + 2 Gy showed the highest response: 37.3% (±2.8). 
Dose dependent decrease in mitosis 
Ki-67 was used to determine the proliferative activity in the epidermis (Figure 4G). 
Proliferation was observed in the basal layers exclusively. Mitotic indices were calculated. 
Overall, a decrease in the mitotic index was observed as radiation doses increased (Figure 
4H) from 60.6% (±11.2) in the unirradiated group to 26.3% (±7.0) in the group receiving 
12Gy. Remarkable, however, was an increase in mitosis index after 2 Gy radiation to 81.9% 
(±4.5). Apparently, the 2 Gy dose results in enhanced proliferation of the epidermis. 
Discussion 
The goal of the present study was to develop a 3D in vitro model to quantitatively study 
radiation damage in cultured mucosa, using morphology as well as markers for DNA damage 
and repair proteins. 
Changes in cell and tissue morphology occurred as ra-diation doses increased. Cell 
nuclei became small and py-knotic. Close observation of the cell nucleus in our 3D mucosa 
revealed an increase in number of pyknotic nuclei in the basal layer, where the proliferative 
cells reside, as radiation doses increased. TUNEL staining showed these atypical nuclei to be 
apoptotic cells. It is well documented that cells go into apoptosis if the DNA damage is too 
severe, as an escape mechanism for malignant transformation. Moreover, the appearance 
of pyknotic nuclei resembles the morphology of so-called sun burn cells (SBCs), observed 
in ultraviolet-irradiated skin (33,34) and skin substitutes (35-37). SBCs develop as cells are 
damaged by ultraviolet light. Morphologically, y pyknotic nuclei with cytoplasmic shrink-
age, mostly observed in the supra basal and mid epidermal layers, characterize SBCs. In the 
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case of gamma-irradiated mucosal substitutes, these cells appeared in the basal layer as 
well as the suprabasal layers. 
Gamma irradiation results in cell damage. Particularly important are DSBs of DNA. An 
alternative for apoptosis is DNA repair. A number of biochemical markers for DNA damage 
and repair have been developed and are used extensively in cell culture. Moreover, in cell 
culture, intra-nuclear presence of damage and repair proteins was correlated to radiation 
(8,21 ,22). The present study tested 53BP138 for suitability in detecting radiation-induced 
DNA damage in CMS. For visualization of DNA repair, MRE11 and RAD51 were used. All 
antibodies proved to be useful. 
Being visible early in the DNA damage response, 53BP1 was useful for quantification 
of radiation damage. Quantification of IRIF revealed a dose response to increasing doses 
of radiation. After 2 fractions of 2 Gy, similar damage was observed as in the 2 Gy group. 
This might be explained from the results of cell culture studies where the number of cells 
with IRIF decrease to normal levels 12-24 h after irradiation. In addition to 53BP1 H2AX was 
tested as an early marker for DSB. IRIFs were observed in the irradiated tissues. However, 
due to rapid bleaching of the IRIFs, quantification proved to be impossible. 
Subsequent markers in the DNA DSB repair cascade in-clude MRE11 and RAD51. As for 
MRE11, this marker showed an early saturation of the number of nuclei with IRIF, making it 
a less suitable marker for quantification of radiation dose responses. The number of MRE11 
induced IRIF in tissue culture has shown to reach a plateau at 6 Gy (22). The percentage 
of cells with IRIF was similar, 60%, con-curring with the data on 3D cell culture. The 
accumulation of damage-load to its maximum most probably explains the plateau at 2 Gy. 
Quantification of HR using RAD51 showed increasing counts from 2 to 12 Gy. No 
RAD51 IRIF were observed in the unirradiated CMS. Two and 12 Gy showed higher counts of 
positive cells. The group of grafts receiving 2 fractions of 2 Gy showed the highest counts 
of IRIF. Concurring with these data are the data on the mitotic indices. This showed a 
proliferative peak in the group receiving 2 Gy. This peak might be a sign of repopulation, 
as was observed in mouse tongue mucosa (5,39). Upon small doses of radiation, basal stem 
cell keratinocytes start proliferating to repopulate the epidermis. The recruit-ment of cells 
24 h after irradiation from GO to S and G2 concurs with the introduction of HR as a repair 
mechanism of choice. In addition, the RAD51 protein has been shown to remain present for 
up to 24 h. HR repairs damage caused by a second fractional dose of 2 Gy to the cells that 
left GO phase. Repopulation has been studied in the mouse tongue model. Here it was shown 
to start 3 to 7 days after irradiation (40,41 ). We found an increase in proliferative index as 
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soon as 8 h after radiation. This might be a result of symmetrical stem cell proliferation, or 
abortive proliferation by damaged stem cells, in which each damaged cell shows a number 
of abortive di-visions before differentiation and dying (5,42). 
Changes observed in the presented in vitro model resemble changes observed in vivo 
in animals and humans, in which radiation damage also is most prevalent in the basal layers 
of mucosa. Similar morphological cell changes are observed, including nuclear condensation 
and pyknosis (41 ,43). Future projects will include the study of the effect of radiation-
preventive cytokines or strategies (44). Also, more-detailed studies of long-term proliferative 
dynamics, such as cell cycle time, the number of cells in abortive divisions, the number of 
cells in repopulating divisions, and the percentage of surviving cells, are ongoing. 
Conclusion 
The authors conclude that the use of DNA repair markers to quantify radiation damage in 
a 3D invitroculture is feasible. Use of these markers in tissue-engineered constructs might 
lead to further insights in molecular mechan-isms of radiation damage in a 3D organa-typical 
structure. The presented model can be considered to be an important step forward as a 
tool in the study of the development, as well as the treatment or prevention, of mucositis 
in a more quantitative way, proving once more the power and clinical importance of tissue-
engineering techniques. 
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General Discussion 
The aim of this thesis was to develop, improve and test a CMS as a step towards clinical 
application in therapy for head and neck oncological procedures. To take a next step from 
lab bench towards bedside a number of goals were set and addressed in the various chapters 
(table 1 ). 
Table 1: Goals in project Cultured Mucosal Substitutes, from Lab Bench Towards Bedside? 
1. Study the performance of current reconstructive techniques to identify possible issues that can 
be improved and challenges that the CMS will meet upon transplantation. 
2. Choose an optimal isolation protocol 
3. Choose an optimal design of the CMS by choosing a dermal carrier and decide on the cell types 
included 
4. Study behavior CMS to clinically relevant environments in vitro 
-Hypoxia 
- gamma irradiation 
Head and neck cancer is increasingly common and Intra-oral reconstructive procedures 
are performed frequently. As mucosa is scarce, reconstruction of large mucosal defects 
is generally performed using free flaps, composed of keratinizing skin flaps. A number of 
workhorse flaps, including the radial forearm flap are used. Flaps should be thin in the 
anterior part of the mouth in order support mobility of the (remnant of the) tongue for 
important functions such as speech. In the posterior part of the mouth, on the other hand, 
more bulky flaps facilitate swallowing of food and saliva. 
Patients require post-reconstructive radiotherapy in 80% of cases 
The majority of our patients (79. 9%) required post-operative radiotherapy so flaps should 
be well-vascularized to withstand irradiation. Chapter 2 discusses clinical experience 
and quality of life outcomes using the Radial Forearm Flap in intra-oral reconstruction of 
the floor of the mouth. Two groups were described, based on location of the flap either 
in the anterior or posterior part of the oral cavity. Reconstructions, in particular in the 
anterior part of the mouth resulted in 26% of cases in too much bulk which impaired tongue 
function. The combination of skin and irradiation gave additional problems with dry mouth 
and swallowing. 
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Donor site morbidity is a problem. Damage to the superficial radial nerve results in decreased 
sensibility and cold intolerance. Furthermore, wound problems, tendon exposure and an 
unattractive and large donor-site scars can occur in up to 28% of patients (1-4). Improvement 
in functional outcome and reduced donor site morbidity would be expected if resected 
mucosa could be replaced with the same tissue according to the principle "replace like with 
like"(5, 6). Therefore, tissue engineering strategies were explored to assess feasibility in 
reconstructive procedures of large mucosal defects. 
CMS can provide In vitro answers to clinical and experimental questions 
Besides for clinical application, CMS as well as cultured keratinizing skin substitutes have 
become important in vitro models to study highly relevant subjects including carcinogenesis 
and congenital disorders such as Junctional Epidermolysis Bullosa (7,8). Others have 
performed important work studying the effect of various growth factors and other proteins 
using genetically modified keratinocytes(9-11 ). These techniques use human cells and new 
insights are gained, without the use of animals. 
Setting up a CMS production line takes time 
Cultured mucosal substitutes have been developed as described in this thesis. A number of 
problems are recognized in both the production phase and in the transplantation phase. 
Generally, a CMS is fragile. One should consider the production process of a CMS to be like 
a card house. Before one can test clinically relevant questions a large number of conditions 
have to be met (table 2). Cells should be isolated, seeded and grafts should be cultured. 
Problems can occur at every step of the protocol, and contamination is a constant danger. 
Infection in vitro means the CMS is prematurely destroyed, leading to frustration of the 
culturing crew, waste of money and time. Culturing CMS demands a learning period in which 
all these risks are encountered, recognized and dealt with. The first step in setting up a line 
is to test cell isolation protocols. 
Dispase is the enzyme of choice in keratinocyte isolation 
Generally, cell expansion in vitro happens exponentially. The rate at which this happens 
depends on the cell cycle of the cell type of interest. Keratinocytes have a cycle of 
approximately 24 hours. For clinical application, culture time should be reduced. One of the 
first steps to be optimized is the number of cells isolated per biopsy. In order to choose an 
optimal protocol for isolation and expansion in vitro, thermolysin and dispase were tested 
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(chapter 4). These enzymes are routinely used by many well-established laboratories (12). 
The results showed a clear advantage for the use of dispase. First of all, cell yields per 
surface area of biopsy were 3.26 times higher in the dispase treated groups. All of the 
dispase treated biopsies separated completely and at the level of the dermo-epidermal 
junction. Thermolysin on the other hand proved to be unpredictable in its effectiveness for 
two reasons. First, only part of the epidermal layers separated at all following overnight 
incubation. Secondly, epidermises that did separate showed a supra-basal separation level of 
the epidermis and dermis. Analysis of expression levels of differentiation marker CK13 (13) 
in the keratinocytes remaining attached to the dermis upon thermolysin treatment proved 
that remaining keratinocytes were basal cells. Basal keratinocytes are undifferentiated 
epidermal cells with the highest proliferative capacities, also the primary cells responsible 
for successful culturing and cell expansion necessary to be able to proceed to the phase of 
seeding onto a dermal scaffold. 
Table 2: Determinants of successful culturing and clinical application of CMS 
Factors for success 
In vitro Isolation protocol Straight-forward surgical protocol 
Communication between laboratory and surgeon 
Planning of isolation before reconstructive procedure 
Bacterial and fungal contamination rates 
Fibroblast contamination 
Cells/ cm2 biopsy 
% stem cells/ cm2 biopsy 
Costs Culture time 
In Vivo Surgery 
Graft take 
Long term 
- Isolation protocol 
- Technical difficulty protocol 
- % of successfully produced CMS 
- Infection rates 
Communication between laboratory and surgeon 
Logistics, e.g. transportation to OR 
Mechanical properties, handling of CMS for surgeon 
Resistance of CMS to handling by the surgeon 
Straight-forward surgical protocol 
Straight-forward wound protocol for surgical and nursing staff 
Angiogenesis 
Resistance to hypoxia 
Resistance to shearing forces 
Susceptibility to Infection 
Wound contraction 
Resistance to radiation 
Impairment of intra-oral functions such as speech 
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Of the various clinically approved dermal analogues, an a-cellular dermis ensures minimum 
wound contraction and optimal mechanical properties. Furthermore, the vasculature 
can invade into the dermis from the wound bed using the basement membrane proteins 
present in the remaining proteins of basal membranes of the donor vasculature (14-17). A 
problem encountered in our laboratory in producing CMS using conventional methods with 
a-cellularized cadaver skin and cultured keratinocytes without the use of fibroblasts was 
varying quality of the newly formed epidermis. 
Recently, a technique was developed to centrifuge fibroblasts into a-cellular dermis 
(18). In keratinizing skin substitutes, a clear improvement in epidermal morphology and 
a better formation of the DEJ was a result of incorporation of fibroblasts. Moreover, 
fibroblasts made the addition of growth factors, such as Keratinocyte Growth Factor (KGF) 
and Epidermal Growth Factor (EGF) unnecessary (18, 19). It has been shown that addition of 
fibroblasts to constructs enhances angiogenesis in vitro and improves graft survival. These 
results suggest that incorporation of fibroblasts in non-keratinizing mucosal substitutes 
might lead to important improvement of the quality of the cultured mucosa. 
Addition of fibroblasts to CMS enhances morphology and quality of the CMS 
To test this hypothesis, in Chapter 5 human fibroblasts were incorporated into the a-cellular 
dermis of CMS and seeded with human keratinocytes. CMS were stained for H&E for gross 
morphology and differentiation markers B1 integrin, cytokeratin 10 and involucrin after one 
and two weeks in culture. Basement membrane formation was analysed by laminin 5 and 
collagen IV and VII staining, proliferation by Ki-67 staining. 
Addition of fibroblasts to CMS enhances proliferation of keratinocytes and 
reduces culturing time 
Our study showed that fibroblasts incorporated into an a-cellular dermis indeed improves 
epidermal morphogenesis and function. Gross morphology showed a better organized 
epidermis with more cell layers in fibroblast containing dermises. Evaluation of integrin 
subunits 81, a6 and 84 revealed a higher number of basal cells per surface area. This 
was confirmed by Ki-67 staining showing suprabasal proliferation and statistically higher 
prolifation rates, which are advantageous to production, as it reduces culture time. 
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Addition of fibroblasts to CMS enhances maturation of the derma-epidermal 
junction 
Fibroblasts promoted early maturation of the epidermis as well as of the derma-epidermal 
junction (DEJ). The DEJ plays an important role in prevention of separation of the epidermis 
from the dermis. Early ventures using cultured keratinocyte sheeths without dermal 
components in burns surgery showed significant problems of blistering, underscoring the 
importance of adding a dermal component to the construct. Combination of epidermis and 
a dermal analogue in vitro results in the formation of this DEJ. Moreover, in a-cellularized 
dermis, the DEJ proteins responsible for anchoring the epidermis, such as laminin, remain 
present after decellularization. A better DEJ formation by fibroblasts has clinical implications 
as a more mature DEJ might result in a firmer anchoring of the epidermis to the dermis, 
reducing blistering or loss of the epidermis upon transplantation into the mechanically 
challenging oral environment. 
The observed effects on the epidermis by dermal fibroblasts in believed to be of 
paracrine origin. Growth factors, such as KGF, also known as FGF-7, play important roles 
in the development and maturation of an epidermis. Especially of interest is KGF, which is 
secreted only by fibroblasts, while keratinocytes express receptors for this growth factor. 
This means this growth factor is not present in grafts without fibroblasts and are introduced 
into the grafts with fibroblasts by the fibroblasts. Addition of KGF has dramatic consequences 
in vitro as well as in vivo (9,20). These changes are remarkably similar to the observed 
changes by addition of fibroblasts to the dermis. 
Hypoxia occurs in physiological conditions 
Epidermal hypoxia occurs frequently under physiological conditions (21 ). For example, 
wound margins become hypoxic immediately after wounding due to a reduced dermal blood 
supply by intravascular cloth formation (22). Also in bone marrow, progenitor cells are 
physiologically subjected to hypoxic conditions, preserving their undifferentiated status 
(23). In vitro, keratinocytes in the CMS survive on diffusion of oxygen from the air and 
culture media. Upon transplantation oxygen levels are expected to decrease while (semi) 
occlusive dressings render oxygen levels to a minimum. 
The aim of our hypoxic experiment (chapter 6) was to characterize three-dimensional 
cultured mucosal substitutes in hypoxia. It was hypothesized that culturing in hypoxic 
conditions could have a beneficial effect post transplantation due to upregulation of 
angiogenic factors. To test this hypothesis CMS were grown for periods up to 72 hours in 
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2% oxygen and were compared to CMS cultured in ambient oxygen concentrations. It is the 
first report on clinically highly relevant behavior of three-dimensional CMS under hypoxic 
conditions. 
Hypoxia decreases proliferation, delays differentiation in keratinocytes of 
CMS 
Hypoxia altered epidermal morphology, development and function. Architecture of the 
epidermis was disturbed and thickness of the epidermis was reduced as less cell layers 
were formed. This is the result of reduced proliferation, a hypothesis that was confirmed 
by our immunohistological data. Expression of the integrin subunit B1 was reduced while 
differentiation marker K10 was enhanced. Confirming Ki-67 data showed a decrease in 
mitosis indices by hypoxia. Our data on proliferation concur with others in two-dimensional 
cell culture where hypoxia in vitro led to growth arrest of cultured keratinocytes. Moreover, 
some groups have shown this arrest to be temporary and reversible upon re-oxygenation 
(24). 
Hypoxia induces early and transient upregulation of VEGF secretion 
In our three-dimensional model, VEGF secretion was increased in hypoxic cultures and 
reached its maximum after 36 hours in culture. At later time points, VEGF levels remained 
constant while secretion in normoxic grafts seem to increase. This observation is in line with 
data obtained by others on cultured keratinocytes (25-27). 
This study validated the use of CMS under hypoxic conditions as a model for the early 
period post transplantation. Whether these two effects enhance survival by decreasing 
demand for nutrients and oxygen while angiogenesis is enhanced in the wound bed is a 
hypothesis that warrants further research. 
After angiogenesis has occurred and grafts become normoxic by adequate supply 
of blood and oxygen, a new phase starts in the clinically applied CMS, involving post-
reconstructive irradiation. As described in chapter 2, most of the patients receive 
postoperative radiotherapy. 
Typical protocols use doses of 2Gy up to a cumulative dose of 66 or 70Gy. Oral mucositis 
is considered a major side effect and complication in patients receiving radiotherapy for 
head and neck tumors. In addition, mucositis is highly relevant for patients undergoing 
chemotherapy and bone marrow transplantation. Clinical symptoms may vary from a mild 
erythema to severe, extremely painful ulcers in the mouth resulting in malnutrition and 
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placement of a feeding tube (28). Incidences of 60% in patients receiving radiotherapy have 
been reported. For many of these patients it necessitates breaks in therapy for periods up 
to several days or weeks and pain relief using morphine (29). This allows the defects to heal, 
while on the other hand oncological therapy is inevitably compromised due to repopulation 
by tumor cells (30). Also, long term effects of radiation therapy, e.g. osteoradionecrosis, 
mucosal atrophy are related to the severity of the acute radiation response (31 ,32). 
Mucositis is caused by a number of changes induced by radiation in the various 
anatomical layers of mucosa (31-33). One of the causes is radiation damage to keratinocytes 
in normal mucosa as this is one of the only constantly proliferating cell types. Proliferation 
maintains the epidermis as a protective layer. Mucositis still is a clinical diagnosis. No scoring 
systems use histological or molecular markers. To date, no three-dimensional in vitro model 
is described to study radiation induced damage to mucosa. Such a model potentially holds 
a large number of benefits. 
Radiation results in dramatic epidermal changes in CMS 
In Chapter 7, tissue engineering proved to be useful in studying radiation damage. CMS 
were irradiated by gamma radiation at doses of 2Gy, 2x2Gy with a 24 hour interval and 
12Gy. Results showed dramatic changes in cell and tissue morphology increasing at higher 
doses. Cell nuclei became small and picnotic. Also, micronuclei were observed as a sign of 
radiation damage. Next we were able to quantify these changes. 
Morphological changes can be used to study radiation damage quantitatively 
Close observation revealed an increase in number of picnotic nuclei especially in the basal 
layer, where proliferative cells reside. TUNEL staining showed these atypical nuclei to be 
apoptotic. Quantification of these damaged basal cells in H&E processed grafts proved to be 
possible, moreover, a dose-response curve was shown. To confirm our histological data, we 
tested various proteins involved in DNA damage and DNA repair to show and quantify DNA 
damage and DNA repair at various radiation doses. 
CMS can be used to study DNA damage and Repair quantitatively 
Gamma irradiation results in DNA damage. Of the various types of DNA damage, gamma 
irradiation typically results in double-strand DNA breaks (DSB) where both strands of the 
DNA are broken. DNA damage can lead to a number of cellular responses. One of the first 
possibilities is malignant transformation of the cell as its genetic information might be 
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altered. In order to prevent this, apoptosis is an escape mechanism that often occurs if the 
DNA damage is too severe. An alternative for apoptosis is DNA repair. 
A number of biochemical markers for DNA damage, as well as repair have been 
discovered and were tested extensively in cell culture studies (34-36). In Chapter 7 a 
number of markers for both DNA damage as well as for DNA repair were successfully tested 
for the first time in a three-dimensional tissue, the CMS. For quantification of radiation 
damage the early marker 53BP1 was useful in visualizing and quantifying DNA damage. Of 
subsequent markers in the DNA DSB repair cascade RAD51 was most useful for quantification. 
Moreover, dose response curves were seen, validating a model measuring radiation damage 
and potentially measuring the effects various radiation protocols and radiation damage 
preventing agents, such as Vitamin C. 
Radiation induces cell proliferation at a single low dose 
In this study, mitotic indices were determined. Results showed a proliferative peak in the 
group receiving 2Gy, a dose that is typically used in the clinical situation. This peak might be 
a sign of repopulation as was observed in mouse tongue mucosa (32,37). Upon small doses 
of radiation, basal stem cell keratinocytes start proliferating to repopulate the epidermis. 
Repopulation has been studied in the mouse tongue model. Here it was shown to start 3 to 
7 days after irradiation (38,39). We found an increase in proliferative index as soon as 8 hrs 
after radiation. This might be a result of symmetrical stem cell proliferation, or abortive 
proliferation by damaged stem cells, where each damaged cell shows a number of abortive 
divisions prior to differentiation and dying (32,40). 
In vitro histological and proliferative changes upon radiation resemble observed 
changes in vivo 
Changes observed in the presented in vitro model resemble changes observed in vivo in 
both animals and humans where radiation damage is most prevalent in the basal layers of 
mucosa. Similar morphological cell changes are observed including nuclear condensation 
and picnosis (39,41 ). Therefore, the model can be considered to be an important step 
forward as a tool in the study of etiology, as well as treatment or prevention of mucositis, 
proving once more the power and clinical importance of tissue engineering techniques. 
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Where are we now, Future Perspectives 
As can be concluded from this thesis, CMS has earned its place in experimental, in vitro 
studies for various subjects. The strength of three dimensional cultures is the fact that 
they behave largely physiologically, as illustrated by our hypoxia and radiation studies. This 
means that clinically relevant questions can be studied closely in vitro. Other purposes can 
be optimization. How long should we treat grafts using hypoxia or hyperoxic condition prior 
to transplantation? What radiation dose results in most rapid restoration of normal cells in 
CMS and compare this to CMS with tumor cells. Adding other cell types than fibroblasts and 
keratinocytes, such as endothelial cells, mast cells and inflammatory cells to the construct 
will increase physiological relevance of the model. Therefore it can be expected that CMS 
will be used increasingly. 
From Lab Bench to Bedside. There have been people using CMS in clinical applications 
such as intra-oral reconstruction. Especially intra-orally the environment is demanding. 
A number of hurdles remain to be conquered as discussed elsewhere in the thesis and in 
Table 1. 
We do believe the aforementioned experiments put CMS a step closer toward the 
clinic. A robust protocol is developed and more importantly tested in clinically relevant 
conditions. The next step can be studying the performance of CMS in vivo. The question 
remains how CMS responds to large numbers of bacteria, enzymes and constantly moving 
tissues intra-orally. 
A technique to cope with these threads is to use a two-step protocol of transplantation 
using a prelaminated flap. In this protocol the CMS is placed subcutaneously on a fascia, 
such as the radial forearm fascia. Here, vascularisation can take place in the first two weeks 
in a sterile environment with a well vascularized wound bed. Next, the fascia with the graft 
firmly attached and vascularized can be grafted to the intra-oral environment using free 
flap techniques. 
We think our CMS is ready for testing in vivo and opt for the technique described and 
hope the CMS will prove to be an addition to the armamentarium of the reconstructive 
plastic surgeon. 
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Doelen project 
Het doel van deze promotie was het ontwikkelen en testen van een nieuw soort kunst 
slijmvlies (mucosa) voor gebruik bij reconstructieve ingrepen in de mond na bijvoorbeeld 
het verwijderen van een tumor. Dit gekweekte mucosale substituut (CMS) wordt vervaardigd 
van een klein biopt (bijvoorbeeld 1cm2) van niet aangetast slijmvlies. In het labarotorium 
(in vitro) kan deze 1cm2 worden uitgegroeid tot enkele honderden cm2 in het verloop van 
enkele weken. Na deze periode kan men dit lichaamseigen slijmvlies terug transplanteren 
naar de patient. Om dit CMS vanuit het labarotorium lijkt me prima om een stap dichterbij 
te zetten de kliniek te krijgen hebben wij ons tevoren een aantal doelen gesteld (tabel1 ), 
die uit worden gediept in de diverse hoofdstukken van dit proefschrift. 
Tabel 1: Doelstellingen in projekt Cultured Mucosal Substitutes, from Lab Bench Towards 
Bedside? 
1. Bestudering van de kwaliteit van huidige reconstructieve technieken in de hoof·hals oncologie 
- ldentificatie van verbeterpunten 
- ldentificatie van milieufactoren voor het CMS. 
2. Kiezen van het beste isolatieprotocol 
3. Optimalisatie van het antwerp van het CMS door verkiezing van dermal carrier en celtypes. 
4. Bestudering van het gedrag van CMS in klinisch relevante condities in vitro 
- Hypoxie 
- gamma bestraling 
Mond-Keel kanker is veel voorkomend 
Hoofdhals kanker komt steeds meer voor. Reconstructieve procedures na het verwijderen 
van tumoren worden frequent verricht. Bij grate defecten in de mond, bijvoorbeeld na 
verwijdering van een halve tong is er een tekort aan slijmvlies. Het verwijderde slijmvlies 
is dun, plooibaar, vochtig en onbehaard. Grote defecten kunnen over het algemeen niet 
worden gesloten met slijmvlies. In plaats hiervan wordt vaak huid van de arm of het been 
gebruikt waarvan de bloedvaten met behulp van microchirurgische technieken in de hats 
worden aangesloten op locale vaatjes (vrije lap). Eigenschappen van de ideate lap zijn 
afhankelijk van de plaats van het defect. In de voorste mondholte is een dunne lap ideaal, 
met name om de bewegelijkheid van de tong niet te beperken. Achterin de mond is een 
meer volumineuze lap idealer om slikken van speeksel en voedsel te ondersteunen. Over het 
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algemeen kan worden gesteld dan huid van de gebruikelijke tappen stugger is dan mucosa, 
uit verhoornend epitheel bestaat zweetklieren bevat en behaard is. Om de resultaten van 
huidige reconstructieve technieken te bestuderen hebben we allereerst een studie verricht 
bij patienten die reconstructie hebben ondergaan met huid van de arm, de zgn Radial 
Forearm Flap. 
Patienten worden in 80% van de gevallen nabestraald 
Hoofdstuk 2 behandelt de klinische ervaring, resultaten en kwaliteit van leven van het 
gebruik van de Radial Forearm Flap (FRFF) in intra-orale reconstructie. De popultatie (n=72) 
werd onderverdeeld naar locatie van de tumor in voorste mondholte (n=39) en achterste 
mondholte (n=33). De studie liet zien dat, met name in de voorste mondholte, reconstructie 
vaak te volumineus waren en in 39% van de gevallen gepaard gingen met verminderde 
tongfunctie. Daarnaast werd de meerderheid van de mensen (79. 9%) postoperatief bestraald 
hetgeen vaak in een droge mond met slikproblemen resulteerde. 
De FRFF wordt geoogst van de onderarm. Deze zogenaamde donor site kan vervolgens 
problemen (morbiditeit) geven, donor site morbiditeit. Een bekend probleem is beschadiging 
van een gevoelszenuw terplaatse, de onderarm radialis superficialis wat kan leiden tot 
verminderd gevoel in de duimrug, koude intolerantie of neuroomvorming. Andere problemen 
zijn blootliggende pezen en grate littekens op de pols in 28% van de gevallen (1-4). 
Een aantal van deze problemen verwacht men te kunnen verminderen door het 
gebruiik van gekweekt slijmvlies. lmmers, gekweekt slijmvlies verminderd de hoeveelheid 
benodigde huid van de arm. Daarnaast wordt mucosa vervangen door mucosa volgens het 
principe 'replace like with like' (5,6). 
CMS kan in het laboratorium klinische vragen beantwoorden 
Naast ontwikkeling van CMS om in de kliniek te gebruiken is gebleken dat CMS dusdanig 
lijken op echte mucosa in gedrag in vitro dat ze steeds meer worden gebruikt om klinische 
vragen te beantwoorden in het laboratorium zonder dat proefdieren of mensen nodig zijn. 
Voorbeelden hiervan zjin de bestudering van aangeboren afwijkingen zoals epidermolysis 
bullosa waarbij er een aanlegstoornis is van de basaal membraan wat resulteert in ernstige 
blaarvorming. Ander voorbeelden zijn de bestudering van werkingsmechanismen van 
kankerverwekkende stoffen/omstandigheden zoals UV licht (7,8). Veel hedendaagse en 
veelgebruikte kennis omtrent de effecten van groeifactoren is met behulp van gekweekte 
weefsels opgedaan, bijvoorbeeld door gebruik van genetische modificatie van cellen in huid 
en mucosa susbstituten (9-11 ). 
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De opzet van een CMS lijn vergt tijd 
CMS zijn ontwikkeld zoals onder andere beschreven in dit proefschrift. Voor een succesvolle 
en snelle productie zijn een aantal problemen herkend (tabel 2) in zowel de productie als 
de transplantatie fase. Over het algemeen kan gesteld worden dat een CMS buitengewoon 
fragiel is. 
In de opzet van een productielijn zullen al deze problemen voorkomen en het team zal 
hier op gepaste wijze mee om moeten leren gaan. 
Tabel 2: Determinanten kweek en klinische applicatie CMS 
In vitro lsolatie protocol 
(in het lab) 
kosten 
In Vivo Chirurgisch 
Take 
Lange termijn 
Factoren voor succes 
Robuust biopterings protocol 
Goede communicatie chirurg/verpleging met labarotorium 
Periode voor transplantatie moet lang genoeg zijn 
Lage infectie percentages in het lab 
Weinig contaminatie van fibroblasten in keratinocytenkweek 
Hoeveelheid cellen/ cm2 biopsie 
% stam cellen/cm2 biopsy 
Kweektijd 
- lsolatieprotocol 
- Moeilijkheid kweekprotocol 
- Succespercentage kweek CMS 
- lnfectiepercentage 
Communicatie chirurg met labarotorium 
Logistiek (transport lab-OK) 
Mechanische kwaliteit CMS (kan het gehecht worden?) 
Makkelijke applicatie door chirurg 
Robuust wand nabehandelingsprotocol 
Angiogenese 
Bestand tegen hypoxie 
Bestand tegen schuifkrachten 
lnfectiegevoeligheid 
Wondcontractie 
Bestralingsgevoeligheid 
Beperking orale functies zoals spreken en slikken 
In de productie is de eerste stap de eel isolatie uit het biopt. Vervolgens moeten de cellen 
worden gekweekt om daarna te worden gebruikt voor het vervaardigen van kunstmucosa. Op 
elk punt van deze cascade kan iets misgaan en met name infectie met gisten, schimmels en 
bacterien zijn een constante bedreiging. In het geval van infectie wordt alles weggegooid, 
hetgeen leidt tot tijdsverlies, geldverspilling en bovenal frustratie van het team. 
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Dispase is het enzym van keuze voor keratinocyten isolatie 
Cel expansie is een exponentieel proces. De snelheid waarmee dit gebeurt is afhankelijk 
van de celcyclus van het betreffende celtype. Keratinocyten (epitheelcellen) hebben een 
cyclus van ongeveer 24 uur. Zoals in tabel 2 is genoemd is een voorwaarde van klinische 
applicatie van CMS minimalisatie van de kweektijd. Een van meest efficiente en eenvoudige 
wijzen om dit te realiseren is om de hoeveelheid cellen waar je mee start te optimaliseren. 
Hierom werden in hoofdstuk 4 twee veel gebruikte enzymen vergeleken, Thermolysine en 
Dispase (12). 
De resultaten lieten zien dat Dispase te prefereren is boven Thermolysine om een 
aantal redenen. Ten eerste was het aantal gei"soleerde cellen per oppervlakte biopt 3.26 
maal groter. Dispase behandeling liet in alle gevallen een totale separatie van epidermis 
van de dermis zien. Thermolysine resulteerde vaak in incomplete of geen separatie 
van de epidermis van dermis waarmee dit enzym minder betrouwbaar was. De partieel 
gesepareerde epidermissen bleken bij microscopisch onderzoek de basale keratinocyten op 
de dermis te hebben Laten staan. Analyse met immunohistochemische kleuringen (CK13) (13) 
wees uit dat de achterblijvende keratinocyten basale cellen waren met hoge proliferatieve 
capaciteiten. 
Van de diverse dermale substituten die tegenwoordig commercieel verkrijgbaar 
heeft acellulaire dermis als kenmerk minimale wondcontractie in combinatie met goede 
mechanische eigenschappen. Daarnaast kunnen de bloedvaten gebruik maken van de 
resten van basaalmembraaneiwitten om vanuit het wondbed in te groeien(14-17). Een van 
de problemen waar wij mee geconfronteerd werden bij het testen van deze dermis met 
gekweekte keratinocyten was de variabiliteit van de kwaliteit van de CMS. Dit probleem was 
dusdanig ernstig dat wij hebben gezocht naar een oplossing. 
Recent is er een techniek beschreven waarbij voor het kweken van huidsubstituten 
fibroblasten in de dermis gecentrifugeerd werden (18). De resultaten waren een drastische 
verbetering in kwaliteit van de huidsubstituten. Deze verbetering was dusdanig dat zelf 
het gebruik van bepaalde groeifactoren in het medium, zoals Keratinocyten Groei Factor 
(KGF) overbodig bleken te zijn(18, 19). Daarnaast hebben andere groepen Laten zien dat het 
gebruik van fibroblasten de vaatingroei (angiogenese) sterk verbetert na transplantatie van 
huidsubstituten. Aan de hand van deze studies hebben wij gekeken of de toevoeging van 
fibroblasten een gunstig effect zou hebben op de CMS die wij maken. 
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Toevoeging van fibroblasten aan de dermis geeft een sterk verbeterde morfologie 
en kwaliteit van CMS 
In hoofdstuk 5 hebben wij deze hypothese getest. Humane fibroblasten werden toegevoegd 
aan a-cellulaire dermis. Hierop werden vervolgens keratinoycten gezaaid. Histologie en 
immunohistochemie om de differentiatie patronen van de epidermis te bestuderen werd 
verricht. Voor morfologie werd een H8:E kleuring gebruikt. Voor differentiatie patronen 
zijn de markers B1 integrine, cytokeratine 10 and involucrine gebruikt. Vorming van de neo-
basaalmembraan werd bestudeerd met kleuringen voor LaminineV en CollageeniV en VII. 
Cel proliferatie werd aangetoond met een Ki-67 kleuring. 
Fibroblasten stimuleren proliferatie en reduceren productietijd 
Onze studie heeft Laten zien dat toevoeging van fibroblasten aan een a-celluaire 
dermis de epidermale kwaliteit verbeterd. Morfologisch werd een beter georganiseerde 
epidermis gezien met meer cellagen dan de dermis zonder fibroblasten. Evaluatie van 
differentiatiepatronen met de genoemde markers lieten meer basale cellen per oppervlakte 
zien, hetgeen suggereert dater meer proliferatie mogelijkzou kunnen zijn. Hierom werd nog 
een proliferatie studie gedaan met Ki-67. Deze kleuring liet naast suprabasale proliferatie 
meer proliferatie zien, iets wat de kweektijd aanzienlijk kan bekorten. 
Fibroblasten stimuleren de maturatie van de dermo-epidermale hechting 
Toegevoegde fibroblasten zorgden voor een snellere vorming van de epidermis en ook van 
de dermo-epidermale hechting (DEJ). Deze DEJ is de lijmlaag tussen de epidermis en de 
dermis en heeft een belangrijke functie. Een goede DEJ voorkomt scheiding van epidermis 
en dermis (blaarvorming). Deze eigenschap is met name in de mond van belang waar de tong 
en voedsel bijvoorbeeld constant over het slijmvlies schuren. 
Hypoxie is een fysiologisch verschijnsel 
Naast mechanische uitdaginen wacht de CMS in de mond een periode van lage zuurstof-
concentratie (hypoxie). Epidermale hypoxie gebeurt onder fysiologische omstandigheden. 
Na een verwonding worden de wondranden hypoxisch door verminderde doorbloeding van 
de dermis na intravasculaire trombosering (22). lndien de CMS worden getransplanteerd 
naar een wondbed is dus de verwachting dat transplantaten hypoxisch worden, wat nog 
verergerd wordt door het gebruik van (semi) occlusieve wondbedekkers. Over het gedrag 
van CMS in vitro onder hypoxische omstandigheden is nog weinig bekend. 
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Dit was de reden om in hoofdstuk 6 ons CMS in een hypoxische milieu te bestuderen. 
Naast observatie was er een hypothese dat hypoxische preconditionering het succes van 
transplantatie zou kunnen verbeteren doordat hypoxie secretie van angiogenetische 
groeifactoren stimuleert. De CMS werden tot 72 uur in 21% zuurstof gekweekt en vervolgens 
vergeleken met een controle groep van CMS die in kamerlucht gekweekt waren. 
Hypoxie verminderd proliferatie en vertraagt differentiate in CMS 
Hypoxie veranderde ontwikkeling, morfologie en functionaliteit van de epidermis. De 
verdeling van verschillende epidermale lagen werd verstoord en er werden minder lagen 
aangelegd. Dit bleek het resultaat van verminderde proliferatie zoals aangetoond met 
immunohistochemische kleuringen. 
Differentiatiemarker K10 kwam meer tot expressie terwijl de marker voor basaal 
cellen, het B1 integrine, minder tot expressie kwam. Analyse van mitose indices met behulp 
van proliferatie marker Ki-67 bevestigde dat proliferatie minder werd onder hypoxie. 
Hypoxie geeft een voorbijgaande toename van VEGF secretie 
VEGF productie in ons drie-dimensionale model werd gestimuleerd door hypoxie en was 
maximaal na 36 uur. Na 36 uur bleef de concentratie constant en bleek de concentratie 
VEGF in normale kweek condities te stijgen. 
Deze studie demonstreerde dat CMS voor bepaalde vraagstellingen gebruikt kunnen 
worden. Of VEGF stimulatie en verminderde celdeling overleving verbeteren en angiogenese 
stimuleren is iets wat uiteindelijk toch in vivo zal worden getest. 
Na volledige take van de CMS met adequate doorbloeding in vivo breekt een volgende 
fase aan waarin, zoals in hoofdstuk 2 beschreven bestraling een grate rol speelt. De meeste 
bestralingsprotocollen gebruiken dagelijkse doses van 2Gy tot een totaal van 66 of 70Gy. 
Naast beschadiging van kwaadaardig weefsel geeft bestraling als neveneffect schade aan 
gezond slijmvlies. Deze beschadiging wordt ook wet mucositis genoemd en komt ook veel 
bij mensen voor die met chemotherapeutica worden behandeld. lncidenties tot 60% zijn 
beschreven voor radiotherapie (29). Het beeld gaat gepaard met blaarvorming, ulceratie en 
is extreem pijnlijk. Vaak is het zo pijnlijk dat de therapie noodgedwongen wordt onderbroken 
voor klinsche pijnstilling en voeding met een voedingssonde (28) tot genezing van de ulcera. 
Gedurende deze pauzes kunnen naast normale cellen kwaadaardige cellen zich herstellen, 
hetgeen niet wenselijk is (30). 
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Bovenop korte termijn complicaties bestaan er lange termijn complicaties van bestraling 
zoals osteoradionecrosis, een soort verlittekening van de (neo)onder kaak gepaard gaand 
met pijn en fisteling en breuken in het bot. Ontstaan van lange termijn complicaties is 
gerelateerd aan het optreden van korte termijn complicaties (31 ,32). 
Mucositis ontstaat door beschadiging van verschillende lagen in de mucosa(31-33). Met 
name cellen die actief aan het delen zjn zijn gevoelig voor straling en chemotherapie. Een 
van de meest gevoelige celtypen is de keratinocyt in de epidermis omdat deze constant aan 
het delen is. 
Tot op vandaag is mucositis een klinische diagnose. Er bestaan geen histologische of 
moleculaire markers die worden gebruikt voor klinische kwantificatie van schade. Daarnaast 
bestaat er geen drie-dimensinaal model om bestralingsgerelateerde schade te bestuderen. 
Hierom hebben we ons CMS model bestraald om bestralingsschade te bestuderen. 
Bestraling resulteert in forse epidermale veranderingen van het CMS 
Het doel van hoofdstuk 7, was het bestuderen van veranderingen in CMS na bestaling. 
Daarnaast hadden we als hypothese dat we DNA schade en reparatiemechanismen en 
kleuringen konden gebruiken om schade te kwantificeren. Hiertoe werden CMS bestraald 
met verschillende doses. Bestraling leidde tot grote morfologische veranderingen. Celkernen 
werden klein en picnotisch. Er ontstonden micronuclei als teken van stralingsschade. De 
veranderingen leken toe te nemen met toenemende doses bestraling. 
Morfologie kan worden gebruikt om stralingsschade te kwantificeren 
Kwantificatie bleek mogelijk. Bij bepaling van het percentage picnotische cellen in de basale 
(proliferatieve) laag van de epidermis bleek dat dit percentage hoger werd naarmate het 
CMS aan meer straling was blootgesteld. Om deze picnotische cellen nader te karakteriseren 
is er een apoptose (= geprogrammeerde celdood) kleuring gedaan met een zgn TUNEL assay. 
De picnotische cellen bleken apoptotische cellen te zijn. Naast morfologische veranderingen 
hebben wij ook geprobeerd met kleuringen voor eiwitten betrokken bij de detectie en het 
herstel van DNA schade bestralingsschade in drie-dimensionale weefsels aan te tonen en te 
kwantificeren. 
Met CMS kun je DNA schade en reparative kwantitaief bestuderen 
Bestraling is schadelijk op een aantal manieren. Een van de manieren is dat het schadelijk is 
voor DNA. Bestraling geeft in DNAzogenaamde 'Double Strand' breuken (DSB). Dit betekend 
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dat beide strengen DNA gebroken zijn. Er zijn een aantal mechanismen beschreven hoe de 
eel met deze schade om kan gaan. In het kort kan hij afsterven (apoptose), of hij kan na 
detectie van de schade deze repareren. 
In deze detectie-reparatie cascade is een aantal markers beschreven die uitgebreid 
in celkweek zijn getest (34-36). Hoofdstuk 7 beschrijft het aantonen van deze eiwitten in 
drie-dimensionale kweek. Bovendien was met name 53BP1, een vroege detectiemarker, 
succesvol in kwantificatie van stralingsschade. Van de markers van DSB reparatie bleek 
rad51 zeer bruikbaar. Van de eiwitten werd een dosis-respons curve aangetoond. Dit is 
met name belangrijk en bruikbaar voor het testen van bestralingsschade beschermende 
protocollen en stoffen zoals vitamine C. 
In vitro histologische en functionele veranderingen komen overeen met de 
veranderingen die in vivo worden gezien 
Histologische verandering in CMS na bestraling waren vergelijkbaar met veranderingen in 
vivo. Ook in vivo worden met name veranderingen in de basale, proliferatieve laag van de 
epidermis gezien. Voorbeelden zijn picnotische kernen en het ontstaan van micronuclei, 
zoals deze ook in de CMS onstaan (39,41 ). Opnieuw is dit een blijk van het feit dat de CMS 
zich gedraagt als echte mucosa. 
Het heden en de toekomst 
Een van de conclusies van dit proefschrift is dat het CMS zijn plek heeft gevonden in 
experimentele, in vitro studies, en dat deze rol zich verder zal ontwikkelen. De kracht van 
een drie-dimensionaal model als het CMS is zijn fysiologische gedrag, zoals geillustreerd 
door onze hypoxie en bestralingsstudies. Met name dit gedrag maakt het dat het zich goed 
leent voor beantwoording van klinisch relevante vraagstellingen en optimalisatie studies. 
Hoe lang kan een CMS overleven in hypoxie? Welke doses bestraling zijn optimaal voor 
overleving, eventueel vergeleken met CMS vervaardigd van tumorcellen. Toevoeging van 
andere celtypes zoals endotheel en onstekingscellen zal de klinische relevantie in de 
toekomst verder doen toenemen. Een ander belangrijke reden waarom dit soort modellen 
toenemend zullen worden gebruikt is de reductie van het aantal proefdieren. Een groot 
aantal vragen kan worden beantwoord met een veellager aantal of zonder proefdieren. 
From Lab Bench towards Bedside, van laboratoriumtafel op weg naar het ziekenbed; 
we zijn er nog niet. Er zijn mensen die CMS klinisch hebben gebruikt. Wij hebben aan een 
aantal vereisten voor succesvolle klinische implementatie voldaan, maar in onze ogen blijft 
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er echter een aantal drempels over (tabel 2). De resultaten van dit proefschrift hebben de 
CMS een stap dichter bij het ziekenbed gebracht. Er is een robuust kweekprotocol, er is een 
CMS en het CMS is in klinisch zeer relevante tests goed uitgekomen. De volgende stap zal 
dan oak de stap naar het proefdier en vervolgens de kliniek moeten zijn. Alteen dan kun je 
uitvinden hoe het CMS presteert in de moeilijke orale omgeving val bacterien en enzymen. 
Een van de transplantatie protocollen waar wij aan denken is het gebruik van een 
tweestappen plan met een geprelamineerde lap. Hierbij wordt het CMS eerst subcutaan op 
de onderarmsfascie (radial forearm fascie) geplaatst. Vervolgens kan het CMS twee weken 
ingroeien waarna het op de fascie gevasculariseerd, als vrije lap, naar de mondholte kan 
worden verplaatst. 
Wij denken dat ons construct klaar is voor het testen in vivo en zullen bovenstaande 
techniek dan oak testen op zijn bruikbaarheid. Wij denken dat de CMS in de toekomst 
naast een plek in het laboratorium een toevoeging zal worden aan het gereedschap van de 
reconstructief chirurg. 
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